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 1 General Introduction 
  
 1.1 Introduction 
Pressure ulcers (PUs) are a common and highly relevant nursing care issue in 
hospitals. They are associated with psychological and physical suffering, 
increased morbidity and mortality rate and higher costs for health care worldwide 
(Baharestani, Black, Carville, et al., 2009a, Gorecki, Brown, Nelson, et al., 2009, 
Allman, Laperde, Noel, et al., 1999; Anthony, Reynolds & Russell, 2004).  
PU development can be attributed to multiple factors that are fairly well-studied in 
adults and elderly people (Whittington & Briones, 2004, Horn, Bender, Ferguson, 
et al., 2004, de Laat, Schoonhoven, Pickkers, et al., 2006, Baharestani et al., 
2009a). Through large-scale, nationwide epidemiological studies, the prevalence 
of PUs in nursing care institutions for adults is now known and well documented. It 
varies from 4% to 49% in intensive care patients (Shahin, Dassen & Halfens, 
2008), from 6% to 13% in hospitals and from 4% to 12% in nursing homes 
(Kottner, Wilborn, Dassen, et al., 2009).  
While the problem of PUs in adults has received a great deal of attention, far less 
is known about PUs in children and neonates (Baharestani and Pope, 2007). 
Recent studies have indicated that PUs are also common in the pediatric 
population, and in the last ten years greater attention has been paid to this 
problem. There is greater awareness that pediatric patients in certain health care 
settings are also at high risk of developing PUs (Kottner, Wilborn & Dassen, 2010; 
Noonan, Quigley & Curley, 2011). Prevalence rates for PUs in hospitalized 
pediatric patients range from 3% to 28% (Kottner et al., 2010). Two cases of 
pediatric patients are presented in box 1.   
 
  
 Box 1 
Case of Alina  
Alina was born after 33 weeks of gestation. Two hours after birth her 
condition changed to critical due to insufficient breathing. It was unclear if 
this was due to her preterm birth or to other influences, and she was 
intubated and transferred to a neonatal intensive care unit (NICU). After 
admission to the NICU a Relaxatio diaphragmatica was diagnosed, this 
necessitated a thoracotomy and tightening of the diaphragm within the first 
36 hours of Alina’s life. About 72 hours after first nasal intubation to support 
the mechanical ventilation, Alina’s condition was stable. The fixation of the 
nasal tube was routinely checked and refixed. At this point a severe skin 
breakdown on her nose, diagnosed as a category 3 PU, was assessed. The 
tube was fixed without pressure or shear to the alinasal or nasal septum, 
providing the greatest possible relief from the tube. The PU demarcated 
within the following two days. After extubation, the PU was treated three 
times a day with pure hydrogel without any secondary dressing. This made 
it possible to assess any changes in the skin immediately; further, the 
hydrogel provided the necessary fluid to the intact skin and protected the 
skin breakdown with a thin layer. Ten days after the first diagnosis of the 
category 3 PU, part of the necrosis peeled off, followed by a total peeling of 
the necrotic skin at day 20 of Alina’s life. After discharge at the age of 28 
days, a slightly visible already light and elastic scar could be seen. At the 
age of six months no visible scar could be seen on Alina’s nose and she 
had no further limitations due to breathing. This case presents a typical 
localization of a PU in a pre-term neonate as well as effective wound 
therapy with unusual but positive effects, meeting the special needs of 
these vulnerable patients. Not only could Alina’s skin be kept intact, but also 
the requirements of treating the category 3 PU could be met, and Alina was 
not affected by any unnecessary substances from wound dressings.  
 Case of Eric 
Eric was 10 years old when, suffering from fulminating septicaemia, he was 
in very critical condition. He was mechanically ventilated and treated with 
extracorporeal membrane oxygenation (ECMO) due to insufficient cardiac 
function for 10 days. He lay on a polyurethane foam mattress, but due to his 
unstable and critical condition, no regular position changes could be carried 
out. When ECMO was turned off at day 15 after hospital admission, several 
occipital PUs were diagnosed. Four of them were necrotic and diagnosed 
as category 3 PUs, two of them as category 2 and one as a category 1 PU. 
No active treatment for any of these PUs were performed, although they 
were carefully assessed for any changes or signs of infection. Four weeks 
after first diagnosis the largest PU presented as a 4x3 cm necrosis, which 
peeled off and presented as granulation tissue. Due to Eric’s on-going 
dialysis at this time and continuous high-dose immunization, wound healing 
was delayed. In consideration of all these factors an appropriate wound 
treatment was chosen and was changed twice a week. After another four 
weeks the wound completely healed with alopecia the size of a one-euro 
coin. Neither Eric nor his family were affected by the scarring at the time, 
and they were informed that a surgical intervention could be performed at a 
later point. 
 
  
Figure 1: Alina’s PU on day 10 
 
 
Figure 2: One of Eric’s PUs 2 months after admission to the Pediatric Intensive Care Unit  
 
 In this dissertation the relevance and prevalence of PUs in pediatric patients was 
explored.  
In this introduction, the definition and etiology of PUs is first explained. In the 
second part an overview of the characteristics of pediatric patients with regard to 
the problem of PUs is presented. Then, the specific aims of this dissertation as 
well as the related research questions are introduced. Finally, a short overview of 
the topic and content of each chapter is given and the introduction ends with the 
ethical considerations of the studies conducted.  
1.2 Theoretical framework 
1.2.1 Definition and etiology of PUs 
A PU is a localized injury to the skin and/or underlying tissue as a result of 
pressure, or pressure in combination with shear forces. (National Pressure Ulcer 
Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP), 
2009). According to the guidelines of NPUAP and EPUAP, PUs are differentiated 
into four different categories, with category one being the least severe, and 
defined as “intact skin with non-blanchable redness of a localized area usually 
over a bony prominence” and category four the worst, being defined as “full 
thickness tissue loss with exposed bone, tendon or muscle” (EPUAP/NPUAP, 
2009). These EPUAP/NPUAP categories are also used frequently in pediatric 
settings (Kottner et al., 2010; Baharestani & Ratliff, 2007, Curley, Quigley & Lin 
2003a). According to Defloor (1999) pressure and shearing force are the main 
reasons for pressure ulcer development; pressure and/or shearing force is/are 
needed to cause a PU. The tissue tolerance of a person is an intermediate 
variable and not a causal factor in the development of PUs. How high the pressure 
must be and how long it must be maintained to cause skin damage depends on 
the individual’s tissue tolerance (Defloor, 1999). “The tissue tolerance of an 
individual is influenced by two major components – the tissue tolerance for 
pressure, meaning the capacity of the tissue to redistribute pressure – and the 
tissue tolerance for oxygen, meaning factors that influence oxygen distribution 
 within the tissue and the oxygen need of the tissue” (Defloor, 1999, p. 211). Tissue 
mass, patient age, nutritional status and dehydration, medications and mental and 
physical condition of the patient, body temperature and co-morbidity are relevant 
determinants which influence tissue tolerance (Defloor, 1999; Nixon, Cranny & 
Bond, 2007; Quintavalle, Lyder, Mertz ,et al., 2006; Kottner, 2012).  
To what extent these PU etiologies are true for pediatric patients and whether 
there are any differences in classifying PUs in pediatric patients according to adult 
categories has not been studied so far and is thus unknown.  
1.2.2 The pediatric patient 
“The United Nations Convention on the Rights of the Child defines a child as “a 
human being below the age of 18 years”. Within this time period one distinguishes 
between neonate, infants, toddlers, preschool child, school child and adolescent 
(Unicef, 2003).  
A neonate is defined as a child from birth up until its first 28 days of life. This 
includes preterm neonates, which means neonates born before 40 weeks of 
gestational age. In preterm neonates one distinguishes further between very low 
term neonates, which includes neonates between 24 and 31 (full) weeks of 
gestational age and low term neonates, which means neonates born from 32 
weeks of gestational age until 36 weeks of gestational age. Children born after 37 
weeks of gestational age are categorized as term-born neonates. A newborn is a 
neonate within his first hours of life. An infant is a child in the time period from the 
age of 4 weeks up to its first birthday, followed by toddlers, which are children from 
the age of 1 up to their third birthday. A preschool child is between 3 and 5 years 
old, a school child between 6 and 12 years of age; adolescence covers the time 
from 12 up to the 18th birthday (American Academy of Pediatrics, 2002, World 
Health Organization, 2005).  
It should be kept in mind that pediatric patients, in comparison to adults, are in 
widely differing health conditions. The overall health status of children is generally 
better and multi-morbidity is limited to a small percentage of patients, like very low 
term neonates (born before 32 weeks of gestation age), newborns with congenital 
 abnormalities or children with chronic conditions. Survival rates of both critically 
and chronically ill neonates, infants and children have improved dramatically in 
recent years, introducing new challenges for medical and nursing care (Jones et 
al., 2001).  
1.2.3 The skin of pediatric patients  
Children’s skin undergoes several changes throughout the first 18 years of life 
(Butler 2007). The most important function of the skin is to protect against water 
loss, absorptions of noxious substances, intrusions of microorganisms and 
physical trauma (Blume-Peytavi, Hauser, Stamatas, et al., 2011). The skin of 
children is morphologically and functionally different from adult skin (Blume-
Peytavi et al., 2011, Nikolovski, Stamatas, Kollias, et al., 2008, Stamatas, 
Nikolovski, Luedtke et al., 2010). Within the first days of life neonates undergo 
various adaptation processes needed to accommodate the transition from the wet 
intrauterine environment to the dry outside environment (Blume-Peytavi et al., 
2011). During the first months and years the skin continues to develop and evolve 
its structure and functions (Blume-Peytavi et al., 2011; Butler, 2007) (Figure 3 & 
4).  
 
Figure 3: Histology of skin of a newborn 
 
Figure 4: Histology of skin of a child  
 The unique physiological needs of children with regard to skin first require some 
explanation. Physiologically, fluid and electrolyte disturbances occur more 
frequently and develop more rapidly in infants and young children than in older 
children and adults. The higher proportion of water content and greater relative 
surface area of young bodies increases the risk of dehydration under the 
metabolic demands associated with fever. Skin cells that are not well perfused 
may be hypoxic and are at risk of breaking down even with minimal trauma (Rossi, 
1989).  
It is known that any skin breakdown, especially in critically ill neonates and infants, 
increases the risk of septicemia as well as related severe complications and higher 
mortality (Dellinger, Mitschell, Rhodes et al., 2013). Pressure ulcers also cause an 
increase in pain, infection and calorie expenditure in pediatric patients (Curley et 
al. 2003a, Zollo, Gastisha, Bernes et al. 1996, Samaniego 2003, Cockett, 2001) 
and therefore it is of great importance to avoid any damage to the fragile skin of 
pediatric patients.   
1.2.4 Specific PU risk factors and PU risk assessments for children 
Potential risk factors for PUs are immobility and decreased skin sensitivity 
(Suddaby, Barnett & Facteau, 2005, Willock, Harris, Harrison, et al. 2005, Willock 
2005). These are well known risk factors for adult patients (de Laat et al., 2006; 
Lindgren, Unosson, Krantz, et al., 2004; Moore & Cowman, 2008; Nonnemacher, 
Stausberg, Bartoszek, et al., 2009; Papanikolaou, Lyne & Ratcliffe, 2007) with 
some evidence that in pediatric patients these risk factors increase the risk of 
pressure ulcer development as well (Suddaby et al. 2005, Willock et al. 2005, 
Willock 2005). With regard to the pediatric patient, sick children in general, but 
also due to limited communication skills, neonates, infants and toddlers, disabled 
and neurologically impaired children, seem to be at particular risk of developing 
pressure ulcers (Willock, 2005; Willock and Maylor, 2004; Curley et al. 2003a, 
Zollo et al. 1996). 
Further, several risk factors with regard to external devices are known for pediatric 
patients. The consequences of immobility and decreased skin sensitivity and risk 
factors related to equipment such as tubes, IV catheterization and CPAP have 
 been described (Willock, 2005; Willock and Maylor, 2004; Curley et al., 2003). 
Especially patients in pediatric intensive care units (PICU) are at increased risk for 
skin failure. Here the pressure of tubes in oscillation and extracorporeal membrane 
oxygenation as well as the decreased tissue tolerance in these patients due to 
their critical condition makes these children most vulnerable (Schindler et al., 
2007; Curley et al., 2003a).  
Furthermore, the need for additional medical and therapeutic aids, such as 
wheelchairs, unadjusted ortheses and prostheses (Noonan, Quigley, Curley, 2006, 
Dixon and Ratliff, 2005, Samaniego 2003, Cockett, 2001) are known risk factors 
for pressure ulcer development in children.   
A problem limited to neonates is their immature skin with regard to the friable skin 
and circulatory system, which leads to extravasation, or skin failure due to 
strapping or tubing or monitoring sensors (Waterlow, 1997, Parnham, 2012).  
Despite the known risk factors, a reliable and valid PU risk assessment tool with 
validated cut-off points, applicable to a wide range of the juvenile population from 
neonates to adolescents, is still not available (Anthony, Willock & Baharestani, 
2010). Avoidance of pressure-related injuries and maintenance of skin and tissue 
integrity are obviously regarded as important goals in the care process, and 
identifying individuals at risk for developing PUs by structured risk assessments is 
recommended as a first step for effective PU prevention (Duncan, 2007; 
Stechmiller et al., 2008). In the published international guidelines by the NPUAP 
and the EPUAP (2009) it is explicitly stated that “Risk assessment scales are the 
foundation of risk assessment practice.” (p. 24). Over the last five decades more 
than 30 standardized PU risk scales for adults have been developed, tested and 
modified. The structure of most of these instruments is comparable: they include a 
number of items that are deemed important in PU development, like "Mobility", 
"Continence", "Nutrition" and many more (Bergstrom, Braden, Laguzza, et al., 
1987; Waterlow, 1985). Item scores are summed resulting in total scores 
indicating individual risk. To be useful in clinical practice, PU risk assessment 
scales must be valid and reliable, they should demonstrate an enhanced quality of 
care, and they must improve patient outcomes. Above all, application of PU risk 
assessment scales should reduce PU occurrence (Jull and Griffiths, 2010; Kottner 
and Balzer, 2010). There are various systematic reviews addressing validity, 
 reliability and clinical impact issues of PU risk scales in the adult population 
(Pancorbo-Hidalgo, Garcia-Fernandez, Lopez-Medina, et al., 2006; Moore and 
Cowman, 2008; Kottner et al., 2009), but there is no up to date systematic 
synthesis of empirical evidence about PU risk scales in children. This is a serious 
limitation since PU risk assessment using an age-appropriate, valid and reliable 
instrument is also recommended for clinical pediatric practice (Loman 2000; 
Baharestani and Pope, 2007). 
Many of the available assessment tools, like the Braden-Q scale, are modifications 
of PU risk scales for adults and include variables deemed especially important for 
PU development in the adult population, e.g. mobility, incontinence, moisture, and 
nutrition. The relevance and clinical effectiveness of specifically pediatric PU risk 
scales has not so far been investigated. 
1.2.5 PU Preventive measures for pediatric patients 
Pressure ulcer prevention is multifaceted and requires skills, knowledge and 
consistency in nursing practice. Risk assessment, skin assessment, repositioning 
and pressure relief are integral components of effective prevention of PUs in 
children (Parnham, 2012). The preventive measures taken for children are often 
those recommended for adult patients (Waterlow, 1997). Baharestani and Ratliff 
(2007) have highlighted the importance of specific age-related preventive 
strategies. Preventive measures should meet the individual needs of each child 
and therefore, with regard to preventive measures, special attention must be paid 
to neonates and infants (Waterlow, 1997).  
Various preventive measures based on the clinical experience of nursing experts 
in the care of children are known and used. However, no research based 
preventive measures with regard to special pediatric needs have been 
established. The preventive measures described for children are skin care, 
pressure-relieving facilities (sheep skin, silk sheets and gel or water pillows for 
neonates; special pressure-relieving mattresses for older children (Waterlow, 
1997), and regular turning of the child/neonate (Waterlow, 1997). With regard to 
neonates it seems most important to meet the baby’s need with regard to its 
immature skin (Waterlow, 1997). Timely skin assessment is recommended but no 
 frequency is described (Collier, 1999); such assessment includes examining the 
skin for evidence of new damage (Collier, 1999).  
Repositioning should be performed regularly in immobile patients and should pay 
special attention to the relevant anatomical localizations in children, which are the 
occipital, sacral, and calcaneal areas (Butler, 2007, Parnham, 2012). 
Repositioning is not recommended for hemodynamically unstable patients (Butler, 
2007). Next to manual repositioning, therapeutic pressure-relieving surfaces may 
also be required (Parnham, 2012). The range of available support surfaces for 
children is limited (Parnham, 2012). Foam mattresses aim to redistribute body 
weight and the movement of a child is only slightly limited (Parnham, 2012). 
Alternating air systems often do not fit well in children. The active and 
spontaneous movement of a child is limited in an alternating air system mattress 
and the lower weight or size of a child will increase the risk that a child lays 
between the effective parts of such devices (Parnham, 2012). The cells of such 
matrasses, which are fitted for adults, are described as being too large for 
children, and pediatric-specific mattress systems are not very common (Law, 
2002).  
Many PUs in neonates and children develop along medical devices (Curley et al., 
2003a; Willock et al., 2005, Parnham, 2012). No specific preventive measures with 
regard to this fact are available today.  
1.2.6 PU treatment 
Epidemiological studies and empirical evidence report that the most common 
wound types in pediatric patients include epidermal stripping, extravasation 
injuries, surgical wounds, incontinence associated dermatitis, chemical and 
thermal injuries, wounds secondary to congenital abnormalities and pressure 
ulcers (Baharestani and Ratcliff, 2007, Baharestani, Amjad, Bookout, et al. 2009b). 
Wound care in pediatric patients needs to take account of several relevant 
differences from care in adult patients (Baharestani et al., 2009b; Baharestani, 
2007; Gabriel, Heinrich, Shores, et al., 2009, Stone McCord and Levy, 2006, 
Singh, Scott, Bartlett, et al., 2002).  
 There are a number of guidelines for wound treatment in adult patients regarding 
both the treatment of PUs as well as wounds in general (Fan et al., 2010, 
Goldberg and Diegelmann, 2012, Adams et al., 2012, Moreira and Markovchick, 
2012, Henzel et al., 2011, Warriner and Carter, 2010, McGinnies and Stubbs, 
2011, McInnes et al., 2011, NPUAP/EPUAP, 2009). No specific guideline for 
wound treatment in pediatric pressure ulcer wounds is available today. Up until 
now, there has been a lack of knowledge and research to guide clinical practice in 
the field of treatment of PUs in pediatric patients (Baharestani et al., 2009b, Stone 
McCord, 2006, Butler, 2007, Cisler-Cahill, 2006).  
1.3 Scope, aim and research questions of thesis 
As has been demonstrated above, there is a considerable lack of knowledge with 
regard to the problem of pressure ulcers in pediatric patients. First, the prevalence 
of pressure ulcer in pediatric patients in terms of different age groups or different 
pediatric care settings (e.g. the PICU) is unknown. In addition, it remains unclear 
what the major risk factors are for pressure ulcer development in pediatric 
patients. Furthermore, it is in fact generally unclear which preventive measures are 
carried out in pediatric patients with regard to pressure ulcer risk and what their 
effect is in clinical practice. Also, we do not know which risk assessment scales 
are valid and reliable for pediatric patients and there is still a lack of knowledge 
and research to guide clinical practice in the field of treatment of PUs in pediatric 
patients.  
The aims of this thesis are therefore to obtain more information about the 
prevalence, potential risk factors, and specific infant populations at risk for PUs 
and also about appropriate PU risk assessment tools for the pediatric health care 
setting. Finally, we also want to explore the prevention and treatment of pressure 
ulcers in pediatric patients.  
  
 The specific aims of this thesis are:  
First, to conduct a pilot study and according to the results to assess the pressure 
ulcer prevalence on a nationwide level in pediatric hospitals in Switzerland, 
answering the following research questions:  
(1) What is the prevalence of pressure ulcers in pediatric care settings in 
Switzerland? 
(2) What is the prevalence of pressure ulcers in different age groups?  
(3) Which factors influence the occurrence of pressure ulcers? 
(4) And what are the characteristics of PU patients? 
Second, to systematically review empirical evidence about validity, reliability and 
clinical impact of PU risk assessment scales for children, answering the following 
research questions:  
(1) What PU risk scales for children currently exist? 
(2) What is the diagnostic accuracy of their scores? 
(3) Are the scores reliable and what is the degree of agreement? 
(4) What is the clinical impact of risk scale scores in pediatric practice? 
Third, to identify factors associated with the occurrence of pressure ulcers in 
hospitalized pediatric patients between one and 18 years of age. Furthermore, to 
identify anatomical regions associated with the highest risk of pressure ulcer 
occurrence and to identify risk factors of PUs in hospitalized pediatric patients 
older than one year of age (>1year). 
(1) What factors are associated with the occurrence of pressure ulcers in 
hospitalized pediatric patients between 1 and 18 years of age? 
(2) Which anatomical regions are associated with the highest risk of pressure 
ulcer occurrence? 
(3) What are risk factors for PUs in hospitalized pediatric patients 1-18 years of 
age? 
  
 Fourth, to assess prevalence, severity and localizations, but also risk factors and 
preventive measures taken in hospitalized neonates and infants in different care 
settings according to PU occurrence using the following research questions:  
(1) What is the prevalence and severity of PUs in hospitalized neonates and 
infants in different pediatric hospital departments? 
(2) What are the most frequent localizations where pressure ulcers occur? 
(3) What are the risk factors of neonates and infants with PUs? 
(4) Which preventive measures against PUs were taken in these patients? 
Fifth, to assess PU treatment in Swiss hospitalized pediatric patients, and to 
determine whether there are differences in pressure ulcer treatment according to 
demographic characteristics of the patients. The following research questions 
were formulated for this study: 
(1) Which pediatric patients show severe PUs of category 2, 3 and 4 compared 
with patients at risk (patients with category 1 PU)? 
(2) What is the current PU treatment in Swiss pediatric hospitals? 
(3) Are there any differences in the treatment of severe PUs (category 2 to 4) 
according to demographic characteristics of patients? 
1.4 Structure of thesis 
This thesis consists of eight chapters. In each of chapters two to seven a different 
study is presented, followed by a general discussion in chapter eight. This chapter 
eight includes a discussion of the results in relation to the existing literature, 
implications for clinical practice and implications for research. The thesis is 
completed with a final summary in English, Dutch and German.  
Chapter two presents the results of the first pilot study on pressure ulcer 
prevalence in four Swiss pediatric hospitals. Few studies are available about the 
prevalence of pressure ulcers in pediatric patients. To obtain more information 
about the problem of pressure ulcers in pediatric patients, a nationwide pressure 
ulcer prevalence study was conducted in Switzerland.  
 The results of the first Swiss nationwide pressure ulcer prevalence study in 
pediatric hospitals are presented in chapter three. This study was undertaken to 
acquire more insight into the problem, the patients at risk and to identify factors 
that increase the risk of pressure ulcer development in pediatric patients.  
Chapter four presents the results of a systematic review of the empirical evidence 
about validity, reliability and clinical impact of PU risk assessment scales for 
children.  
In chapters five and six, factors associated with the occurrence of pressure ulcers 
in hospitalized pediatric patients between 1 and 18 years of age (Chapter five) and 
neonates and infants (Chapter six) were assessed. It is important to know and 
identify anatomical regions associated with the highest risk of pressure ulcer 
occurrence and to identify risk factors for PUs in hospitalized pediatric patients in 
different age groups.  
Chapter seven contains an overview of pressure ulcer treatment conducted in 
hospitalized Swiss pediatric patients with regard to the unique needs of children 
with wound care.  
1.5 Ethical considerations 
The studies presented in this thesis were approved by all cantonal ethics 
committees, and when necessary by the ethics board of the hospitals concerned. 
After the patients and their legal representatives had been verbally informed of the 
study’s content and aim, they also received the information in written form along 
with an informed consent form to sign. The information letter as well as the 
informed consent form for the legal representatives was available in eight different 
languages (German, French, Italian, English, Portuguese, Albanian, Serbian, and 
Turkish). Children 10 years of age and older, as well as their legal representatives, 
were both asked to give their written consent.  
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 Abstract 
Aim and Objective: Pressure ulcers are a common nursing care issue in hospitals. 
They are associated with psychological and physical suffering, an increased 
morbidity and mortality rate and higher overall health care costs. The aim of the 
current study is to describe the frequency of pressure ulcers in a pediatric care 
setting and to identify the population at risk, as well as to assess the factors 
predisposing to the development of pressure ulcers. 
Design: A point prevalence study. 
Methods: The study was conducted in four pediatric hospitals in the German-
speaking part of Switzerland and included children from the age of 0-18 years. The 
method of data collection was a direct systematic inspection and assessment of 
the skin, taking into account the clinical condition of the patient for risk 
assessment. A valid risk assessment and data collection instrument was used 
and, each patient was assessed by a previously instructed rater pair.  
Results: Of all possible patients, 81% (n=155) were included. An overall pressure 
ulcer prevalence of 27.7% (including grade 1) was registered. Thirty-six patients 
(84%) had category 1 ulcers, including many caused by external medical devices. 
Sixty-five percent (n= 100) of all patients were considered at risk (Braden score ≤ 
20) of developing a pressure ulcer. Thirty-five percent of patients in the risk group 
were afflicted with one or more pressure ulcers.  
Conclusion: The prevalence of pressure ulcers in pediatric patients is greater then 
previously appreciated and the problem requires further exploration. The high 
percentage of category 1 pressure ulcers caused by medical devices requires 
nursing interventions to prevent lesions for these patients. 
Relevance to Clinical Practice: The high prevalence rate in pediatric patients is 
disconcerting and requires further exploration in terms of interventions needed to 
improve outcomes for this patient group.  
 2.1 Introduction 
Pressure ulcers are a common nursing care issue in hospitals. They are 
associated with psychological and physical suffering, an increased morbidity and 
mortality rate and higher costs in health care institutions worldwide. In the 
Netherlands, annual expenses for the prevention and therapy of pressure ulcers 
amount to approximately US $350 million, which constitutes about 1.3% of the 
total annual health care costs (Bours et al. 2002). In Germany, the average cost of 
a pressure ulcer treatment and therapy is estimated at 50,000 Euro. The annual 
economic and financial cost is estimated to be between 1.5 and 3 billion Euros 
(Woltemade 2004). In the UK the treatment costs for one pressure ulcer vary from 
£1,064 (Category 1) to £10,551 (Category 4) and total costs in the UK amount to 
£1.4-2.1 billion annually (Bennett et al., 2004). It can be assumed that with 
sufficient prevention measures in England, up to £324,000 per hospital could be 
saved every year (Thomson & Brooks 1999).  
Through large-scale, nationwide epidemiological studies, the prevalence of 
pressure ulcers in nursing care institutions for adults is known and well 
documented today. It varies from 9-33% (Bours et al. 2002, Dassen 2002, Heller 
2003, Hopkins et al. 2000, Lahmann et al. 2002, Meraviglia et al. 2002, O’Dea 
1999, Tannen et al. 1999, Thoroddsen 1999, Whittington et al. 2000). Besides 
evidence-based preventive nursing interventions, a first step in improving care 
quality is the periodic collection of data regarding prevalence and incidence of 
pressure ulcers. Accordingly, the Agency for Healthcare Research and Quality 
(AHRQ, 2000) recommends periodic prevalence studies to evaluate the efficiency 
of pressure ulcer prevention programs and standards (Whittington et al. 2000).  
Pediatric patients are often excluded from pressure ulcer prevalence studies. This 
fact may be surprising, since the few studies conducted in pediatric care settings 
show a prevalence rate variation between 0.47% and 23% for this specific group 
(Dixon and Ratliff 2005, Suddaby et al., 2005, McLane et al., 2004, Groeneveld et 
al., 2004, Baldwin 2002, Willock et al. 2000). The incidence rate lies between 
0.29% and 32.8% (Dixon and Ratliff 2005, Suddaby et al. 2005, Groeneveld et al. 
 2004, Baldwin 2002, Willock et al. 2000, Curley et al. 2003). Pressure ulcers 
cause an increase in pain, infection and calorie expenditure in pediatric patients 
(Curley et al. 2003, Schmidt et al. 1998, Zollo et al. 1996, Samaniego 2003, 
Cockett, 2001). Sick children, premature infants and toddlers, but also disabled 
and neurologically impaired children, seem to be at particular risk of developing 
pressure ulcers (Curley et al. 2003, Schmidt et al. 1998, Zollo et al. 1996). 
One known risk factor for the development of pressure ulcers in the pediatric care 
setting is the need for additional medical and therapeutic aids, such as 
wheelchairs, unadjusted ortheses and prostheses (Samaniego 2003, Cockett, 
2001).  Further potential risk factors mentioned are immobility and decreased skin 
sensitivity (Suddaby et al. 2005, Willock et al. 2005, Willock 2005). Furthermore, it 
should be kept in mind that pediatric patients are, in comparison to adults, in 
widely differing health conditions. The overall health status of children is generally 
better and multi-morbidity is limited to a small percentage of patients only. Survival 
rates of both critically and chronically ill infants and children, on the other hand, 
have improved dramatically in recent years, introducing new challenges for 
medical and nursing care, among them an increase in the pressure ulcer risk 
(Jones et al. 2001). Moreover, age-related, limited communication faculties of 
infants and toddlers or of mentally handicapped children lead to an increased 
pressure ulcer risk (Curley et al. 2003, Willock 2005, Willock and Maylor, 2004). 
Due to the above-mentioned lack of information, there is an urgent need for 
studies of pressure ulcer prevalence in the pediatric population to improve the 
quality of health care. The aim of the current study is to describe the frequency of 
pressure ulcers in a pediatric care setting and to identify the population at risk, as 
well as to assess the factors predisposing to the development of pressure ulcers. 
  
 2.2 Methods 
2.2.1 Design 
A multicenter, descriptive point prevalence study was conducted in four pediatric 
hospital institutions on 6 July 2006. All pediatric disciplines in the participating sites 
were included and represented. 
A convenience sample of all hospitalized children from the age of 24 hours 
(including premature babies) up to and including 17 years was considered in the 
study. Children had to have been hospitalized for at least one day in the respective 
institutions. All wards (including burn patients, premature babies and rehabilitation 
patients) were included. Those excluded were children who were hospitalized in 
psychiatric wards as well as children whose legal representatives did not allow 
their participation or who themselves refused to participate.  
2.2.2 Ethical aspects 
The study was performed following approval from the local ethics board. After the 
patients and their families had been verbally informed about the study’s content 
and aim, they were given the same information in written form as well as the 
'informed consent' sheet to sign. Children 10 years of age and older were asked to 
give their own written consent.  
2.2.3 Data collection  
To assess the prevalence, severity, risk factors as well as the preventive and 
therapeutic interventions of pressure ulcers the instrument of Bours et al. was 
used in this study (Bours et al. 1999). This instrument is widely used in Europe 
and includes six categories of data to be collected: (1) characteristics of the health 
care institutions, (2) characteristics of the ward or team, (3) characteristics of the 
patients (demographic and clinical data), (4) assessment of the risk of pressure 
 ulcer development using the Braden scale, (5) assessment of the severity of 
pressure ulcers and (6) preventive interventions already in place. 
The Braden Scale is one of the most well-known and widely used tools for 
evaluating pressure ulcer risk, as its good psychometric properties in assessing 
risk have been verified. The Braden Scale has also been used previously to 
assess pressure ulcer risk in pediatric patients (Samaniego 2003, Suddaby et al. 
2005). It includes six subscales, five of which have four, and the sixth three 
answer categories (Dassen et al. 2001, Boes 2000, Bergstrom et al. 1998, 
Bergstrom et al. 1987). For the composite score of the Braden scale, a Pearson 
correlation coefficient between the two raters was established at r=0.81 (Bours et 
al. 1999). Internal consistency with the total Braden scale has been demonstrated 
by Halfens et al. (2000) and is judged as being sufficient, with a Cronbach’s alpha 
value of 0.78. Interrater reliability for the individual risk factors varied between 0.71 
and 0.86 (Cohen’s kappa). The stability of the Braden score between the first and 
the second measurement and between the second and third measurement has 
been established at r=0.52 (Halfens et al. 2000). The total scores range from 6 to 
23 points, with the lower score indicating a higher risk for the patient of developing 
a pressure ulcer. There is no agreement regarding the cut-off point of the Braden 
scale for defining patients at risk. The cut-off score varies between 16-21 and 
highlights the importance of the specificity and sensitivity of risk assessment tools 
(Defloor & Grypdonck, 2004). In the present study the cut-off point for patients at 
risk was set at ≤ 20, following the recommendation of the European Pressure 
Ulcer Advisory Panel (EPUAP, 2004).  
2.2.4 Procedure for collecting the data 
The method of data collection was a direct and systematic inspection and 
judgment of the skin, as well as of the clinical condition of the patient before the 
risk assessment. The EPUAP (EPUAP, 2004) pressure ulcer grading system was 
used. Category 1 ulcers were measured by finger pressure because transparent 
disks were not available on all institutions.  
Demographic and clinical data, such as date of birth, weight and size, body mass 
index and diagnosis were collected from patients' charts. The criteria were 
 assessed by a rater pair for each patient. A total of ten rater pairs were involved in 
the inquiry. On each unit, an internal and an external rater were working together. 
If the pair disagreed on their assessment, they were asked to find consensus. If no 
consensus could be found, the external rater was given the right of decision. 
2.2.5 Selection and preparatory training of the raters  
To be selected, raters were required to have had more than two years of nursing 
practice with children. In all participating hospitals, nurses who either worked as 
wound consultants in their units or as clinical nursing specialists acted as raters. 
Preparatory training included methodological aspects, detailed and exact 
information about the progression of the data collection, the role and 
responsibilities of the raters, as well as a detailed introduction to the measurement 
instruments and a special training in rating pressure ulcer grading and using the 
Braden scale in infants. 
2.2.6 Pilot study 
A balanced incomplete block design with 15 children and 10 rater pairs was used 
to assess the inter-rater reliability for grading and risk assessment (Fleiss 1981). 
The grading of pressure ulcers had sufficient inter-rater reliability (Kappa 0.81). 
For risk assessment with the Braden scale an analysis of variance concerning 
discrepancies between rater pairs was used. No significant discrepancies or 
variations occurred (p<0.001). The intra-class correlation coefficient of reliability of 
the Braden scale was estimated at ICC = 0.98. As to whether the patient 
developed a pressure ulcer or not, three of 60 observations differed, which 
represents a data consistency of 98%. The inter-rater agreement for the different 
pressure ulcer categories deviated for only two of the fifteen patients, with one 
rater pair considering a pressure ulcer as non-existent whilst the three other rater 
pairs assessed it as category 1 and two rater pairs rating a pressure ulcer as 
category 1 whereas two other pairs classified the same ulcer as category 2. 
  
 2.2.7 Statistical analysis 
SPSS (version 14.01 for Windows) was used to analyse the study data with 
descriptive and uni-variate statistical methods. Distributions and frequencies were 
calculated. The description of correlation between dependent variables and 
influencing factors was conducted with cross tabs. Group differences were 
accorded to the type of data with nonparametric tests for categorical and not 
normally distributed data. For the analysis of the correlation between Braden score 
and variables, a uni-variate analysis of variance was performed. The relationship 
between pressure ulcers and possible influencing and conflicting factors were 
studied by logistic regression. To find the most suitable model for the analysis of 
variance as well as logistic regression, the following variables were applied to the 
model: age, sex, operation, BMI, preventive action, Braden score, institutions, 
disciplines and all quality indicators of the institutions. The data were entered into 
the model followed by a forward stepwise selection of the important variables 
according to the use of likelihood quotients. The entry and removal probabilities 
were 0.05 and 0.10. The Receiver Operating Characteristics curve (ROC), which 
plots sensitivity against 1-specificity over the range of Braden scores, was used to 
confirm the cut-off value of the Braden scale. A p-value of 0.05 and lower is 
statistically significant. 
  
 2.3 Results 
The overall sample size of potential study participants was 213, of whom 191 
(100% adjusted sample) met the inclusion criteria; of these, 36 dropped out, with 
28 (15%) refusing to participate. The other eight patients dropped out because of 
unexpected discharge, examination or operations with a duration of more than the 
length of the total survey. In the four selected clinics, the participation rate differed 
from 15-83 children (69%-80%). The total number of participants was 155 (81%). 
2.3.1 Demographic characteristics 
Demographic characteristics are presented in Table 1. Twenty one percent of all 
patients were hospitalized on a surgical ward (n=33), a third of all patients were on 
a pediatric medical ward (n= 51), while a fifth of all patients were in a rehabilitation 
setting (n= 30) and a quarter of all patients were neonates (n=41). Eighty-six 
patients (55.5%) were male. Due to the comparatively high rate of neonatology 
patients, age distribution is not very symmetric. If one considers the children in the 
age group of less than one year of age only (n=56; 36%), the average age in 
weeks is 7.6 weeks with a Median of three weeks. Twenty five percent (n=38) of 
all patients were 12 years and older.  
Table 1: Demographic features of the study sample 
 Mean Median SD min max IQR 
Duration of stay 
according to divisions 
(weeks) 
Surgery 
Pediatric medical  
Rehabilitation 
Neonatology 
3.5 
3.5 
46 
1.7 
1 
1 
22 
1 
6.8 
7.8 
71.2 
1.9 
0 
0 
1 
0 
28 
38 
305 
7 
3 
2 
55.5 
3 
Age (years) Male 
Female 
5.4 
6.6 
4 
6 
5.7 
6.6. 
0 
0 
86 
305 
5 
5.75 
Age group < 1 year 
(weeks) 
 7.6 3 11.4 0 47 5 
 
The length of stay varies, too, with the overall duration showing an average of 11.2 
weeks, a Median of one week and a range of 304 weeks. Allowing for the different 
settings, including the rehabilitation settings where patients tend to stay longer, it 
 is crucial to note that for patients whose stay lasts for less than one week (n=63), 
the average is 3.2 days (SD 2.1; Median = 3). 
Patients with a pediatric medical care problem constitute the largest group (n=51, 
33%) of participants, with cardiologic (n=12, 8%) and oncology patients (n=8, 5%) 
as subpopulations of these pediatric medical patients. These are followed by 
patients hospitalized in a neonatal intensive care unit (NICU) (n=41, 27%) and by 
patients in a rehabilitation care setting (n=30, 19%). Beyond these categories, 
surgical patients (n=33, 21%) - including orthopedic patients (n=10, 6.5%) – also 
constitute a significant number. 
2.3.2 Pressure ulcer risk 
The average Braden score is 18.6 (SD 3.7), with the lowest score at 7 and a 
maximum score of 23 (Fig.1). 
 
Figure 1: Braden Score per division, patient with and without risk with cut-off line for patient at 
risk/not at risk at 20. 
The average of the overall Braden score for patients at risk (Braden score less 
than 21) is 16.8 (SD 3.4) and for the patients not at risk 21.8 (SD 0.8). 
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 Of all patients, 100 (64.5%) were considered to be at risk of developing pressure 
ulcers. The average risk as related to age group shows a statistically significant 
difference, (X2=12.79; p<0.05) (Table 2). The most crucial statistical significance of 
patients at risk is found in relation to the various medical disciplines (X2=18.42; 
p<0.001). Two thirds of the patients hospitalized on a surgical ward, either with 
surgical treatment or in a rehabilitation care setting, must be considered at risk of 
being afflicted with a pressure ulcer. The patient group most at risk is that of 
neonatology patients, with a percentage of 84.5%. 
Table 2: Age and divisions distribution patient at risk 
 Age categories Divisions 
<1 1<4 4<8 8<12 12<18 Surgery Pedi. 
medi. 
Neo. Rehab. Total 
Patient 
not at risk 
n 
(%) 
13 
(23.2) 
5 
(27.8) 
5  
(25) 
12 
(21.8) 
20 
(52.6) 
10 
(30.3) 
29 
(56.9) 
6 
(14.6) 
10 
(33.3) 
55 
(35.5) 
Patient at 
risk 
n 
(%) 
43 
(76.8) 
13 
(72.2) 
15 
(75) 
11 
(47.8) 
18 
(47.4) 
23 
(69.7) 
22 
(43.1) 
35 
(85.4) 
20 
(66.7) 
100 
(64.5) 
Total n 
(%) 
56 
(36) 
18 
(11) 
20 
(13) 
23 
(15) 
38 
(25) 
33 
(21.3) 
51 
(32.9) 
41 
(26.5) 
30 
(19.4) 
155 
Mann Whitney: 1917.5 **    X2: 18.42  **   
**
= p< 0.001   
*
= p < 0.05   n.s. = not significant 
2.3.3 The prevalence of pressure ulcers 
Of the 155 children taking part in this study, a total of 43 showed one or more 
pressure ulcers on the day of inquiry, which constitutes a prevalence rate of 27.7% 
(Table 3). Among these 43 patients, 34 (79%) showed one, seven (16%) were 
affected by two and two patients (5%) showed five occurrences of pressure ulcers. 
The most frequent type of pressure ulcer found was of category 1. The prevalence 
of pressure ulcers of category 2 and higher was 4.5% (n=7), with one patient 
suffering from a category 4 ulcer. No significant demographic differences between 
patients with and without pressure ulcers were found with the only difference 
relating to the length of stay before the measurement, which was higher for 
patients with a pressure ulcer (Table 4). 
  
  
Table 3: Prevalence of pressure ulcers 
Number of pressure  
ulcers per patient 
Total (%) 
1 34 (21.9) 
2 7 (4.5) 
3 0 
4 0 
5 2 (1.2) 
Prevalence of pressure  
ulcer per category 
Total (%) 
overall 43 (27.7) 
1 36 (23.2) 
2 6 (3.9) 
3 0 
4 1 (0.6) 
 
 
Table 4: Characteristics of patients with a pressure ulcer  
 Pressure ulcer 
Yes  No  Total (%) 
43 (27.7%) 112 (72.3%)  
n (%) n (%) X
2 
 
Sex Male 26 (30.2%) 60 (68.8%) 0.6  
n.s. 
86 (55.5%) 
Female 17 (24.6%) 52 (75.4%) 69 (44.5%) 
Divisions Surgery 10 (30%) 23 (70%) 10.7 
n.s. 
33 (21.3%) 
Ped. Med. 12 (24%) 39 (76%) 51 (32.3%) 
Neo.  11 (27%) 30 (73%)  41 (26.5%) 
Rehab.  10 (33%)  20 (67%) 30 (19.4%) 
Age groups  
< 1 year (in weeks)  
< 20  15 (31.9%) 32 (68.1%) 7.4 
n.s. 
47 (83.9%) 
21-52  2 (22.2%) 7 (77.8%) 9 (16.1%) 
Age groups  
> 1 year (in years)  
> 1 (details see above)   
3.1 
n.s. 
56 (36.1%) 
1 to 4 2 (11.1%) 16 (88.9%) 18 (11.6%) 
4 to 8 5 (25%) 15 (75%) 20 (12.9%) 
8 to 12 7 (30.4%) 16 (69.6%) 23 (14.8%) 
> 12  12 (30.4%) 26 (68.4%) 38 (24.5%) 
Operation  
in last two weeks 
No 34 (27.6%) 89 (72.4%) 0.0 
n.s. 
123 (79.4%) 
Yes 9 (28.1%) 23 (71.9%) 32 (20.6%) 
Age in years Mean (SD) 
Median 
6.14  
(6.02) 
6.5 
5.84 
 (6.18) 
4 
Mann-Withney:  
(0.993) n.s. 
Length of stay in days Mean (SD) 
Median 
74.72 (118.00) 
25 
83.52 
(285.61) 
9 
Mann-Withney:  
(0.019)* 
**
= p< 0.001   
*
= p < 0.05   n.s. = not significant 
 Anatomic localization varies and nearly half of the pressure ulcers were located in 
an anatomic area, which cannot be precisely specified (n=25, 43%) (Table 5). 
Most of these pressure ulcers where assessed along equipment, such as tubes, 
splints or monitoring cable.  
Only a marginal number of pressure ulcers (n=2, 3%) developed at home, with 
most (n=45, 78%) developing on the ward where the child was hospitalized. Most 
of the pressure ulcers (n=47, 81%) had developed in the two weeks before the 
inquiry. Only nine pressure ulcers (16%) had persisted between two weeks and 
three months and two pressure ulcers (3%) remained for more the six months.  
Table 5: Anatomic localizations of pressure ulcers 
Anatomic 
localizations 
n (%) 
Other area 25 (43.1) 
Heels 9 (15.6) 
Ankle 6 (10.4) 
Ear 6 (10.4) 
Bottom 5 (8.6) 
Knee 2 (3.4) 
Elbow 2 (3.4) 
Sacrum 1 (1.7) 
Hip 1 (1.7) 
Occiput 1 (1.7) 
 
2.3.4 The prevalence of pressure ulcers in the risk group 
Thirty five percent of all patients in the risk group were afflicted with one or more 
pressure ulcers. In the group of patients classified as not being at risk, a pressure 
ulcer prevalence of 14.5% (n=8) was found. Alternatively, 81.4% of the patients 
with a pressure ulcer were assigned to the risk group (Sensitivity: 0.8). The 
specificity of the Braden scale in this survey was 0.42. Using pressure ulcer and 
the total Braden score a Receiver Operating Characteristics Curve (ROC) plotting 
sensitivity and 1-specificity for each possible Braden score was then constructed. 
 The Area under the Curve (AUC) was 0.7 (CI: 0.604-0.794). A cut-off score of 20 
provided a high sensitivity and an adequate specificity. At a score of 16, sensitivity 
was 0.395 and specificity was 0.134. At a cut-off score of 18 the sensitivity was 
0.605 and specificity 0.241.  
  
Figure 2: Braden Scale ROC curve with diagonal reference line.  
 
2.3.5 Pressure ulcers and influencing factors 
The risk factors age, sex, operation, BMI, preventive action taken, Braden score, 
institutions, wards and all quality indicators of the institutions were examined with a 
multiple logistic regression analysis. Only the Braden score, institution and wards 
contributed significantly to the fit. The odds ratios and associated confidence 
intervals of the variables in the final model are presented in Table 6. The Hosmer-
Lemeshow-test shows an adequate goodness of fit for this model (p=0.57; 
Nagelkerke R2=0.32). 
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 Table 6: Logistic regression model with pressure ulcer as dependent variable 
Variables in the Equation 
 95% CI for EXP 
(B) 
 B S.E. Wald df Sig. Exp (B) Lower Upper 
Step 
1 
Braden 
Score  
.170 .056 9.196 1 .002 1.186 1.062 1.324 
Division   13.447 3 .004    
Division (1) -2.816 1.249 5.087 1 .024 .060 .005 .691 
Division (2) -3.107 1.359 5.229 1 .022 .045 .003 .641 
Division (3) -5.109 1.489 11.780 1 .001 .006 .000 .112 
Institution   15.019 3 .002    
Institution 
(1) 
-2.714 .925 8.599 1 .003 .066 .011 .407 
Institution 
(2) 
-5.759 1.519 14.373 1 .000 .003 .000 .062 
Institution 
(3) 
18.474 10031.
722 
.000 1 .999 1E+008 .000 . 
Constant 3.751 1.701 4.861 1 .027 42.543   
a. variable(s) entered on step 1: Bradenscore, Division, Institution 
  
 2.4 Discussion 
Our study reveals a high prevalence rate of 27.7% in the four pediatric hospitals. 
This rate is higher than the previously found prevalence rates in pediatric care 
settings, which varied between 0.47% and 23% (Dixon & Ratliff 2005, Suddaby et 
al. 2005, McLane et al. 2004, Groeneveld et al. 2004, Baldwin 2002, Willock et al. 
2000). The prevalence of pressure ulcers in the risk group was 35% and 14.5% in 
the non-risk group.  
This high prevalence rate demands critical appraisal. First, an already well-known 
problem is the diagnosis of pressure ulcers of category 1 (Halfens et al. 2001). 
Several authors have therefore recommended defining pressure ulcer prevalence 
by starting the grading system at category 2 (Defloor and Gryponck 2004, Halfens 
et al. 2001). In this study, however, the prevalence of pressure ulcers at categroy 
2 and above accounts for only 4.5% of the total. This value is comparable to the 
prevalence of pressure ulcers in the study of Suddaby et al. (2005) and 
Groeneveld et al. (2004) (both 5.1%). In several pediatric studies the rates 
differentiated between a pressure ulcer prevalence rate as well as a skin 
breakdown wounds rate caused by, for example, diaper rash or cast areas 
(McLane et al. 2004, Zollo et al 1996, Samaniego 2003). 
Second, most pressure ulcers developed on the ward. Over 85% were facility 
acquired. Their persistence in 81% of the cases was less than two weeks, which 
mirrors the findings of previous studies (McLane et al. 2004, Groeneveld et al. 
2004). Although not all pressure ulcers are preventable, the high prevalence rates 
indicate a need to improve preventive actions as well as risk assessment and to 
start raising staff’s awareness of the pressure ulcer issue in the pediatric health 
care setting (McLane et al. 2004, Curley at al. 2003). 
One known risk factor for the development of pressure ulcers in the pediatric care 
setting is the additional need for medical and therapeutic aids, such as 
wheelchairs, unadjusted ortheses and prostheses (Samaniego 2003, Cockett 
2001). Pediatric patients are unable to differentiate pressure from or sensory 
perceptions of such devices properly and are for this reason most vulnerable.  
 Equipment-related risk factors, e.g. those connected with traction, tubes and 
iv.catheterization, are additional potential risk factors in the pediatric health care 
setting (McLane et al. 2004, Zollo et al. 1996, Samaniego 2003, Willock et al. 
2005, Noonan et al. 2006). The most frequent localization of a pressure ulcer in 
the present study is, in almost 50% of the cases, in ‘other anatomic parts’. The 
reason for this might be the fact that the majority of pressure ulcers were 
developed with reference to splints or cables and tubes. Another frequently 
affected area is the lower extremity with ankle and heels as well as the ear. 
Furthermore, it is known that, for children, the ear, the occiput and the nose are 
the anatomic sites most likely to develop a pressure ulcer (Suddaby et al. 2005, 
McLane et al. 2004, Groeneveld et al. 2004, Curley et al. 2003). In this study, 
however, we had a remarkably low incidence of pressure ulcers in the occiput.  
More than two thirds of all patients were defined as being at risk in the present 
study. According to individual disciplines, the overall Braden score of surgical and 
rehabilitative patients is lower than for others, indicating a higher risk of pressure 
ulcer development. One possible explanation could be that the sample of surgical 
and rehabilitation patients had a high level of other impairments, with differing 
conditions influencing the health status of a child. In our setting patients in these 
two divisions are often limited in their activity and mobility opportunities. In surgical 
patients skin sensitivity is often limited due to oedema, intense pain therapy and 
peridural analgesia. In the rehabilitation care setting, chronically ill as well as 
physically handicapped children are treated. Immobility and reduced sensation has 
been previously defined as a major risk factor in the study of Willock et al. (2005).  
The neonatology sample in this study shows homogeneity for both the Braden 
score and the overall population at risk. Due to their special condition, specifically 
their underdeveloped skin cells, such as the dermis and epidermis bond which is 
still weak, it seems plausible that this population is most affected by pressure 
ulcers in varying anatomic locations related to the positioning of tubes or cables. 
Further studies are needed to establish the special risk factors of this highly 
vulnerable population. 
Although the prevalence rate for pressure ulcers in pediatric patients described in 
this study is high and demands further exploration of the phenomenon, some 
critical points need to be mentioned. The small sample size, especially for the 
 different divisions, as well as the heterogeneity of the clinics involved, only allow 
limited generalization of the findings to other institutions. An adapted, reliable and 
valid risk assessment tool, applicable to the wide range of population from 
neonates to adolescents, in combination with validated cut-off points, is still not 
available for the pediatric population (Curley et al. 2003a, Cockett, 2001, Willock, 
2005, Jones et al. 2001). The cut-off for patients at risk with ≤ 20 is high, but 
seems the most precise and accurate for this setting. At the time of data collection 
for the present study the Braden-Q scale was the only tool available for risk 
assessment in the pediatric population (Curley et al. 2003b). Still it is not validated 
for children more than eight years of age and no validated German version is 
available. Recently, a new tool – the Glamorgan Pediatric Pressure Ulcer Risk 
assessment scale – has been developed and should be considered for use in 
further studies (Willock et al., 2008, Willock et al. 2007a, Willock et al. 2007b). Due 
to this lack of alternatives the Braden scale was used to assess pressure ulcer 
risk. The use of the Braden scale is problematic insofar as no defined cut-off point 
for specifying patients at risk is known. Further, it has been criticized that the 
Pearson correlation is not appropriate for the validation of tools like the Braden 
Scale (Bland & Altman, 1986). Thus, a validation according to this 
recommendation of results is completely missing. Further criticisms claim that the 
Braden scale offers inadequate reliability and insufficient predictive performance 
(Papanikolaou et al, 2007).  
However, the data collected for this study mark an important first step in 
recognizing the relevance of the pressure ulcer issue in the pediatric health care 
setting. Larger studies are necessary to validate our findings and to generalize the 
result to the general pediatric hospital population. 
  
  
2.5 Conclusion  
Children are beyond doubt at risk of developing pressure ulcers. The evaluated 
prevalence rate in pediatric patients is disconcerting and requires further 
exploration in terms of preventive and therapeutic interventions to improve 
outcome for this patient group.  
2.5.1 Relevance to Clinical Practice 
It is vital that pediatric nurses are trained to recognize the early stages of pressure 
ulcers. Further, they need to be aware of the specific risk factors for children. To 
avoid pressure, the performance of an appropriate risk assessment for this patient 
group and preventive interventions based on evidence are mandatory.  
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 Abstract  
Pressure ulcers (PU) are a common care problem in hospitals. Although these 
lesions often are considered as a problem of older patients, also pediatric patients 
are confronted with PUs. The aim of this study was to assess the prevalence of 
PU in pediatric care settings. A cross-sectional study was conducted in all 14 
pediatric hospitals in the German-speaking part of Switzerland and included all 
hospitalized children from 0-18 years. The method of data collection involved a 
direct systematic inspection and assessment of the skin. A standardized data 
collection instrument was used and each patient was assessed by a previously 
instructed rater pair. The total number of participating children was n=412 (75%). 
An overall PU prevalence of 35% (including category 1) was registered. Most of 
the patients (80%) had category 1 ulcers. Patients in Pediatric Intensive Care 
Units (PICU) were affected mostly, followed by neonates and newborns. The 
prevalence of PUs in pediatric patients is greater than expected and the problem 
therefore requires further exploration. The high percentage of category 1 PU 
requires a focus on interventions to prevent lesions for these patients. Future 
studies are needed to further assess the risk factors especially for patients in 
PICUs.  
 
 
 3.1 Introduction  
A pressure ulcer (PU) is a localized injury to the skin and/or underlying tissue as a 
result of pressure, or pressure in combination with shear forces(National Pressure 
Ulcer Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel 
(EPUAP), 2009). While this care problem has gained a great deal of attention in 
adults, far less is known about PUs in children and neonates (Baharestani and 
Pope, 2007). It should be kept in mind that pediatric patients, in comparison to 
adults, are in widely differing health conditions. The overall health status of 
children is generally better and multi-morbidity is limited to a small percentage of 
patients only. Survival rates of both critically and chronically ill infants and children 
have improved dramatically in recent years, introducing new challenges for 
medical and nursing care (Jones, Tweed, Marron, 2001). One of these is an 
increase of pressure ulcer risk (Jones et al., 2001). In addition, several risk factors 
predisposing a pressure ulcer in children are known including the need for 
additional medical and therapeutic aids, such as wheelchairs, unadjusted ortheses 
and prostheses (Samaniego, 2003, Cockett, 2001). The consequences of 
immobility and decreased skin sensitivity (Suddaby, Bernett, Facteau, 2005, 
Willock, Askew, Bolland, Maciver, James, 2005, Willock, 2005) and risk factors 
related to equipment, like tubes and IV catheterization and CPAP have been 
described earlier (Samaniego, 2003, McLane, Bookout, McCord, McCain, 
Jefferson, 2004, Zollo, Gostisha, Berens, Schmidt, Weigle, 1996, Noonan, 
Quigley, Curley, 2006, Schlüer, Cignacco, Müller, Halfens, 2009). Limited age-
related communication skills of infants and toddlers or of mentally handicapped 
children lead to an increased pressure ulcer risk as well (Willock, 2005, Curley, 
Razmus, Roberts, Wypij, 2003, Kottner, Wilborn, Dassen, 2010). The skin may be 
affected due to external influences like increased pressure and friction and shear 
forces due to intervention with external devices. Especially in patients in the 
pediatric intensive care units (PICU) the influence due to pressure of tubes for 
patient on oscillation and extracorporeal membrane oxygenation as well as a 
decreased tissue tolerance in these patients due to their critical life condition, 
 increases the risk for skin failure and makes these patients in critical life conditions 
most vulnerable (Baharestani and Pope, 2007, Curley et al., 2003).  
Recent investigations indicate that PUs are also common in infants and children: 
reported PU prevalence rates including all PU categories range from 
approximately 3% to 28% in hospitals (Kottner et al., 2010). The prevalence for PU 
within the group for children in hospitals being at risk, diagnosed through a risk 
assessment tool has been reported to lie at 35% (Schlüer et al., 2009). The few 
published incidence and prevalence figures vary widely (Willock and Maylor, 2004, 
Kottner et al., 2010) and therefore it is difficult to make any evidence based 
statements about PU frequency in pediatric populations. Often basic reporting 
issues like descriptions of samples, inclusion and exclusion criteria, or provision of 
clear PU definitions are missing in studies or vary between studies conducted 
earlier. Due to these methodological considerations, the results of these earlier 
studies are hardly comparable (Kottner et al., 2010). There is a deficit of research 
about pediatric PU risk assessment and age specific PU interventions (Willock and 
Maylor, 2004) and the magnitude of this health problem in the pediatric population 
is in fact largely unknown. Having a clear understanding of the incidence and 
prevalence of PUs is important for the evaluation of the effectiveness of PU 
prevention, of resource requirements, and of resource allocation to this group.  
3.1.1 Study purpose 
Due to the general and specific lack of information about PUs among this 
population, there is a need for studies on pressure ulcer prevalence in the 
pediatric population to recognize the actuality and the extent of the problem and to 
improve the quality of PU-care. Therefore, the aim of the current study was to 
assess the prevalence of pressure ulcers in pediatric care settings and age 
groups, as well as to assess influencing factors and characteristics of these PU 
patients. 
 3.2 Methods 
3.2.1 Study design  
A multicentre, cross-sectional study was conducted in all 14 pediatric hospitals in 
the German-speaking part of Switzerland in June 2009. These hospitals have a 
total of approximately 70 wards. All pediatric disciplines at the participating sites 
were included. These involved children from all departments like PICU, Neonatal 
intensive care units (NICU), all surgical disciplines, all pediatric medical disciplines 
as well as the departments for pediatric rehabilitation care. All hospitalized children 
aged 24 hours (including premature babies) up to and including 17 years of age 
were included in the study. Children had to be hospitalized for at least one day in 
the respective institutions. Exclusion criteria were a) hospitalization in psychiatric 
wards, b) children whose legal representatives did not allow participation, and c) 
children who refused to participate. The ethics board of each hospital approved 
the study where necessary, as well as all cantonal ethics committees. After the 
patients and their families had been verbally informed about the study’s content 
and aim, they were given the same information in written form along with an 
informed consent form to sign. The information letter as well as the informed 
consent form for the parents was available in eight different languages (German, 
French, Italian, English, Portuguese, Albanian, Serbian, Turkish). Children 10 
years of age and older were asked to give their own written consent.  
3.2.2 Measurements 
To assess the prevalence, severity, as well as predisposing factors of pressure 
ulcers the instrument and method of data collection of the Dutch National 
Prevalence Measurement Care Problems (LPZ) (Halfens, Meijers, Neyens et al., 
2010) was used in this study. This instrument is widely used in Europe and has 
been shown to be reliable and valid (Bours, Halfens, Lubbers, Haalboom, 1999). It 
collects the following categories of data: (1) patient characteristics (demographic 
and clinical data), (2) assessment of the prevalence and severity of pressure 
ulcers, (3) PU risk assessment using the Braden scale, (4) predisposing factors for 
 PU development, (5) preventive interventions, as well as (6) therapeutic 
interventions. In addition to the original instrument, we assessed also all 
installations on the patient’s body at the time of the assessment (e.g. tubes, IV 
catheterizations, Continuous positive airways pressure (CPAP), splints, and other 
installations). These adaptations based on the findings of a previous study 
(Schlüer et al., 2009) were verified by the clinical nurse specialists in the 
participating hospitals.  
The method of data collection related to PUs themselves was a direct and 
systematic inspection and judgment of the skin, as well as of the clinical condition 
of the patient. The EPUAP (NPUAP/EPUAP, 2009) pressure ulcer category 
system of four categories was used. Demographic and clinical data, such as date 
of birth, weight and size, body mass index and diagnosis, were collected from the 
patient charts.  
PU risk assessment was predicted using the original Braden scale (Bergstrom, 
Braden, Laguzza, Holman, 1987). The Braden Scale is one of the most well-
known and widely used tools for evaluating pressure ulcer risk in adults, as its 
good psychometric properties in assessing risk have been verified. The Braden 
Scale has also been used previously to assess pressure ulcer risk in pediatric 
patients (Samaniego, 2003, Suddaby et al., 2005, Schlüer et al., 2009). It includes 
six subscales, five of which have four and one, which has three answer categories 
(Bergstrom et al., 1987, Bergstrom, Braden, Kemp, Champagne, Ruby, 1998).  
Previously trained rater pairs gathered data of each patient. Each rater pair 
consisted of a health care worker working on the measured ward, and a health 
care worker not working at that ward. A total of 35 rater pairs were involved in the 
inquiry. If the pair disagreed on their assessment, they were asked to find a 
consensus. If no consensus could be reached, the rater not working on that ward 
was given the right of decision. To be selected, raters were required to have more 
than two years of nursing practice with children. In all participating hospitals, 
nurses who worked either as wound consultants in their units or as clinical nurse 
specialists acted as raters. Preparatory training included methodological aspects, 
detailed information about the data collection, the role and responsibilities of the 
raters, a detailed introduction to the measurement instruments, and special 
training in the grading of a pressure ulcer as well as in the Braden scale in infants 
 and children. Pilot studies in all sites with more than two rater pairs were 
conducted to assess the inter-rater reliability for grading and risk assessment20, 
with a balanced incomplete block design. A data consistency of 95% as to whether 
the patient developed a pressure ulcer or not was observed. Overall, inter-rater 
reliability (Kappa 0.79) for the grading of pressure ulcers was sufficient. 
3.2.3 Data analysis 
Predictive Analytics Software (PASW) (version 18, formerly SPSS) was used to 
analyze the study data with descriptive and uni-variate statistical methods. 
Distributions and frequencies were calculated. The relations between dependent 
variables and influencing factors were conducted with cross tabs. Group 
differences were due to the type of data tested with nonparametric tests for 
categorical and not normally distributed data. The relationship between pressure 
ulcers and possible influencing and confounding factors were studied by logistic 
regression analysis. To find the most suitable model for the analysis of variance as 
well as logistic regression, the following variables were applied to the model: age, 
sex, operation, BMI, preventive action, Braden score, institutions and divisions. 
The data were entered into the model followed by a forward stepwise selection of 
the important variables according to the use of likelihood quotients. The entry and 
removal probabilities were 0.05 and 0.10. A p-value of 0.05 and lower was 
considered as statistically significant. 
3.3 Results 
3.3.1 Demographics 
The overall sample size of potential study participants who met the inclusion 
criteria was 560 (100%). The total number of participants was 412 (75%), because 
141 (25%) dropped out before the assessment. In 67 cases (12%), either the 
parents or the child refused participation. Sixty patients were excluded due to 
unexpected discharge or because examination or operations lasted longer than 
 the survey (11%). Four patients were not assessed due to an unexpected change 
in their condition to a critical level. Only 5 patients dropped out due to language 
problems of the parents. 
In the 14 clinics, the participation rate ranged from 6-97 patients (43-100%). The 
length of stay was on average 25 days and showed a median of 7 days. Out of the 
412 assessed patients, 67% (n= 275) had been hospitalized for less than 14 days. 
In this subcategory, the average length of stay was 5 days, with a median of 3 
days. Patients with an oncology diagnosis, acute gastroenteritis, pneumonia and a 
cardiology diagnose consisted the largest group with 32% (n=130) and are 
sampled as pediatric medical division, followed by neonates (n=109, 27%), and 
patients in the surgery divisions (including, plastic and burn surgery, visceral 
surgery, neurosurgery and orthopedic and trauma patients) (n=99, 24%). The 
patient population in the PICU consisted of 36 children (9%). Furthermore, 33 
patients (8%) were hospitalized for rehabilitation and 5 because of psychosomatic 
problems (1%).  
The average age of all patients was four years with a median of one year. 
Approximately 50% (n=203) was less than one year old on the day of inquiry. In 
this subgroup, the average age was 6 weeks, with a median of 3 weeks (table 1).  
  
 Table 1: demographic characteristics 
  Mean Median SD n (%) 
Sex Female    181 (44) 
 male    231 (56) 
Age (years)  4 1 5.4  
Age (months)  52 14 66.7  
Age group < 1 
year of age 
(weeks)  
 6 3 9 203 (49) 
Age category < 1 year    203 (49.3) 
 1-4    61 (14.8) 
 4-8    44 (10.7) 
 8-12    43 (10.4) 
 >12    61 (14.8) 
Weight (Kg)  16.84 9.4 18.4  
Size (cm)  84.7 69 45.5  
Age group <1 weight (kg) 3.58 2.49 4.88  
 size (cm) 48.5. 45 13.8  
Body mass index (BMI) 
relating to age categories  
<1 11.9 11.4 3.3 203 (49) 
 1-4 15.2 15 1.8 61 (15) 
 4-8 15.5 15.4 1.8 44 (11) 
 8-12 18 17 4.3 43 (10) 
 >12 18.8 18 4.1 61 (15) 
Duration of stay (days) related to divisions 
 surgery 9.13 4 16.6 99 (24) 
 Pediatric medical 17 4.5 44.8 130 (32) 
 rehabilitation 110.4 64 137.9 33 (8) 
 psychosomatic 25 13 29 5 (1) 
 neonatology 19.9 14 20.9 109 (27) 
 PICU 14.8 7 16.2 36 (9) 
 
  
 3.3.2 Pressure ulcer prevalence and characteristics of patient showing a pressure 
ulcer 
Of the 412 patients taking part in this study, a total of 142 showed one or more 
pressure ulcers on the day of inquiry, which constitutes a PU prevalence rate of 35 
%. Out of these 142 patients 77 (54%) showed one, 35 (25%) two, 17 (12%) three, 
6 four (4%), 2 five (2%), 3 six (1%), 1 nine and one patient showed 10 pressure 
ulcers. This constitutes in a total number of 269 PU’s (table 2).  
Table 2: pressure ulcer prevalence according to divisions, age category and sex 
  PU yes 
n(%) 
PU no 
n (%) 
total n (%) 
Sex n.s. Male 84 (36.4) 147 (63.6) 231 (56.1) 
 Female 58 (32) 123 (68) 181 (43.9) 
Age category** <1 88 (43.3) 115 (56.7) 203 (49.3) 
 1-4 15 (24.6) 46 (75.6) 61 (14.8) 
 4-8 7 (15.9) 37 (84.1) 44 (10.7) 
 8-12 13 (30.2) 30 (69.8) 43 (10.4) 
 >12 19 (31.1) 42 (68.9) 61 (14.8) 
Division** Surgery 33 (33.3) 66 (66.7) 99 (24) 
 Rehabilitation 5 (15.2) 28 (84.8) 33 (8) 
 Pediatric medical 41 (31.5) 89 (68.5) 130 (31.6) 
 Psychosomatic 0 5 (100) 5 (1.2) 
 PICU 16 (44.4) 20 (55.6) 36 (8.7) 
 Neonatology 47 (43.1) 62 (56.9) 109 (26.5) 
 ** signifiant p ≤ 0.05  n.s.: not significant 
The most frequent type of PU was PU category 1 (94%). The prevalence of 
category 2 and higher was 3% (n=16). A total of three PU category 3 and 2 PU 
category 4 where assessed. The three children with category 3 PU were all 16 
years of age, with multiple diagnoses and treated for orthopedic surgery. One PU 
category 3 occurred within the last 2 weeks on the ward where the patient was 
hospitalized while the two other PUs category 3 existed since 3-6 month after 
being occurred in another hospital. The two children with category 4 PU were 9 
respectively 16 years of age. The younger child was treated after a multiple 
trauma incident in the surgery department and developed the PU cat 4 within the 
last two weeks while the other patient was treated for an orthopedic surgery 
indication. The PU in this patient already existed for more than one year and 
developed in another care setting.  
 The PU prevalence differed between the divisions (Χ2: 13.8, df: 5, p=0.002) with 
the highest PU prevalence of 44% for patients in PICU (table 2).  
As can be seen in table 3 the prevalence of PU for patients with an external device 
is 40%. According to the age category the PU prevalence for patients younger 
than 1 year of age lays at 43%, followed by 31% for patients older than 12 years of 
age. Related to the length of stay, patients with a PU stayed slightly longer in 
hospital, than without a PU (p=0.036) (table 3).  
Within the risk group for PU (meaning patients with a Braden scale score ≤ 20) 93 
patients showed a PU (49%), whereas 24% (n=46) of the patients not at risk had a 
PU (X2: 26.4; df: 1; p<0.001). According to divisions the PU prevalence for patients 
at risk is 50% for patient after a surgical intervention as well as neonates, 46% for 
pediatric medical patients, 25% for patients in the rehabilitation setting and 60% 
for patients in the PICU. Seventy six percent of all patients with at least one PU 
were assessed as being at risk (sensitivity 67%), while the percentage of patients 
who did not have a pressure ulcer although they were assessed as being at risk, 
was 40% (specificity).  
Table 3: Characteristics of patient showing a PU 
 Pressure ulcer 
yes n (%) no n (%) Χ2, (df), p total n (%) 
142 (34.5%) 270 (65.5)   
Patient with medical 
devices* 
Yes 131 (39.5) 201 (60.5)  332 (83.6) 
No 11 (16.9) 54 (83.1) 12.0, (1), 
p<0.001 
65 (16.4) 
Age category (years) < 1  88 (43.3) 115 (56.7)  203 (49.3) 
 1-4  15 (24.6) 46 (75.4)  61 (14.8) 
 4-8  7 (15.9) 37 (84.1)  44 (10.7) 
 8-12  13 (30.2) 30 (69.8)  43 (10.4) 
 >12  19 (31.1) 42 (68.9) 17.1, (4), 
p=0.14 
61 (14.8) 
Age in month* Mean (sd) 43 (67) 57 (66) Mann-
Whitney-
U-test 
p= 0.002 
Median 2 28   
Length of stay 
(days)* 
Mean (sd) 24 (49) 23 (58) Mann-
Whitney-
U-test 
p=0.036 
Median 10 7   
*significant p<0.05 
  
 3.3.3 PU influencing factors 
The risk factors age, sex, surgery (which means that the patient had at least one 
surgical intervention during the present hospitalization), BMI, preventive action, 
Braden score, institution and division were examined with a multiple logistic 
regression analysis. The factors division, age, Braden score and institution 
contributed significantly to fit into the model. The Hosmer Lemeshow-test showed 
an adequate goodness of fit for this model (Nagelkerke R2= 0.248) (table 4). This 
means that those remaining four variables explain 25% of the variance when PU is 
the dependent variable. 
Table 4: Regressions model with PU as dependent variable 
 
Regression 
coeffient B Standard error Wald df Sig. Exp(B) 
Schritt 0 Konstante -.563 .106 28.038 1 .000 .570 
 
  
 3.4 Discussion 
Our study reveals a very high PU prevalence rate of 35% in the fourteen pediatric 
hospitals. However the prevalence rate of category 2 and higher is only 3%. 
Especially the age of the patients, the Braden risk score for PU development as 
well as the institution in which the patients were hospitalized appear to be related 
to the development of PU.  
The prevalence rate of 35% is higher than previously found prevalence rates in 
pediatric care settings, which varied from 3% (Noonan et al., 2006, Dixon and 
Ratliff, 2005) to 28% (Schlüer et al., 2009). This high prevalence rate demands a 
critical appraisal. First, an already well-known problem is the diagnosis of pressure 
ulcers category 1 (Halfens, Bours, Bronner, 2001). Furthermore, most category 1 
PUs are reversible (Halfens et al., 2001). Several authors have therefore 
recommended defining pressure ulcer prevalence by starting the category system 
at category 2 (Halfens et al., 2001, Defloor and Grypdonck, 2004). Moreover, in 
our interrator pretest we found a 95% agreement, suggesting that our findings are 
reliable. And even, if category 1 PU will not be defined as a pressure ulcer, a 
category 1 PU can be considered as the most important risk factor (Defloor and 
Grypdonck, 2004, Noonan, Quigley, Curley, 2011), which subsequently can be 
interpreted as for this study that a lot of pediatric patient in fact are at high risk of 
developing PUs. The data collection in all involved clinics took part at one day 
within the same time span from the morning (7.30am) to as longest to 3pm in the 
afternoon. This is so far important as it’s been known from the adult population 
that approximately 50% of all category 1 PUs disappear during the day, whereas 
on the other hand around 22% of all category 1 PUs worsen during the day 
(Halfens et al., 2001). No study related to this particular phenomenon has been 
undertaken so far for the pediatric setting. 
The prevalence of pressure ulcers category 2 and above accounts for 3% of the 
total. This is lower than the prevalence of pressure ulcers in the study of Suddaby 
et al. (2005) and Groeneveld et al. (2004) (both 5.1%) and also lower as the PU 
prevalence in an earlier study of Schlüer et al. (2009) (4.5%). This means that 
however a lot of patients are vulnerable, in fact the progression to a higher 
 category occurs rather infrequently. Nevertheless this implies that the diagnosis of 
a category 1 PU requires a related preventive intervention.  
The most affected patient group in this study involved very young patients in the 
PICU setting showing mostly category 1 PU. This is in line with results of Curley et 
al. (2003). The prevalence of PU of nearly 45% in this patient group and the figure 
of 60% being at risk is disconcerting and needs special attention. Patients in the 
NICU care setting show an overall prevalence of 43%. Children treated in a NICU 
or/and PICU care setting are most vulnerable due to several factors like the 
immaturity of the skin in very young neonates and newborns and anatomical, 
physiological and immunological differences (Schlüer et al., 2009, Curley et al., 
2003). In general these children are in a critical clinical condition and often 
undergo life saving treatments. If one takes in consideration that at these patients 
often a lot of external medical devices are applied, which might affect the skin, the 
high vulnerability for getting a PU seams feasible (Schlüer et al., 2009, Curley et 
al., 2003, Kottner et al., 2010, Baharestani, 2007). Until now, there is a lack of 
longitudinal research on the development and deterioration of PUs in pediatric 
patients.  
Although not all pressure ulcers are preventable, the high prevalence rate 
detected in this study indicate a need to improve PU care and to start raising 
staff’s awareness of the pressure ulcer issue in the pediatric health care setting; 
especially in the PICU and/or NICU care setting (McLane et al. 2004, Schlüer et 
al., 2009, Curley et al., 2003, Kottner et al., 2010). Preterm babies, Newborn 
babies, Infants and toddlers are unable to judge pressure or sensory perceptions 
from technical devices properly and are for this reason most vulnerable. Besides 
their communication possibilities and skills are limited due to their age and 
development status.  
An adapted, reliable and valid risk assessment tool, applicable to the wide range 
of population from neonates to adolescents, in combination with validated cut-off 
points, is still not available for the pediatric population (Kottner, Hauss, Schlüer, 
Dassen, 2013). At the time of data collection for the present study the Braden-Q 
scale as well as Glamorgan scale were the only tools available for risk assessment 
in the pediatric population (Curley et al., 2003, Willock, Baharestani, Anthony, 
2007a, Willock, Baharestani, Anthony, 2007b, Willock, Anthony, Richardson, 
 2008). The Braden-Q developed and introduced for immobile patients from 21 
days of age still is not validated for children more than eight years of age and no 
validated German version is available. There is also a lack of a validated German 
version of the Glamorgan scale. Therefore, due to this lack of alternatives the 
original Braden scale was used to assess pressure ulcer risk. The use of the 
Braden scale for this target group is problematic insofar as no defined cut-off point 
for specifying children at risk is known. Additionally, it is claimed that the Braden 
scale offers inadequate reliability and insufficient predictive performance 
(Papanikolaou, Lyne, Anthony, 2007). 
Due to this aspect and the findings presented in this study the question arises 
whether in the pediatric population a prevalence rate for children with and without 
external medical devices like tubes, and fixation devices might be an important 
marker. The impact of pressure and friction and shear forces due to these external 
devices seems much more risky for children than for adults, as these devices 
seem responsible for most of the pressure ulcers in pediatric patients (Schlüer et 
al., 2009, Baharestani, 2007, Kottner et al., 2013, Willock et al., 2007a, Willock et 
al., 2007b, Willock et al., 2008, Baharestani and Ratliff, 2007). On the other hand it 
should be noted that there are only a few studies that have investigated factors for 
PU development in the pediatric population (Cockett, 2001, Schlüer et al., 2009). 
There are several limitations to this study. We have to realize that prevalence 
studies are always subject to daily variations. However in general it shows that 
prevalence figures over the years are relative constant (Halfens et al., 2001). No 
findings about detailed differences in specific age categories can be presented. 
The number of eligible patients was affected by the requirement of a signed 
informed consent of both parents and all patients older than 10 years of age. 
Studies elsewhere are necessary to validate our findings and to generalize the 
results to other pediatric care settings. Further studies are needed to establish the 
special risk factors of this highly vulnerable population and possibly incorporate 
these into a target group specific risk assessment instrument. Furthermore one 
has to establish the fact that in this studies only older children show category 3 
and 4 PU. Detailed research according to this phenomena is needed. 
 3.5 Conclusion  
This study confirms the relevance and importance of a high quality of care to 
target the issue of Pressure Ulcers in pediatric care, especially in PICU and NICU 
care settings. The prevalence rate is high, or at least the risk of developing a 
pressure ulcer is high. Especially the use of medical devices seems to cause 
pressure ulcers in hospitalized children. Therefore, it is important that staff will be 
trained in the early recognition of pressure ulcers, in risk factors for children and in 
evidence based preventive methods.  
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 Abstract 
Background: Pressure ulcer risk assessment using an age-appropriate, valid and 
reliable tool is recommended for clinical pediatric practice. 
Objectives: (1) What PU risk scales for children currently exist? (2) What is the 
diagnostic accuracy of their scores? (3) Are the scores reliable and what is the 
degree of agreement? (4) What is the clinical impact of risk scale scores in 
pediatric practice? 
Design: Systematic review. 
Data sources: MEDLINE (1950 to December 2010), EMBASE (1989 to December 
2010), CINAHL (1982 to December 2010), reference lists. 
Review methods: Two reviewers independently screened databases, selected and 
evaluated articles and studies. Diagnostic accuracy, reliability/agreement, and 
experimental studies investigating the performance and clinical impact of PU risk 
scale scores in the pediatric population (0 to 18 years) were included. PU 
development was used as reference standard for diagnostic accuracy studies. 
Methodological quality of the validity and reliability studies was assessed based on 
the QUADAS and QAREL checklists. 
Results: The search yielded 1141 hints. Finally, 15 publications describing 12 
pediatric pressure ulcer risk scales were found. Three of these scales (Neonatal 
Skin Risk Assessment Scale for Predicting Skin Breakdown, Braden Q Scale, 
Burn Pressure Skin Risk Assessment Scale) were investigated in prospective 
validation studies. Empirical evidence about interrater reliability and agreement is 
available for four instruments (Neonatal Skin Risk Assessment Scale for Predicting 
Skin Breakdown, Starkid Skin Scale, Glamorgan Scale, Burn Pressure Ulcer Risk 
Assessment Scale). No studies were identified investigating the clinical impact. 
Conclusions: Sound empirical evidence about the performance of pediatric 
pressure ulcer risk assessment scales is lacking. Based on the few results of this 
review no instrument can be regarded as superior to the others. Whether the 
application of pressure ulcer risk assessment scales reduces the pressure ulcer 
 incidence in pediatric practice is unknown. Maybe clinical judgment is more 
efficient in evaluating pressure ulcer risk than application of risk scale scores.  
   
 4.1 Introduction 
A pressure ulcer (PU) is localized injury to the skin and/or underlying tissue as a 
result of pressure, or pressure in combination with shear (National Pressure Ulcer 
Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP), 
2009). While this phenomenon has gained a great deal of attention in adults, far 
less is known about PUs in the pediatric population including children from birth to 
adolescence (Baharestani and Pope, 2007). Recent investigations indicate that 
PUs are common in infants and children: reported PU prevalence rates including 
all PU categories range from approximately 3% (Dixon and Ratliff, 2005; Noonan 
et al., 2006) to 23% (Suddaby et al. 2005) to 27% (Schlüer et al., 2009). 
Avoidance of pressure-related injuries and maintenance of skin and tissue integrity 
are regarded as important goals in the care process. Identifying individuals at risk 
for developing PUs by structured risk assessments is recommended as a first step 
for effective PU prevention (Duncan, 2007; Stechmiller et al., 2008). In the recently 
published international guideline by the NPUAP and the EPUAP (2009) it is 
explicitly stated that “Risk assessment scales are the foundation of risk 
assessment practice.” (p. 24). 
During the last five decades more than 30 standardized PU risk scales for adults 
were developed, tested and modified. The structure of most of these instruments 
is comparable: They include a number of items that deemed important for PU 
development, like "Mobility", "Continence", "Nutrition" and many more (e.g. 
Bergstrom et al., 1987; Waterlow, 1985). Item scores are summed resulting in total 
scores indicating individual risk. To be useful in clinical practice PU risk 
assessment scales must be valid and reliable, they should demonstrate an 
enhanced quality of care, and they must improve patient outcomes. Above all, 
application of PU risk assessment scales should reduce PU incidence (Jull and 
Griffiths, 2010; Kottner and Balzer, 2010). 
There are various systematic reviews addressing validity, reliability and clinical 
impact issues of PU risk scales in the adult population (e.g. Pancorbo-Hidalgo et 
al., 2006; Moore and Cowman, 2008; Kottner et al. 2009) but there is no up to date 
systematic synthesis of empirical evidence about PU risk scales in children. This is 
 a serious limitation since PU risk assessment using an age-appropriate, valid and 
reliable tool is also recommended for clinical pediatric practice (Loman 2000; 
Baharestani and Pope, 2007). 
To our knowledge a review published by Gray in 2004 was the only attempt to 
systematically review performance measures of pediatric PU risk scales. He 
identified limited evidence to support the use of the Braden Q scale (Curley et al., 
2003) and the Neonatal Skin Risk Assessment Scale (Huffines and Logsdon, 
1997). Although he performed a systematic database search the review methods, 
the study selection and the data extraction process were not well described and a 
quality appraisal of included studies was not conducted. 
When investigating validity different approaches may be used (Streiner and 
Norman, 2008). Regarding PU risk scales one question is most important: Does 
the obtained score measure PU risk correctly? Most often this question is 
answered by diagnostic accuracy studies: estimated PU risk scale scores are 
compared with subsequent PU development (yes/no). In these studies application 
of a prospective design is crucial to establish causes (PU risk) and effects (PU 
development). On the other hand, using PU development as a reference standard 
is limited because preventive measures usually reduce PU risk determined by the 
scale scores under investigation (Defloor and Grypdonck, 2004). Consequently, 
when investigating diagnostic accuracy preventive measures should be taken into 
account (Halfens, 2000; Kottner and Balzer, 2010).  
Estimates of interrater reliability and agreement are also important quality issues 
for PU risk scale scores because in clinical practice the instruments are usually 
used by different team members scoring the same child. Interrater reliability and 
agreement are often used synonymously but both of these terms are conceptually 
distinct (De Vet et al., 2006; Kottner, 2009; Griffiths and Murrells, 2010). Interrater 
reliability can be defined as the degree to which two or more raters are able to 
differentiate among subjects under similar assessment conditions whereas 
interrater agreement is the degree to which raters achieve identical results 
(Kottner et al., 2011). Both, interrater reliability and agreement are needed to 
evaluate the instrument’s performance. 
 Evidence of validity and reliability of scores is necessary but not sufficient to 
determine whether a scale should be used in practice. Also important is the 
question of the clinical importance of the scores: How do PU risk scale scores 
influence clinical decisions and management based on the scores (e.g. starting or 
withholding therapeutic interventions)? Randomized study designs are the best 
way to assess the clinical impact of the scores and subsequent clinical decision-
making. Before-after studies may also be used but contain higher risk of bias 
(Knottnerus et al., 2009; Lijmer and Bossuyet, 2009). 
The overall aim of this study was to systematically review empirical evidence 
about validity, reliability and clinical impact of PU risk assessment scales for 
children. The objectives were to address the following questions: 
(1) What PU risk scales for children currently exist? 
(2) What is the diagnostic accuracy of their scores? 
(3) Are the scores reliable and what is the degree of agreement? 
(4) What is the clinical impact of risk scale scores in the pediatric practice? 
4.2 Methods 
4.2.1 Search 
A concurrent search was run in the databases MEDLINE (1950 to December 03, 
2010) and EMBASE (1989 to December 03, 2010) via Ovid. The database 
CINAHL (1982 to December 2010) was searched using EBSCOHOST. To identify 
as many relevant sources as possible a broad search strategy was applied 
containing terms to identify the population and the condition. Due to incomplete 
reporting, inconsistent indexing, and a lack of availability of subject headings, no 
other search filters were used to maximize sensitivity (De Vet et al., 2008; 
Leeflang et al., 2008; Kottner et al., 2011). For both searches subject headings 
and natural language terms were used in all fields: 
#1 child* OR infant* OR pediatric* 
 #2 pressure ulcer OR pressure ulcers OR bedsore OR bedsores OR bed sore 
OR bed sores OR decubitus 
#3 #1 AND #2 
Reference lists from potentially relevant studies were screened as well. Finally, 
using the Science Citation Index (SCI) and Scopus, articles were searched citing 
the included articles from the database and reference list search (forward search). 
The database searches and study selections were conducted independently by 
two reviewers. Due to the wide coverage of the SCI (11000 journals) and Scopus 
(18000 journals plus conference proceedings) it was decided to take no other 
steps to locate other literature. 
4.2.2 Study selection 
The results of the database and reference list searches were screened by two 
investigators independently. The target population consists of infants from 0 to 23 
month (including premature newborns), children from 2 to 12 years, and 
adolescents from 13 to 18 years). No setting was excluded. More specific inclusion 
criteria were set according to the four study questions: 
(1) What PU risk scales for children currently exist? We included every source 
introducing or describing a standardized PU risk scale. 
(2) What is the diagnostic accuracy of their scores? Studies were included 
when they used a prospective design and PU development (incidence) of 
any PU category as reference standard. Prospective designs are 
considered crucial for PU risk validation (Pancorbo-Hidalgo et al., 2006), 
because the degree of PU risk (quantified by risk scales) was regarded as 
the predictor for possible subsequent PU development. Consequently, 
studies using cross sectional designs were excluded due to their inability to 
establish relations between possible predictors and the outcome PU 
development. Temporality can only investigated in longitudinal studies 
(Twisk, 2003). Studies using other validation approaches (e.g. known 
groups) were also excluded.  
 (3) Are the scores reliable and what is the degree of agreement? All studies 
comparing PU risk scale scores of different raters using the same scale 
(interrater) or of the same raters using the same scale at different times 
(intrarater) were included (Kottner et al., 2011). No raters or rater pairings 
were excluded. 
(4) What is the clinical impact of risk scale scores in the pediatric practice? To 
evaluate the clinical impact of PU risk scale scores in the pediatric practice 
we included RCTs, CCTs and before-after studies. The application of a 
pressure ulcer risk scale was regarded as intervention compared to the use 
of another or no risk scale. PU incidence (as defined by the authors) was 
regarded as outcome. 
Further exclusion criteria were narrative reviews, opinions and studies dealing with 
general risk factors for PU development.  
Figure 1: Identification and selection process of studies 
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searching in MEDLINE, EMBASE, 
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Records excluded  
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Studies included in 
synthesis  
(n = 15) 
 4.2.3 Data extraction and assessment of methodological quality 
Authors, years, target groups and items of identified PU risk scales were 
extracted. For diagnostic accuracy a second data extraction sheet containing 
authors, years, instruments, setting, sample, methods, reference standard and 
results was used. Methodological quality of included papers was assessed by 
using the QUADAS tool (Whiting et al., 2003). This instrument was developed 
based on systematic reviews of methodological literature and three Delphi rounds 
with nine experts in diagnostic accuracy studies. This tool was designed to be 
used in systematic reviews and its use is recommended (Buntinx et al., 2009). The 
QUADAS checklist is also recommended for the quality assessment of studies 
included Cochrane Systematic Reviews of Diagnostic Test Accuracy (Reitsma et 
al., 2009). 
Data from interrater reliability and agreement studies were gathered using a third 
data extraction sheet. It contained: authors, years, instrument, setting, sample of 
raters, sample of subjects, methods and results. The recently developed QAREL 
checklist (Lucas et al., 2010) was used to evaluate the methodological quality of 
included interrater reliability and agreement studies. In an iterative process a 
group of researchers with expertise in diagnostic research developed this tool for 
use in systematic reviews. The QAREL checklist was chosen because this seems 
to be the only available quality appraisal tool for reliability studies at the moment. 
Data extraction and methodological evaluation was conducted independently by 
two reviewers. Disagreements were resolved by consensus. 
During the search and study selection process it became clear that there are no 
studies about the clinical impact of PU risk scale scores in the pediatric practice. 
Therefore neither a data extraction sheet nor a methodological evaluation was 
needed. 
  
 4.2.4 Data synthesis and interpretation 
Settings, populations, authors, years, and items of identified scales were 
summarized descriptively in one table. To enable comparisons, instruments were 
ordered chronologically and items were sorted according to the frequency of joint 
items. 
Study results regarding the second and third research questions were also 
described and synthesized qualitatively. Due to only few eligible studies 
investigating different scales a meta-analysis or alternative forms of statistical 
pooling (e.g. reliability generalization) were impossible. 
ROC curves in the original investigations were regarded as necessary for 
determining adequate cut-off points. These cut-off points should maximize both 
sensitivities and specificities. Positive likelihood ratios (LR+) above 10 and 
negative likelihood ratios (LR-) below 0.1 were regarded as providing convincing 
diagnostic evidence, whereas those above 5 and below 0.2 were regarded as 
giving strong diagnostic evidence (Deeks, 2001). Interrater reliability coefficients 
above 0.9 were regarded as the minimum for individual clinical decision-making 
(Nunnally and Bernstein, 1994; Polit and Beck, 2008). Results were taken from the 
study reports or recalculated when raw numbers were given. 
4.3 Results 
4.3.1 Search results 
The identification and selection process is shown in Figure 1. After removal of 
duplicates 1141 entries were obtained. After screening and reviewing the title 
and/or abstract 20 full text articles were read. Five articles were excluded for the 
following reasons: no standardized scales were described (n = 3) and diagnostic 
accuracy was investigated in a cross sectional way (n = 2). No other relevant 
publications were found by the SCI and Scopus searches. 
 4.3.2 Pressure ulcer risk scales 
Twelve out of the 15 included publications described standardized PU scales for 
children (Table 1). Four instruments were developed for pediatric intensive care 
settings (Bedi, 1993; Garvin, 1997; Cockett, 1998; Olding and Patterson, 1998), 
one tool was developed for neonates (Huffines and Logsdon, 1997) and one scale 
was introduced for pediatric burn patients (Gordon, 2008, 2009). Pediatric patients 
in general were the target group for the remaining scales. 
Some authors (Quigley and Curley, 1996; Huffines and Logsdon, 1997; Suddaby 
et al., 2005) presented modifications of the Braden scale for adults (Bergstrom et 
al, 1987). Taking population specific characteristics into account Quigley and 
Curley (1996) added the item "Tissue Perfusion and Oxygenation" to the original 
scale and Huffines and Logsdon (1997) replaced the items "Sensory perception" 
and "Friction & shear" by "General physical condition" and "Mental state". Based 
on the aim to create a one-page, easy-to-use scale Suddaby et al. (2005) 
developed the "Starkid Skin Scale" by "...rewording and simplifying the concepts 
presented in the Braden Q ..." (p. 134). 
Pickersgill (1997) introduced a "Pediatric Risk Assessment Score" by combining 
items from the Medley (Williams, 1991) and Waterlow scales (Waterlow, 1985). 
Also Bedi (1993) modified the Waterlow scale for adults by adapting the contents 
in each Waterlow item to pediatrics. In subsequent stages this tool was further 
modified and new items were included. 
Gordon (2008, 2009) used a modified Delphi technique with 15 nurses 
experienced in burn care to develop a new scale. Other scales were developed 
based on opinion and literature reviews (Garvin, 1997; Cockett, 1998; Waterlow, 
1998; Barnes, 2004) and based on empirical data (Willock et al., 2007). 
As shown in Table 1 there were considerable differences of included items 
between the scales. The item “Mobility” was part of every instrument, followed by 
the items "Nutrition/food intake" (included in seven scales) and "Continence" 
(included in six scales). 
  
 Table 1: Suggested items for pediatric pressure ulcer risk assessment scales 
Items 
Setting/population (Author, year)   
PICU 
(Bedi, 
1993) 
Pediatric 
(Quigley
, Curley, 
1996) 
PICU 
(Garvin, 
1997) 
Neonates 
(Huffines, 
Logsdon, 
1997) 
Pediatric 
(Pickersgill, 
1997) 
Pediatric 
(Cockett, 
1998) 
PICU 
(Olding, 
Patterson, 
1998) 
Pediatric 
Waterlow 
(1998) 
Pediatric 
(Barnes, 
2004) 
Pediatric 
(Suddaby 
et al., 
2005) 
Pediatric 
(Willock 
et al., 
2008) 
Pediatric 
Burn 
Patients 
(Gordon, 
2009) 
Total 
Gestational age 
   X        
 1 
Weight according to 
age 
X    X X X  X  X 
 6 
Continence X    X X X  X  X X 7 
Moisture  X X X      X  X 5 
Skin condition/ skin 
damage 
X    X X X X X   
 6 
Mobility X X X X X X X X X X X X 12 
Activity  X  X      X   3 
Appetite X    X        2 
Nutrition/ food intake  X X X  X X X  X X X 9 
Age X            1 
Tissue perfusion/ 
oxygenation/ 
cyanosis 
X X        X X 
 4 
Cachexia X            1 
Circulatory/ vascular 
disease 
X           
 1 
Heamodynamic 
status/inotropic 
X     X X     
X 4 
 support 
Infection X            1 
Neurological/ 
mental state/ 
Glasgow Coma 
Scale 
X   X  X   X   
 4 
Major surgery/trauma X     X  X X    4 
Medication X    X        1 
Sensory perception  X X      X X   4 
Friction & shear  X       X X   3 
Sedation      X   X  X  3 
Respiratory status/ 
ventilation 
     X X X    
 3 
Body temperature      X X    X  3 
Physical disabilities        X     1 
Head injury        X     1 
Severe illness        X     1 
ICU        X     1 
Anaemia           X  1 
Albumin           X  1 
Devices (casts, 
splints, tubes, lines) 
     X  X X X X 
X 6 
Prior PU            X 1 
 4.3.3 Diagnostic accuracy 
Three diagnostic accuracy studies using a prospective design met the inclusion 
criteria (Huffines and Logsdon, 1997; Curley et al, 2003; Gordon, 2009). Results of 
the methodological quality assessment are shown in Table 2. Studies met eight 
(Huffines and Logsdon, 1997) and nine (Curley et al., 2003; Gordon, 2009) of 14 
quality criteria. Information regarding blinding against results of the reference 
standard and the index was missing in all studies. Since preventive measures 
were not considered in the calculation of the validity estimates it is likely that the 
reference standard was biased. 
Table 2: Quality assessment according QUADAS 
Items Huffines 
and 
Logsdon 
(1997) 
Curley et 
al. (2003) 
Gordon 
(200) 
1. Was the spectrum of patients representative of the patients 
who will receive the test in practice? 
Y Y 
Y 
2. Were selection criteria clearly described? N N Y 
3. Is the reference standard likely to correctly classify the 
target condition? 
N N 
N 
4. Is the time period between reference standard and index 
test short enough to be reasonably sure that the target 
condition did not change between the two tests? 
Y Y 
Y 
5. Did the whole sample or a random selection of the sample 
receive verification using a reference standard of diagnosis? 
Y Y 
Y 
6. Did patients receive the same reference standard 
regardless of the index test result? 
Y Y 
Y 
7. Was the reference standard independent of the index test 
(i.e. the index test did not form part of the reference 
standard)? 
Y Y 
Y 
8. Was the execution of the index test described in sufficient 
detail to permit replication of the test? 
Y Y 
Y 
9. Was the execution of the reference standard described in 
sufficient detail to permit its replication? 
U Y 
Y 
10. Were the index test results interpreted without knowledge 
of the results of the reference standard? 
U N 
U 
11. Were the reference standard results interpreted without 
knowledge of the results of the index test? 
U N 
U 
12. Were the same clinical data available when test results 
were interpreted as would be available when the test is used 
in practice? 
Y Y 
Y 
13. Were uninterpretable/ intermediate test results reported? U U N 
14. Were withdrawals from the study explained? U U N 
Y = yes, N = no, U = unclear. 
 Study characteristics are shown in Table 3. Huffines and Logsdon (1997) scored 
32 neonates according to the “Neonatal Skin Risk Assessment Scale” consisting 
of six items. The observation period was two month. Due to low interrater reliability 
of the items “Mental state”, “Mobility” and “Moisture” the authors only used the sum 
scores of the items “General physical condition”, “Activity” and “Nutrition” for 
validity investigation. The best balance between sensitivity (83%) and specificity 
(81%) was achieved at a cut-off of 5 with a positive likelihood ratio of 4.3 and a 
negative likelihood ratio of 0.2. 
Table 3: Results of prospective diagnostic accuracy studies 
Author Instrument 
(score range) 
Setting/ 
sample 
Methods Reference 
standard 
Results Comments 
(Quality Score 
according 
QUADAS) 
Huffines 
and 
Logsdon 
1997 
Items “general 
physical condition”, 
“activity”, “nutrition” 
of the Neonatal 
Skin Risk 
Assessment Scale 
for Predicting Skin 
Breakdown 
(NSRAS) (3 to 12) 
Neonatology, 
n = 32, 
convenience, intact 
skin, mean age  
33 weeks’ 
gestation 
Assessment with 
NSRAS within 24h 
post delivery; skin 
assessments for 
two months, until 
discharge or skin 
breakdown 
Skin breakdown Incidence 6/32 
(19%); at cut-off 5 
sensitivity = 0.83, 
specificity = 0.81,  
PPV = 0.50, NPV = 
0.95, LR+ = 4.3,  
LR- = 0.2 
Reference 
standard not 
clearly defined, 
LRs recalculated 
(7/14) 
Curley et 
al. 2003 
Braden Q (7 to 28) PICU, n = 322, 
convenience, intact 
skin, mean age  
3 years 
Assessment with 
Braden Q and skin 
assessments by 
two trained nurses 
independently until 
discharge 
Pressure ulcers 
Stage I to IV 
(NPUAP 1998) 
Incidence 86/322 
(26.7%); for Stage 
II and higher PUs 
AUC = 0.83, at cut-
off 16 sensitivity = 
0.88, specificity = 
0.58,  
PPV = 0.15, NPV = 
0.98, LR+ = 2.1,  
LR- = 0.2 
 
Only subscales 
“sensory 
perception”, 
“mobility”, “tissue 
perfusion” 
contributed greater 
than 0.7 to AUC 
LR- recalculated 
(8/14) 
Gordon 
(2009) 
Burn Pressure 
Ulcer Skin Risk 
Assessment Scale 
(?) 
3 pediatric burn 
intensive care 
units, n=163, 
convenience, 
mean age 7.2 y (2 
months to 18 
years) 
Not speaking 
English or 
Spanish, length of 
stay <3 days, 
primary diagnosis 
not acute burn 
injury, total surface 
aera burned > 85% 
Risk assessment 
on post op day 
one, two or three; 
daily skin 
inspection by 
trained nurses until 
PU occurrence or 
discharge 
Incidence 44/163 
(27%) based on 
logistic regression 
model comparing 
predicted vs. 
observed PUs 
sensitivity = 0.54, 
specifity =0.95; 
PPV=0.80, 
NPV=0.85, 
LR+=11.1, LR-
=0.48 
Only itemas 
“prior/current PU”, 
“precent total body 
surface area 
burned”, “number 
of splints” were sig. 
predictors 
Mean age and 
results 
recalculated; 
sample size 
determenination 
for logistic 
regression was 
performed; no cut-
off point 
established (9/14) 
 
 Curley et al. (2003) used a modified version of the Braden scale to score 322 
children of three pediatric intensive care units. Using newly developed stage II to 
IV PUs as the reference standard the best balance between sensitivity (88%) and 
specificity (58%) was achieved at a cut-off of 16. The positive likelihood ratio was 
2.1 and the negative likelihood ratio was 0.2. Performance in terms of AUC, 
sensitivity, specificity and likelihood ratios of a modified Braden Q scale including 
only the items “Mobility”, “Sensory perception” and “Tissue perfusion/oxygenation” 
was similar to the long version. 
Based on a literature review and consensus of 15 burn nurses Gordon (2009) 
evaluated a newly developed "Burn Pressure Ulcer Skin Assessment Scale" in 
three pediatric burn units (n = 163). A logistic regression model was used to 
calculate the predictability of the scale items (independent variables) for the 
occurrence of PUs (dependent variable). Compared with the observed PU 
occurrence sensitivity was 54% and specificity was 95% (LR+ = 11.1, LR- = 0.48). 
Due to this statistical procedure no cut-off points were established. 
4.3.4  Reliability and agreement 
Five studies provided evidence about interrater reliability and agreement (Huffines 
and Logsdon, 1997; Suddaby et al., 2005; Willock et al., 2008; Gordon, 2008, 
2009). Results of the methodological quality assessment are displayed in Table 4. 
Expect one study with missing information (Gordon, 2008) authors used 
representative samples of raters (persons similar to intended users in clinical 
practice) and subjects, raters were blinded to each other’s scores and the time 
interval between ratings was considered appropriate. On the other hand 
information about the assessment process and scale application (e.g. order of 
examination) was not stated. Willock et al. (2008) and Gordon (2008, 2009) 
calculated proportions of agreement, kappa and ICC coefficients that were 
appropriate statistical measures (Lucas et al., 2010). Huffines and Logsdon (1997) 
and Suddaby et al. (2005) used Persons r that is inappropriate to indicate reliability 
(Kottner and Dassen, 2008; Lucas et al., 2010). 
  
 Table 4: Quality assessment according QUAREL 
Items Huffines 
and 
Logsdon 
(1997) 
Suddaby 
et al. 
(2005) 
Willock 
et al. 
2008 
Gordon 
(2008) 
Gordon 
(2008) 
1. Was the test evaluated in a sample of subjects who were 
representative of those to whom the authors intended the 
results to be applied? 
Y Y Y 
 
U 
 
Y 
2. Was the test performed by raters who were 
representative of those to whom the authors intended the 
results to be applied? 
Y Y Y 
 
Y 
 
U 
3. Were raters blinded to the findings of other raters during 
the study? 
Y Y Y 
U U 
4. Were raters blinded to their own prior findings of the test 
under evaluation? 
N/A N/A N/A 
N/A N/A 
5. Were raters blinded to the subjects’ disease status or the 
results of the accepted reference standard for the target 
disorder (or variable) being evaluated? 
U U U 
 
U 
 
U 
6. Were raters blinded to clinical information that was not 
intended to form part of the study design or testing 
procedure? 
N/A N/A N/A 
 
N/A 
 
N/A 
7. Were raters blinded to additional cues that are not part 
of the test? 
U N U 
U U 
8. Was the order of examination varied? U U U U U 
9. Was the stability (or theoretical stability) of the variable 
being measured taken into account when determining the 
suitability of the time interval among repeated measures? 
Y Y Y 
 
U 
 
Y 
10. Was the test applied correctly and interpreted 
appropriately? 
U U U 
U U 
11. Were appropriate statistical measures of agreement 
used? 
N N Y 
Y Y 
Y = yes, N = no, U = unclear, N/A = not applicable. 
Study characteristics and results are shown in Table 5. Huffines and Logsdon 
provided correlation coefficients for neonatal nurse rater pairs over 9 days for each 
item. The values for the items “General physical condition”, “Activity” and 
“Nutrition” ranged between 0.8 and 1. Correlation among remaining items “Mental 
state”, “Mobility” and “Moisture” was much lower ranging between -0.27 to a 
maximum of 0.57. Due to the low correlations coefficients the authors decided to 
exclude the latter from subsequent investigations of validity. 
In a strict sense Suddaby et al. (2005) did not perform a reliability study because 
they compared the scorings made by staff nurses with scorings made by clinical 
nurse specialists. The correlation for the total score was 0.85. Most disagreements 
were observed for the item “Nutrition”. 
Willock et al. (2008) compared 15 ratings made by seven randomly selected 
qualified nurses with ratings made by one researcher. This design is more of a 
validation study than an interrater reliability study. Except one rating for the item 
“Inadequate nutrition” all other ratings were identical (100% agreement). 
 Gordon reported results of two interrater reliability studies comprising 21 (2008) 
and 20 (2009) duplicate assessments. ICC values indicate nearly perfect interrater 
reliability for the total score. 
  
 Table 5: Results of interrater reliability and agreement studies 
Author Instrument 
(score range) 
Setting Raters (k) Subjects (n) Methods Results Comments 
(Quality Score  
according 
QUAREL) 
Huffines 
and 
Logsdon 
(1997) 
Neonatal Skin Risk 
Assessment Scale 
for Predicting Skin 
Breakdown 
(NSRAS) (6 to 24) 
 
Neonatology Nurses providing 
care (k not stated) 
Neonates, mean 
age 33 weeks’ 
gestation (n = 32) 
Independent 
assessment of 
neonates by 
researcher and the 
nurse providing 
care within 9 
subsequent 
occasions (256 
paired ratings) 
r = -.27 to 1.00 
across all items 
and rater pairs; r = 
0.97 for “physical 
condition”, 
“activity”, 
“nutrition” across 
two raters  
Calculation and 
kind of interrater 
reliability 
coefficients not 
clearly described 
(QS 4/9) 
Suddaby 
et al. 
(2005) 
Starkid Skin Scale 
(6 to 24) 
Pediatric hospital Staff nurses (k = 
4), clinical nurse 
specialists (k = 3) 
n = 30 Independent 
assessment of 
staff nurse and 
clinical nurse 
specialists on 
same day 
r = 0.85 for total 
score; most 
differences (10/30) 
for “nutrition” 
No interrater 
reliability study in a 
strict sense (QS 
4/9) 
Willock et 
al. (2008) 
Glamorgan scale 
(0 to 42) 
Pediatric wards of 
tertiary hospital 
Randomly 
selected nurses (k 
= 15) and one 
researcher  
Not described (n = 
15) 
Independent 
assessment of 
children by 
researcher and 
one nurse within 
ten minutes (15 
paired ratings) 
100% agreement 
between 
researcher and 
nurses rating all 
items; one 
disagreement for 
rating “Inadequate 
nutrition” 
No interrater 
reliability study in a 
strict sense (QS 
5/9) 
Gordon 
(2008) 
Burn Pressure 
Ulcer Skin 
Assessment Scale 
(?) 
? Burn nurses (k =5) (n=21) ? ICC= 0.99 for total 
score 
QS (2/9) 
Gordon 
(2009) 
Burn Pressure 
Ulcer Skin 
Assessment Scale 
(?) 
3 pediatric burn 
intensive care 
units 
Burn nurses (k =2) (n=20) Nurses rated 
patients at the 
same point in time 
ICC= 0.99 for total 
score; ICC for 
items ranging form 
0.86 tp 1.00 
QS (3/9) 
 4.4 Discussion 
This systematic review aimed at providing an overview of existing PU risk for the 
pediatric population and synthesizing empirical evidence about their performance. 
In total, 12 instruments were identified. Since many of them are modifications of 
PU risk scales for adults they contain many variables deemed important for PU 
development in the adult population as well, e.g. continence, moisture, nutrition. 
“Mobility” was part of every scale. Assessing the degree of mobility to determine 
PU risk in children seems reasonable, because the relation between mobility and 
PU development is well established (NPUAP & EPUAP, 2009). On the other hand 
it should be noted that there are only a few studies investigating factors for PU 
development in the pediatric population (Cockett, 2002). Although long known to 
be a problem in infants and children (Okamoto et al., 1983), the risk factor 
“devices on the skin” is only considered in the newer scales since 1998. 
Given that 12 instruments are available, the degree of validation is poor. We 
identified only three single validation studies: one for the Neonatal Skin Risk 
Assessment Scale (Huffines and Logsdon, 1997), one for the Braden Q scale 
(Curley et al., 2003) and one for the Burn Pressure Ulcer Skin Risk Scale (Gordon, 
2009) meeting our inclusion criteria.  
Huffines and Logdsdon (1997) used the items “General physical condition”, 
“Activity” and “Nutrition” that are scored between 1 and 4 each leading to sum 
scores from 3 to 12. Irrespective of methodological limitations they showed that a 
score of 5 leads to an optimal balance between sensitivity and specificity and 
calculated positive and negative likelihood ratios indicate strong diagnostic 
evidence. Based on this result it seems that the applied items have power to 
discriminate between neonates with high and low PU risk. 
Similarly, Curley et al. (2003) also provided a cut-off score for the Braden Q scale 
for discriminating between PU risks in children on the ICU. Compared to the 
results by Huffines and Logdsdon (1997) specificity was much lower and positive 
and negative likelihood ratios provide only weak diagnostic evidence. The strength 
 of this study was that the authors used PU stages II to IV as reference standard. 
Excluding grade 1 PUs from statistical analysis enhances interrater reliability and 
therefore internal validity of studies (Kottner et al., 2009). Interestingly, the authors 
calculated nearly the same validity estimates when using the items “Sensory 
perception”, “Mobility” and “Tissue perfusion” only. This indicates that not all PU 
risk scale items are equally important, a finding that is supported by numerous 
studies today (e.g. Fischer et al., 2004; Papanikolauo et al., 2003). Scoring the 
items “Sensory perception”, “Mobility” and “Tissue perfusion” in the pediatric ICU 
population might be as good as using the whole Braden Q scale. 
The newly developed Burn Pressure Ulcer Skin Risk Scale (Gordon, 2009) 
comprises nine items but only three items were statistically significant in a 
multivariate logistic regression model. No cut-off points were provided and 
therefore the obtained validity estimates are difficult to interpret. 
Although being included, the studies had severe methodological limitations. 
Especially the convenience sampling, the small sample size in Huffines and 
Logsdon's study (1997) and the missing replications limit the generalisability of 
results. All three investigations were conducted in PICUs and therefore results are 
not transferable to other pediatric settings. During our search we found more 
empirical studies about the development and testing of pediatric PU risks scales 
(Suddaby et al., 2005; Willock et al., 2008; Anthony et al., 2010) but they all used 
cross sectional designs that are clearly inappropriate for prognostic research 
(Buckley et al., 2010). 
Five studies provided evidence about interrater reliability and agreement of four 
instruments: (1) Neonatal Skin Risk Assessment Scale (Huffines and Logsdon, 
1997), (2) Starkid Skin Scale (Suddaby et al., 2005), (3) Glamorgan scale (Willock 
et al., 2008) and (4) Burn Pressure Ulcer Skin Risk Scale (Gordon, 2009). All 
investigations had methodological limitations reducing the generalisability of the 
findings. Furthermore, results provided by Huffines and Logsdon (1997) and 
Suddaby et al. (2005) are difficult to interpret, because Pearson’s correlation 
coefficients are presented. Since they only provide information about the degree 
and direction of association they are inappropriate interrater reliability measures 
(Kottner and Dassen, 2008; Lucas et al., 2010). Willock et al. (2008) showed, that 
ratings made by nurses and one researcher were nearly identical. This provides 
 strong evidence, that the Glamorgan scale items are easily and accurately to 
interpret. Findings by Gordon (2008, 2009) indicate that the Burn Pressure Ulcer 
Skin Risk Scale scores have the potential to differentiate between pediatric burn 
patients. 
Beside the discussed validity and reliability aspects the question arises if it is 
feasible to develop a PU risk scale covering all the necessary aspects of the whole 
pediatric population. Considering the immaturity as well as the anatomical, 
physiological and immunological differences and vulnerability of this population’s 
skin and tissues, especially during the neonatal period, it is clear that PU risk 
profiles vary across the different age group (Bahasterani, 2007, Bahasterani & 
Ratliff, 2007, Schlüer et al., 2009).  
We found no publication investigating the clinical impact of pediatric PU risk 
scales. This finding is very well comparable to the state of research in the adult 
population (Moore and Cowman, 2008). 
4.5 Limitations 
Due to database restrictions our results may be biased. Perhaps we missed some 
relevant publications or empirical findings indexed in other databases or published 
in the grey literature. We also not considered publication bias. Like systematic 
reviews of PU risk scales for adults (e.g. Pancorbo-Hidalgo et al., 2006) we 
focused on diagnostic accuracy in prospective studies and on reliability/agreement 
only. We did not review other approaches that might be also important for 
instruments validation (e.g. content validation). Using the occurrence of PUs 
(yes/no) as criterion to validate the construct "PU risk" is also limited, because 
being at risk does not mean getting a PU (Kottner and Balzer, 2010). Taking PU 
preventive measures into account may be one way to improve the precision of a 
validation criterion but such an approach would require very precise definitions 
and operationalizations of PU prevention. Finally, while rating the methodological 
quality based on QUADAS and QAREL we were unable to decide whether the 
quality criteria were unmet or not reported. 
 4.6 Conclusions 
Based on this systematic review we conclude that there is little evidence about the 
performance of PU risk assessment scales in the pediatric practice. Based on the 
sparse results no instrument can be regarded as superior to the others. Although 
users of the Glamorgan and the Burn Pressure Ulcer Skin Risk Scales showed 
excellent interrater agreement/reliability the degree of diagnostic accuracy of both 
tools is unclear. Whether the application of PU risk scales makes any differences 
to PU incidence is unknown. Based on this review the regular scoring of 
standardized PU risk scales in clinical practice is not justified. Maybe clinical 
judgment is as efficient as the use of standardized scales. Well-conducted RCTs 
might be necessary to answer the question whether pediatric patients get fewer 
PUs when PU risk scales are applied.  
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 Abstract 
Purpose: This study aimed to identify factors for the development of pressure 
ulcers in hospitalized patients between 1 and 18 years of age.  
Design and Methods: A multicenter, descriptive, cross-sectional study in 13 
hospitals was conducted in Switzerland.  
Results: The prevalence of pressure ulcers in this population is 26.5%%, with 83% 
category 1 pressure ulcers. A third of all pressure ulcers developed along external 
devices. Older children developed more pressure ulcers due to ineffective 
positioning and limited mobility.  
Practice Implications: Activity and mobility and the risk associated with the use of 
external devices have to be assessed for each child.  
  
 5.1 Introduction 
A pressure ulcer (PU) is a localized injury to the skin and/or underlying tissue as a 
result of pressure, or pressure in combination with shear forces (National Pressure 
Ulcer Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel 
(EPUAP), 2009). Avoidance of pressure-related injuries and maintenance of skin 
and tissue integrity are important goals in the care process, and identifying 
individuals at risk of developing PUs by structured risk assessments is 
recommended as a first step for effective PU prevention (Stechmiller et al., 2008). 
The NPUAP and EPUAP have published an international guideline (NPUAP/ 
EPUAP 2009), which explicitly states that “a structured approach may be achieved 
through the use of a risk assessment scale” in combination with clinical judgment 
(NPUAP/ EPUAP 2010, p. 10).  
While the problem of PUs has received a great deal of attention in adults, far less 
is known about PUs in children and neonates (Baharestani and Pope, 2007). 
Recent investigations have indicated that PUs are also common in the pediatric 
population: Reported PU prevalence rates including all PU categories range from 
approximately 2% to 28% (Kottner, Wilborn, Dassen, 2010) or 35% (Schlüer, 
Halfens, Schols, 2012). One explanation for these high rates involves the 
dramatically improved survival rates of both critically and chronically ill infants and 
children, introducing new challenges for medical and nursing care (Jones, Tweed, 
Marron, 2001). The skin may be affected due to external influences like increased 
pressure and shear forces due to the application of external devices. Particularly in 
patients in pediatric intensive care units (PICUs), the influence of pressure by 
tubes for patients on oscillation and extracorporeal membrane oxygenation as well 
as their decreased tissue tolerance due to their critical life condition increase the 
risk of skin failure, making these patients in critical life conditions most vulnerable 
for PUs (Baharestani and Pope, 2007, Curley, Razmus, Roberts, Wypij, 2003, 
Schlüer et al., 2012). 
An adapted, reliable and valid PU risk assessment tool with validated cut-off 
points, applicable for a wide range of the population from neonates to adolescents, 
is still not available (Kottner, Hauss, Schlüer, Dassen, 2013, Anthony, Willock, 
Baharestani, 2010). Due to the different risk factors in neonates, infants and 
 children it does not seem feasible to develop a risk assessment tool for PU risk 
assessment covering a broad range of the pediatric population (Kottner et al., 
2013). Many of the available assessment tools, like the Braden-Q scale are 
modifications of PU risk scales for adults and include variables deemed especially 
important for PU development in the adult population, e.g. mobility, incontinence, 
moisture, and nutrition. The relevance for clinical effectiveness of specifically 
pediatric PU risk scales has not been investigated so far (Kottner et al., 2013). 
Due to the specific lack of information about factors associated with PU risk in 
children of different age groups, there is an urgent need for studies on pressure 
ulcers in the pediatric population to obtain insight into the importance of the 
problem and to gain knowledge about child-specific risk and associated factors. 
Based on such studies, assessment with a specialized and standardized risk 
assessment tool as well as clinical judgment may lead to an improvement of the 
prevention of PUs and the quality of PU-care for these patients.  
5.1.1 Research aims 
The aim of the present study was to identify factors associated with the occurrence 
of pressure ulcers in hospitalized pediatric patients between one and 18 years of 
age. Further, the aim was to identify anatomical regions associated with the 
highest risk of pressure ulcer occurrence and to identify risk factors of PUs in 
hospitalized pediatric patients.  
  
 5.2 Methods 
5.2.1 Study design  
A multicenter, cross-sectional, descriptive study was conducted in all 13 pediatric 
hospitals in the German-speaking part of Switzerland in June 2009. These 
hospitals have a total of 69 wards. All hospitalized children from one year of age 
up to 18 years were included in the study. Children had to be hospitalized for at 
least one day. Exclusion criteria were a) hospitalization in psychiatric wards, b) 
children whose legal representatives did not allow participation, and c) children 
who refused to participate. The study was approved by all state ethics committees, 
and when necessary by the ethics board of the hospital concerned. After the 
patients and their legal representatives had been verbally informed about the 
study’s content and aim, they also received the information in written form along 
with an informed consent form to sign. The information letter as well as the 
informed consent form for the legal representatives was available in eight different 
languages (German, French, Italian, English, Portuguese, Albanian, Serbian, and 
Turkish). Children of 10 years and older as well as their legal representatives were 
both asked to give their written consent.  
5.2.2 Measurements 
The instrument and method of data collection of the Dutch National Prevalence 
Measurement of Care Problems (LPZ; Halfens et al, 2010) was used to assess the 
prevalence, severity, location and risk factors, as well as factors associated with 
the occurrence of pressure ulcers. Associated factors included assessment of first 
occurrence of a PU and the setting in which a PU occurred. This information was 
taken from the patient’s chart. This instrument is widely used internationally and 
has been assessed as reliable and valid in adult patients (Bours, Halfens, 
Lubbers, Haalboom, 1999). It comprises the following categories of data for 
assessment: (1) patient characteristics (demographic and clinical data), (2) 
assessment of the location and severity of pressure ulcers, (3) PU risk 
assessment using the Braden scale, (4) predisposing factors for PU development, 
 (5) preventive interventions, as well as (6) therapeutic interventions. In addition to 
this instrument, we assessed all external devices on the patient’s body at the time 
of the assessment (e.g. tubes, IV catheterizations splints/iv boards, and other 
devices), which might cause the occurrence of a PU in these children.  
The Braden scale is part of the measurement tool and includes six subscales, five 
of which have four answer categories and one, only three (Bergstrom, Braden, 
Kemp, Champagne & Ruby, 1998, Bergstrom, Braden, Laguzza, & Holman, 1987). 
The total scores range from 6 to 23 points, with a lower score indicating a higher 
risk for the patient to develop a pressure ulcer. A cut-off point for patients at risk 
set at ≤ 20 (Schlüer, Cignacco, Müller & Halfens, 2009). 
5.2.3 Data collection 
The method of data collection involved a direct and systematic inspection and 
judgment of the skin of the patient. The NPUAP/EPUAP (NPUAP/EPUAP, 2009) 
pressure ulcer category system was used. Demographic and clinical data, such as 
date of birth, weight and size, body mass index and diagnosis, were collected from 
patient charts. Assessments of installations on the body site as well as other 
associated factors (like cloths and clothes, incorrect positioning, and cables in 
beds) that may lead to the development of PU were clinically assessed. The total 
information was gathered both by direct inspection of the patient and from the 
patient files.  
Data were gathered by previously trained rater pairs for each patient. A total of 34 
rater pairs were involved in the study. On each unit, an internal and an external 
rater worked together. The internal rater was from the unit itself, the external rater 
was from another unit or department. If the pair disagreed on their assessment, 
they were asked to find consensus. If no consensus could be reached, the 
external rater was given the right of decision. No statement about disagreement 
within the rater pairs can be made as this was not an objective of the study. To be 
selected, raters were required to have had more than two years of nursing practice 
with children. In all participating hospitals, nurses who worked either as wound 
consultants in their units or as clinical nursing specialists acted as raters. 
Preparatory training included methodological aspects, detailed information about 
 data collection, the role and responsibilities of the raters, a detailed introduction to 
the measurement instruments, and special training in the grading of a pressure 
ulcer as well as in the Braden scale in infants and children. Pilot studies in all sites 
with more than two rater pairs were conducted to assess the inter-rater reliability 
for grading and risk assessment. The different rater pairs had to assess the same 
patients independently to check agreement or disagreement within the rater pairs 
in rating the category of PUs and use of the Braden scale. A balanced incomplete 
block design was chosen (Fleiss, 1981). Overall, inter-rater reliability (Kappa 0.79: 
n=180) for the grading of pressure ulcers was sufficient. A data consistency of 
95% as to whether the patient developed a pressure ulcer or not was observed. 
5.2.4 Data analysis 
Predictive Analytics Software (PASW) (version 18, formerly SPSS) was used to 
analyze the study data with descriptive and univariate statistical methods. 
Explorative statistics was used (e.g. boxplots) to describe the distribution of the 
Braden score in relation to departments. Distributions and frequencies were 
calculated. The relation between dependent variables and risk factors was 
distributed with cross tabs and calculated. Group differences were due to the type 
of data tested, with nonparametric tests for categorical (Chi-Square) and not 
normally distributed data (Wilcoxon). A p-value of 0.05 and lower was considered 
as statistically significant. 
  
 5.3 Results 
5.3.1 Demographics 
The overall sample size of potential study participants who met the inclusion 
criteria was 268 (100%). The total number of participants was 204 (76%), because 
64 (24%) dropped out before the assessment. In 42 dropout cases (65%), either 
the legal representative or the child refused participation. Seventeen patients were 
excluded due to unexpected discharge or because examination or operation lasted 
longer than the survey took place (30%). Two children were not assessed due to 
an unexpected change in their condition to a critical level. Only three patients 
dropped out due to language problems. 
In the 13 hospitals, the participation rate ranged from 43-100%. Of the 204 
assessed patients, 67% had been hospitalized for less than 14 days. In this 
subcategory, the average length of stay was five days, with a median of three 
days. The mean length of stay was 29 days (sd: 75.1), with a median stay of 5 
days (table 1). 
  
 Table 1: Demographic characteristics of the total study sample 
 Total n (%) 
Number of patients enrolled (%) 204 (100) 
Gender Male    113 (55.4) 
      
Age categories 1-≤4    60 (29.4) 
 >4-≤8    42 (20.6) 
 >8- ≤12    41 (20.1) 
 >12    61 (29.9) 
      
Department PICU    10 (4.9) 
 Surgery    82 (40.2) 
 Pediatric medical    84 (41.2) 
 Rehabilitation    28 (13.7) 
      
Patients with at least one operation prior to observation  91 (44.6) 
Patients with medical devices (like tubes, IV, CPAP)  149 (76.8) 
Patients at risk (Braden ≥ 20)  65 (34) 
   
  Mean Median Range sd 
Length of hospital stay (days) 29.33 5 1-497 75.1 
Age (years) 7.92 7.5 1-18 5.218 
 
A third of all children where under the age of four, or older than 12 years of age 
(table 1). Nearly 80 percent of all patients were hospitalized either in the surgical 
or the pediatric medical department, while only five percent were hospitalized at 
the PICU. Ninety-one patients (including PICU cases) had at least one operation 
during the hospitalization before the assessment (45%) (table 1).  
5.3.2 Pressure ulcer risk 
The mean PU risk for all patients according to the Braden scale was 20 (sd =3.3), 
with a median of 22 and a range of nine to 23. According to the Braden scale, a 
total of 65(32%) patients were assessed as being at risk (score of ≤ 20) with a 
mean of 16.5 and a median of 17 (sd: 2.8), whereas patients not at risk had a 
mean Braden of 22 and a median of 23 (sd: 1.0) (table 2, table5). No significant 
differences were found between boys and girls (X2 0.03; df=1; p=0.43) whereas 
 age (Wilcoxon rank sum test Z= -13.748, P= 0.000) and the type of department 
was significantly related to being at risk (X2 25.8; df=4; p<0.001) (table 4).  
Table 2: summary of patients showing PUs 
Total patients with at least one PU (%) 
Number of patients showing at least one PU (%) 54 (26.5) 
  
Gender Male    34 (63) 
      
Age categories 1-≤4    15 (28) 
 >4-≤8    7 (13) 
 >8- ≤12    13 (24) 
 >12    19 (35) 
      
Department PICU    4 (40) 
 Surgery    28 (34) 
 Pediatric medical    17 (20) 
 Rehabilitation    5 (18) 
      
Patients with at least one operation prior to observation  32 (59) 
Patients with medical devices (like tubes, IV, CPAP)  48 (89) 
Patients at risk (Braden ≥ 20)  26 (49) 
5.3.3 Subcategories of Braden scale 
In table 3 the subcategories of the Braden scale are described for all patients as 
well as for patients at risk and for those showing at least one PU. The highest 
percentage of patients were affected in the subcategory nutrition (Score 1-3) with 
45.6%, followed by activity with (Score 1-3) 40.7%, mobility with (Score 1-3) 
33.8%, friction and shear forces with (Score 1+2) 30.9%, moisture with (Score 1-3) 
29.4%. Only 19.6% of all patients were affected in their sensory perception (Score 
1-3) (table 5). It is interesting to note that patients at risk (Braden score of ≤ 20) as 
well as patients showing at least one PU had higher values in all subcategories of 
the Braden scale, except for nutrition and friction and shear, than patients who 
were not at risk or did not have a PU (table 3). 
  
 Table 3: subcategories of the Braden scale for the whole population divided into at risk/ not at risk 
patients 
  Patients not 
at risk n(%) 
Patients at risk 
n(%) 
n (%) 
sensory 
perception 
completely limited 0 2 (100) 2 (1) 
 very limited 0 12 (100) 12 (5.9) 
 slightly limited 1(8) 12 (92) 13 (6.4) 
 no impairment 125 (76) 39 (24) 164(80.4) 
moisture constantly moist  0 0 0 
 very moist 0 5 (100) 5 (2.5) 
 constantly moist 16 (38) 26 (62) 42 (20.6) 
 rarely moist  110 (76) 34 (24) 144 (70.6) 
activity bed fast 0 30 (100) 30 (14.7) 
 chair fast 0 15 (100) 15 (7.4) 
 walks occasionally  12 (48) 13 (52) 25 (12.3) 
 walks frequently 114 (94) 7 (6) 121 (59.3) 
mobility completely immobile 0 9 (100) 9 (4.4) 
 very limited 0 19 (100) 19 (9.3) 
 slightly limited 7 (25) 21 (75) 28 (13.7) 
 no limitation 119 (88) 16 (12)   135 (66.2) 
nutrition very poor 0 8 (100) 8 (3.9) 
 probably inadequate  12 (46) 14 (54) 26 (12.7) 
 adequate 32 (70) 14 (30) 46  (22.5) 
 excellent 82 (74) 29 (26) 111 (54.4) 
friction and 
shear 
problem 1 (7) 13 (93) 14 (6.9) 
potential problem 4 (11) 32 (89) 36 (17.6) 
no apparent problem 121 (86) 20 (14) 141 (69.1) 
5.3.4 PU development, localization  
A total of 54 patients showed at least one PU (26.5%) (table 2).The most 
frequently assessed PU category was category 1 (83.3%), but in one case a 
category 4 PU was assessed (table 3). Most patients showed only one PU (n=33), 
12 patients showed two PUs, five patients showed three PUs, two patients showed 
foru PUs and one showed five or six PUs (table 4). Most of the observed PUs had 
developed on the ward where the child was hospitalized during the measurement 
(68%) (table 6). In addition, most of the PUs had developed in the two weeks 
 before the measurement (70.3%) (table 6). The lower extremity, and, of that, the 
foot (34.1%) was most often affected, followed by the upper extremity with most 
often the hand (12.1%). The sacral region including the hip followed by the head 
area were affected less frequently (table 5). Most often PUs developed as a result 
of external medical devices (n=35, 38.5%) (table 7).  
Table 4: PU risk assessed with the Braden scale of the total study sample and differentiated into 
department, sex and age categories 
  mean median sd 
Total study sample 20 22 3.3 
Department Surgery 20 21 3.1 
 Rehabilitation 20 23 3.4 
 Pediatric medical 21 22 2.8 
 PICU 15 16 3.3 
Gender Male 20 21 3 
 Female 20 20 2 
Age categories 
(in years) 
1-≤4 20 21 3.1 
>4-≤8 21 22 2.5 
>4-≤8 20 22 3.4 
>12 20 21 3.7 
 
Table 5: Frequency of PUs according to category and patients with more than one PU 
   Total n (%) 
Number of PUs   91 (100) 
 Category 1  45 (83.3) 
 Category 2  6 (11.1) 
 Category 3  2 (3.7) 
 Category 4  1 (1.9) 
Patients with more than one PU 1 PU 33 (61.1) 
  2 PU 12 (22.2) 
  3 PU 5 (9.3) 
  4 PU 2 (3.7) 
  5 PU 1 (1.9) 
  6 PU 1 (1.9) 
 
  
 Table 6: Setting in which PU occurred, point of time and localization of PU 
Setting in which PU occurred n (%) 
 Unknown 10 (11) 
 On the ward where the child is 
hospitalized 
67 (68) 
 External ward 7 (7.7) 
 External hospital 4 (4.4) 
 At home  6 (6.6) 
 Residential home 2 (2.2) 
Point of time  
 < 2 weeks 64 (70.3) 
 2weeks to 3 months 17 (18.7) 
 3-6 Months 7 (7.7) 
 6-12 Months 1 (1.1) 
 >12 Months 2 (2.2) 
Localization differentiation n % 
Lower extremity.    35 40.7 
  Knees. 5 5.5 
 Feet  31 34.1 
  Heels  23 25.3 
  Toe  4 4.4 
Upper extremity   21 23.1 
  Forearm 6 6.6 
  Elbow 4 4.4 
 Hand  11 12.1 
Sacrum, bottom   16 17.6 
  Bottom  6 6.6 
  Sacrum 4 4.4 
Back  Spinal 5 5.5 
  Clavicula 2 2.2 
Head   10 11 
  Ears 3 3.3 
  Nasal septum 5 5.5 
Thorax/ abdomen   5 5.5 
Others   5 5.5 
Total   91 100 
 
  
 Table 7: Pressure ulcers related to the suspected cause for the development of PU  
Suspected cause n (%) 
Shear or pressure 17 (18.7) 
Splints due to IV catheterization* 16 (17.6) 
Ineffective Positioning 15 (16.5) 
Unknown 11 (12.1) 
Cast* 9 (9.9) 
Intraoperative 7 (7.7) 
Clothes 4 (4.4) 
Tube* 3 (3.3) 
Oxygenation sensor* 2 (2.2) 
Nasogastric tube* 2 (2.2) 
Neck collar* 2 (2.2) 
Cables in bed 1 (1.1) 
Fixation 1 (1.1) 
Nasal O2 tube* 1 (1.1) 
total 91 (100) 
* All together summarized as external devices 
5.4 Discussion  
In this study hospitalized pediatric patients older than one year of age showed a 
PU prevalence rate of 26.5%. These patients present with several factors that may 
lead to the development of a PU. First of all the presence of medical devices 
seems to be a particular risk factor in all age categories. Second, in these patients 
limited activity and mobility appeared to be particular risk factors as well. The most 
affected anatomical region for the development of a PU was the lower extremity 
especially the foot.  
The PU prevalence of 26.5% in this study sample is rather high but in line with 
previous results reported (Schlüer et al., 2009) (28%). Older patients over the age 
of 12 years showed slightly more frequent PUs (32%) than children under the age 
of eight years. Patients hospitalized in the PICU setting were most often affected 
by a PU (40%). Forty percent of the patients assessed as at risk (Braden scale 
 ≥20) showed a PU, whereas 32% of all patients with an external medical device 
showed at least one PU.  
Most of the PUs assessed in this study developed due to external devices 
(38.5%). This problem has long been recognized in infants and children (Okamoto, 
Lamers, Shurtleff, 1983). In the development of risk assessment tools for the 
pediatric population, the risk factor “devices on the skin” has only become part of 
these scales since 1998 (Kottner et al, 2013). These devices on the skin are 
known as the most predominant risk factors of all for PUs in children and infants 
(Schlüer et. al, 2012). However, the Braden scale fails to include this potential risk 
factor. Therefore, in this study external medical devices were additionally 
assessed. Young pediatric patients (under the age of five years) are, due to their 
developmental status, unable to differentiate pressure from other sensory 
perceptions of such devices properly and are therefore most vulnerable. 
Equipment-related risk factors, e.g. those connected with traction, tubes and IV 
catheterization, are therefore additional potential PU risk factors in the pediatric 
health care setting (Willock, Askew, Bolland, Maciver & James, 2005, Noonan, 
Quigley & Curley, 2006, Schlüer et al., 2009, Kottner et al., 2013). So far the only 
published and tested pediatric PU risk assessment tool for the wide range of the 
child population (from 1-18 years), which includes the category ‘external devices 
on the skin’ is the Glamorgan scale (Willock, Baharestani & Anthony, 2007a, 
Willock, Baharestani & Anthony, 2007b, Willock, Anthony & Richardson, 2008). It 
is indispensable to include this risk factor in PU risk assessment for pediatric 
patients in the future (Kottner et al., 2013). 
In this study risk assessment was conducted using the Braden scale. The use of 
the Braden scale in a pediatric population in fact needs to be reflected upon 
critically. The Braden Scale is one of the best-known and widely used tools for 
evaluating pressure ulcer risk in adults, the psychometric properties in assessing 
the PU risk of adults have been evaluated, still there are limited psychometric 
properties of that scale (Papanikolaou, Lyne, Anthony, 2007, Pancorbo-Hidalgo, 
Garcia-Fernandez, Lopez-Medina, Alvarez-Nieto, 2006; Moore and Cowman, 
2008; Kottner, Raeder, Halfens, Dassen, 2009). Thus, additional clinical judgment 
by experienced nurses is recommended (Papanikolaou et al., 2007). The original 
Braden scale has not been validated for use in pediatric populations. Since this 
 instrument is a risk scale for adults, it contains many variables deemed important 
for PU development in the adult population, such as incontinence, moisture and 
nutrition, but, as mentioned, lacks potential specific risk factors for pediatric 
patients. Specificity and sensitivity for PU risk assessment in pediatric patients is 
therefore rather weak, and many patients with no specific risk potential for PU 
development are categorized as ‘at risk’ (Schlüer et al., 2009, Schlüer et al., 
2012). An adapted, reliable and valid risk assessment tool, applicable to the wide 
range of population from neonates to adolescents, in combination with validated 
cut-off points, is, however, not available for the pediatric population (Kottner et al., 
2013). At the time of data collection for the present study the common pediatric 
risk assessment scales available, like the Braden-Q scale and the Glamorgan 
scale, were the best-known PU risk assessment scales for the pediatric population 
(Kottner et al., 2013, Curley et al., 2003, Willock et al., 2007a, Willock et al., 
2007b, Willock et al., 2008). The Braden-Q, developed and introduced for 
immobile patients from 21 days of age, has not been validated for children more 
than eight years of age and no validated German version is available. There is 
also no validated German version of the Glamorgan scale. Due to this lack of 
possible alternative pediatric risk assessment tools in German and because the 
Braden scale is part of the instrument used (LPZ), we decided to use the Braden 
scale to describe potential risk factors in these pediatric patients. As stated by 
Kottner et al. (2013) the only indicator included in all pediatric specific risk 
assessment tools is mobility, which is also included in the Braden scale. Due to 
the knowledge that devices represent a high risk of PU development, especially in 
younger children, we added the assessment of devices to the original instrument 
as stated in the methods section (Kottner et al., 2013, Willock 2005, Willock et al., 
2007a). 
 
The most frequent localization of a pressure ulcer was the lower extremity, 
especially the feet (40%). The reason for this might be the fact that the majority of 
pressure ulcers were developed because of splints/iv boards or cables and 
sensors, as well as IV catheterization. Pediatric patients in infancy often have IV 
catheterization on the metatarsal or the ankle, additionally fixated by splints/iv 
boards. These splints/iv boards related to IV catheterization are suspected of 
 causing the development of a PU in 18% of all PUs. Another frequently affected 
area is the upper extremity, especially the hand. In line with the suspected cause 
of PUs in the feet, another frequently used site for insertion of an IV catheter and 
additional fixation with splints/iv boards in children is the hand, especially the back 
of the hand. From the results of this study the feet seem to be more at risk for PU 
development than the hand in small children. These findings require ongoing 
investigation to distinguish different factors that might elucidate this finding. 
Up to now, the ears, the occiput, heels and ischeal tuberosities and the nose are 
the anatomic sites in pediatric patients found to be most likely to develop a 
pressure ulcer (Kottner et al., 2010, Suddaby, Barnett, Facteau, 2005, Curley et 
al., 2003, Schlüer et al., 2009). However, this seems especially true for children 
under the age of one year, who were not included in this study, where the head 
area was only affected in 11% of those surveyed. Patients in PICUs most 
frequently developed PUs on the head, especially the face. This is in line with the 
fact that these children need numerous medical devices such as tubes, CPAPs 
and nasogastric tubes, which are attached to the face area. In this study the 
number of patients treated in a PICU was relatively low, with 10 patients (5%). 
Even the prevalence rate in PICU patients is high at 40% (n=4), but this obviously 
needs further investigation. 
In our study, 18% of all PUs developed in the sacral region. This seems to contrast 
with studies of adult patients, where the sacral region is, next to the heel, most 
often affected (Kottner et al., 2011). These findings confirm the idea that the 
localization of PUs may differ between adult and pediatric patients. Further 
investigations along this line are needed. 
Additional potential risk factors for pediatric patients mentioned in the literature are 
immobility and decreased skin sensitivity (Suddaby et al. 2005, Willock et al. 2005, 
Willock 2005). This study shows that 40% of all assessed children show a higher 
risk of PUs due to inactivity, immobilization and nutrition when risk assessment is 
done with the Braden Scale. These findings are in line with previous studies 
(Huffiens& Logsdon, 1997, Kottner et al. 2013), in which mobility is the only 
subcategory of assessment in all so-far-published pediatric risk assessment tools 
(Kottner et al., 2013). In all, 40% of at risk pediatric patients (meaning patients with 
a Braden scale score ≤ 20) show at least one PU. This is slightly lower than the 
 49% reported for the pediatric population (neonates to 18 years) by Schlüer et al. 
(2012). Neonates and infants need intense treatment when admitted to the 
hospital, often involving external devices. Therefore it seems possible that 
neonates and infants are due to their immature and vulnerable skin within the first 
12 month of life on a general risk for PU occurrence. It therefore seems feasible 
that in this study were only children older than one year of age were included this 
rate is lower. 
Nutrition was a relevant risk factor in this study as well. Nutrition is known as a 
relevant factor with regard to skin integrity (Rodriguez-Key, 2007) in pediatric 
patients. So far to our best knowledge no clinical trials conducting the influence of 
under- or malnutrition in pediatric patients with regard to PU occurrence were 
conducted and need further investigation.  
5.5 Limitations 
The study was conducted within 13 different pediatric hospitals; the participation 
rate differed between 43% and 100%. Most of the dropouts where due to the fact 
that parents or patients refused to participate in the study (n=42). According to the 
ethical approval necessary for this study, patients older than 10 years of age had 
to sign their own informed consent as did their parents or legal representative. 
This meant that for all these patients two informed consents were necessary.  
It is important to realize that prevalence studies are always subject to daily 
variations. However, in general, prevalence figures over the years are relatively 
constant (Gunningberg, Stotts, 2008). Most of the PUs in this study were category 
1. To what extent the category 1 PUs were over- or underdiagnosed in this study 
remains unclear, although the inter-rater reliability between the rater pairs 
suggests that the scores are reliable. The results of this study were gathered on 
one day and provide no information about the development of PU in pediatric 
patients over time. 
The results of this study provide insight into the risk and associated factors that 
lead to the development of PUs in hospitalized pediatric patients older than one 
 year of age. The use of the Braden scale is of limited reliability because the 
original Braden scale is not validated for use in pediatric populations. Since this 
instrument is a risk scale for adults, it contains many variables deemed important 
for PU development in the adult population, it lacks potential specific risk factors 
for pediatric patients. Differences between adult and pediatric patients regarding 
the risk categories of the Braden scale require further investigation. Moreover, the 
question arises whether it would not be feasible and necessary to develop a PU 
risk scale covering all the necessary aspects for the pediatric population. With 
regard to this we added the assessment of medical devices in our study. In what 
extend these medical devices are the real cause for the PU occurrence in this 
study remains unclear. Due to the nature of the study, no causes of the 
development of Pus can be presented. Furthermore, no assumptions can be made 
about when the highest risk levels within a patient’s hospital stay occur, or which 
devices represent the highest risk of PU development. In this study we only 
describe factors that might be associated with the occurrence of a PU in 
hospitalized pediatric patients older than one year of age. There is a need for 
longitudinal research in this population to determine at what times and within 
which settings pediatric patients most often develop PUs. 
5.6 Practice Implications 
PUs are a relevant care problem in children as well as in adults. This study shows 
that the risk factors, the anatomical localities of PU as well as the risk of PUs due 
to external devices differ from those in an adult population. Therefore specialized 
preventive interventions based on the needs of the pediatric population are 
mandatory. The use of risk assessment scales in pediatric health care should 
focus specifically on external medical devices and limited mobility and activity. 
Risk assessment scales for adults are not precise enough to cover pediatric risk 
factors. Age-related factors such as limited communication skills in children under 
the age of two years have not been addressed in any risk assessment tool so far. 
According to our findings, and in line with clinical expertise in the field of PU 
development in children, it is more reliable to focus on different risk populations, 
 such as children hospitalized in a PICU, and also to assess equipment-related 
factors contributing to the development of PUs.  
Clinical practice needs to be aware of the particular PU risk potential of specific 
populations, e.g. children, and of the importance of decreasing preventable PUs in 
this group.   
How might this information affect nursing practice? Younger patients (under the 
age of five years) should be assessed carefully with regard to their inability to 
distinguish pressure on the skin adequately. Patients in the PICU setting seem 
most vulnerable to developing PUs in the face due to external devices on the skin. 
The risk assessment criterion ‘external devices to the skin’ needs to be 
implemented in the pediatric setting and therefore evaluated in all age categories. 
Hospitalized children over the age of one year have to be assessed daily for their 
PU risk from decreased mobility and activity and from external medical devices. It 
is of key importance to develop and implement pediatric specific PU prevention 
guidelines and highlight risk factors for this population.  
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 Abstract  
Aims and objectives: The aim of this study was first to assess the prevalence, 
severity and localization of pressure ulcers in hospitalized neonates and infants (< 
1 years) and second to assess possible risk factors and preventive measures 
taken in these patients. 
Background: Pressure ulcer prevalence rates in neonates and infants in the 
literature vary from 11% to 61.5%. Different risk factors like a lower age (< 2 years) 
of patients and use of external medical devices are associated with the 
development of pressure ulcers, especially in neonates and infants. 
Design: A multicenter, cross-sectional, descriptive study was conducted in all 14 
pediatric hospitals in the German-speaking part of Switzerland in June 2009.  
Methods: All hospitalized neonates and infants were included in the study. The 
instrument and method of data collection of the Dutch National Prevalence 
Measurement of Care Problems was used. 
Results: The total number of patients included was 194 (72%). The overall 
pressure ulcer prevalence rate in the total study sample was 45.4% (n= 88). 
Almost all pressure ulcers were category 1 ulcers (99%). Ventilation support 
devices such as continuous positive airways pressure or mechanical ventilation 
increased the risk for pressure ulcers more than twofold. Total skin assessment 
(66.5%), repositioning (68.1%) and skin care (50%) were conducted most 
frequently as preventive measures.  
Conclusion: Pressure ulcer prevalence in hospitalized neonates and infants is 
high, but most of the pressure ulcers are category 1. The use of ventilation support 
devices increased the risk for pressure ulcer occurrence more than twofold. 
Relevance to clinical practice: Staff are recommended to use under-padding, 
careful fixation and positioning of medical devices, especially ventilation support 
devices, in these highly vulnerable patients to decrease the risk of pressure ulcers.  
  
 6.1 Introduction 
Pressure ulcers (PU) in adult patients cause considerable suffering and, in 
addition, higher morbidity and mortality and a substantial increase in costs of 
treatment (Allman et al., 1999; Anthony et al., 2004). Pressure ulcer development 
can be attributed to multiple factors that are fairly well studied in adults and elderly 
people (de Laat et al., 2006). In the last ten years greater attention has been paid 
to the PU problem in the pediatric population. There is greater awareness that 
pediatric patients in certain health care settings are at high risk of developing PUs 
(Kottner et al., 2010; Schlüer et al., 2012a; Noonan et al., 2011). Prevalence rates 
for PUs in hospitalized pediatric patients (0-18 years) range between 3%and 35% 
(Kottner et al., 2010; Schlüer et al., 2012a). In different care settings, such as 
pediatric intensive care units (PICUs) and according to different risk factors, such 
as medical devices, different PU prevalence rates have been published (Kottner et 
al., 2010; Schlüer et al., 2012a). An overview of PU prevalence rates for neonates 
and infants is presented in table 1. 
A PU is a localized injury to the skin and/or underlying tissue as a result of 
pressure, or pressure in combination with shear forces. (National Pressure Ulcer 
Advisory Panel (NPUAP) and European Pressure Ulcer Advisory Panel (EPUAP), 
2009). According to the guidelines of NPUAP and EPUAP, PUs are basically 
classified into four different categories, with category 1 as the least severe, and 
defined as “Intact skin with non-blanchable redness of a localized area usually 
over a bony prominence” and category 4 as the worst, defined as “Full thickness 
tissue loss with exposed bone, tendon or muscle” (EPUAP/NPUAP, 2009). These 
EPUAP/NPUAP categories are also used frequently in pediatric settings (Kottner 
et al., 2010; Schlüer et al., 2012a).  
  
 Table 1: PU prevalence rates and risk factors for PU development in pediatric patients under the age 
of one year 
Author Setting and sample 
characteristic 
Risk factor for PU 
development 
PU prevalence rates  
Groenveld et 
al. (2004) 
97 children in a pediatric 
hospital in Canada 
n = 41 < 1 year of age 
 Prevalence: 61.5% 
Schlüer et al. 
(2009) 
4 pediatric hospitals in 
Switzerland 
Total 155 patients 
n = 56 < 1 year of age 
 Prevalence: 31.9% for children 0-
20 week 
22.2% for children 21-52 week 
McLane (2004) 1064 patients in nine US 
pediatric hospitals including all 
care settings 
113 patients < 1 year of age 
 Prevalence: 0-3 month: 26% 
McCord et al. 
(2004) 
n= 118 PICU patients 
n = 37 < 1 year age 
Presence of edema 
Length of PICU stay > 
96 hours 
Increased positive-end 
expiratory pressure 
(PEEP) 
Not turned/turned by a 
low air bed 
Weight loss 
 
Huffines and 
Lodgson 
(1997) 
Neonatal Intensive care Unit 
(NICU) 
n = 32 (26-40 weeks gestation 
age) 
 Prevalence: 19% skin breakdown 
Schindler et al. 
(2007) 
PICU, USA 
n = 120 < 1 year of age 
assessing skin breakdown 
Age < 2 year of age 
Length of stay 4 days 
and longer 
Mechanical ventilation 
Risk of mortality 
 
Escher Neidig 
et al. (1989) 
n = 59 children following open 
heart surgery in a PICU, USA 
n= 15 <1 year of age 
Younger age 
Type of congenital heart 
defect 
Length of intubation 
Duration of PICU stay 
Prevalence: 40% 
Willock et al. 
(2000) 
N = 82 for incidence study 
N = 183 for prevalence study 
All pediatric care settings, UK 
Altogether (incidence and 
prevalence study) 18 patients 
showed PU 
 Total of 7 neonates and infants 
showed PU (combined data 
incidence and prevalence) = 38% 
Waterlow 
(1997) 
302 pediatric patients in UK 
pediatric hospitals 
n = 54 in NICU 
Immature skin in 
neonates 
Epidermal stripping 
Prevalence: 11% for NICU patients 
Curley et al., 
(2003) 
n= 322 form 21 days of age 
up to 8 years of age in three 
PICU, USA 
n= 98 < 1 year of age 
Younger age 
Mechanical ventilation 
hypotension 
 
 6.1.1 Background  
A neonate is defined as a child from birth up to and including 28 days of life, 
whereas an infant is defined as a child from 4 weeks of life up to its first birthday 
(The World Health Organization (WHO), 2005; the American Academy of 
Pediatrics (AAP), 2002). Neonates born before 40 weeks of gestation are defined 
as preterm neonates (Hack et al., 1996). Preterm neonates of lower gestation age 
are at great risk for skin breakdown due to the fact that their skin is immature 
(Nikolovski, et al., 2008; Stamatas et al., 2010; Blume-Peytavi, 2011). Within their 
first days of life, children undergo various adaptation processes needed to 
accommodate the transition from the wet uterine environment to the dry 
environment. During the first months and years of life the skin constitutes to 
develop and evolve its structure and function (Nikolovski, et al., 2008; Stamatas et 
al., 2010; Blume-Peytavi, 2011). In neonates the stratum corneum is 
underdeveloped until about 32 weeks of gestation age. Skin surface pH changes 
and the trans epidermal water loss (TEWL) are high in very low term neonates 
(Nikolovski, et al., 2008). In the first four weeks of life skin surface pH changes 
continuously (Garvin, 1997).  
PU prevalence rates in neonates and infants vary from 11% to 61.5% (table 1) 
(Groneveld et al., 2004; Schlüer et al., 2009; McLane 2004; McCord et al., 2004; 
Huffines and Lodgson, 1997; Escher-Neidig et al., 1989; Willock et al., 2000; 
Waterlow 1997; Curley et al., 2003). Different risk factors are associated with the 
development of PUs, especially in neonates and infants (Baharestani and Ratliff, 
2007). Younger patient age, especially the age period under 2 years, has been 
described as a risk factor for PU development in pediatrics (Schindler et al., 2007; 
Escher-Neidig et al., 1989; Waterlow, 1997; Curley et al., 2003). Therefore it is of 
great importance to pay attention to infants and neonates according to their 
specific risks for developing a PU.  
Risk factors for hospitalized neonates and infants are shown in table 1. A PICU 
stay leads to a higher risk of PU occurrence and the risk increases the longer this 
PICU stay lasts (McCord et al., 2004; Schindler et al, 2004; Escher Neidig et al., 
1989). Length of stay and increased positive-end-expiratory-pressure (PEEP) and 
mechanical ventilation are described as risk factors as well (McCord et al., 2004; 
 Schindler et al., 2007). Thus, critically ill patients of younger age are at very high 
risk of developing PUs (Baharestani and Ratliff, 2007; Curley et al., 2003) (table 
1). 
Most of the PUs in pediatric patients appears to be preventable (Schlüer et al., 
2009; Schlüer et al., 2012a; Brandeis et al., 2001). Two mayor steps in preventing 
PUs have to be taken: (1) identifying patients at risk and, (2) implementing reliable 
prevention strategies for all patients identified as being at risk (Association of 
Womens Health, Obstetrics and neonatal nurses (AWHONN) & National 
Association of neonatal nurses (NANN) (2001)). Several specific pediatric risk 
assessment tools are implemented nowadays like the Braden Q scale (Noonan et 
al., 2011), the Glamorgan scale (Willock et al., 2008; Anthony et al, 2010; Kottner 
et al., 2011) and the Neonatal Risk Assessment Scale (Huffines and Lodgson, 
1997). Only limited evidence is available yet to support a specific risk assessment 
tool in the pediatric care setting (Kottner el al, 2011; Anthony et al., 2010).  
Baharestani and Ratliff (2007) highlighted the importance of developing age-
related preventive strategies for PUs. However, the prevention of PUs in neonates 
and infants has not been thoroughly studied so far. Timely skin assessment is 
recommended but no frequency is prescribed (AWHONN/NANN, 2001). 
Repositioning is recommended but not for haemodynamically unstable pediatric 
patients and no specifications for infants and neonates are made (Butler, 2007). 
The same is seen for pressure relief support surfaces: no research-based 
recommendations for infants and neonates can be found. Due to the risk of 
pressure ulcer development in infants with tracheostomies, Boesch and colleges 
(2012) implemented a prevention program, including frequent whole-body skin and 
device assessment at least every 24 hours, with a further device-related skin 
assessment every 8 hours. They created a moisture-reducing device interface 
(including a foam-layer between skin and device) and pressure-free device 
interface (Boesch et al., 2012) with a significant decrease – from 8.1% to 0.3% – in 
tracheostomy-related pressure ulcers in young children. Most of these 
tracheostomy-related PUs occurred in children of 2 years and younger, but no 
information about infants under the age of one can be found.  
Because of this lack of knowledge, it is not only of great importance to assess 
prevalence, severity and localizations, but also risk factors and preventive 
 measures taken in hospitalized neonates and infants in different care settings 
according to PU occurrence.  
The aims of this study therefore were:  
(1) to assess the prevalence, severity as well as most frequent localizations of 
PUs in hospitalized neonates and infants in different pediatric hospital 
departments; 
(2) to explore risk factors of neonates and infants with PUs; 
(3) to assess which preventive measures for PUs were taken in these patients. 
6.2 Material and Methods 
6.2.1 Study design  
A multicenter, cross-sectional, descriptive study was conducted in all 14 pediatric 
hospitals in the German-speaking part of Switzerland in June 2009. These 
hospitals have a total of 70 wards. All hospitalized neonates and infants from 1 
day old up to their first birthday were included in the study. Children had to have 
been hospitalized for at least one day. Exclusion criteria were children whose legal 
representatives did not permit participation and healthy new-borns hospitalized 
after birth in a maternity ward/department.  
6.2.2 Ethical approval 
The study was approved by all cantonal ethics committees, and when necessary 
by the ethics boards of the hospitals themselves. After the parents or legal 
representative had been verbally informed about the study’s content and aim, they 
also received written information along with an informed consent document to 
sign. After parents or a legal representative signed the informed consent form, 
neonates or infants meeting the inclusion criteria were included in the study. 
  
 6.2.3 Measurements 
The instrument and data collection method of the Dutch National Prevalence 
Measurement of Care Problems (LPZ) (Halfens et al, 2010) was used in this study 
to assess the prevalence, severity, location, prevention, as well as risk factors for 
the occurrence of pressure ulcers. This instrument is widely used internationally 
(Halfens et al., 2010), and comprises amongst others the following categories of 
data for assessment: (1) patient characteristics (demographic and clinical data), 
(2) assessment of the location and severity of pressure ulcers, (3) risk factors for 
PU development, and (4) use of preventive measures. In addition to this 
instrument, we assessed all external devices on the patient’s body at the time of 
the assessment (e.g. tubes, IV catheterizations, Continuous Positive Airways 
Pressure (CPAP), splints, and other devices), which might cause the occurrence 
of a PU.  
6.2.4 Data collection 
The method of data collection involved a direct and systematic inspection and 
judgment of the skin of the patient. Here, the NPUAP/EPUAP (NPUAP/EPUAP, 
2009) pressure ulcer category system was used. Demographic and clinical data, 
such as date of birth, weight and size, body mass index and diagnosis, were 
collected from patient charts. Assessments of installations on the body site as well 
as other risk factors (like cloths and clothes, incorrect positioning, and cables in 
beds), which can lead to the development of PUs, as well as preventive measures 
taken, were assessed by direct inspection. This information was gathered both by 
a direct inspection of the patient and from the patient files.  
Previously trained rater pairs gathered data for each patient. A total of 35 rater 
pairs were involved in the study. All raters were trained nurses with at least two 
years’ experience in working with neonates and infants. Preparatory training, given 
by the first author, included methodological aspects, detailed information about the 
data collection, the role and responsibilities of the raters, a detailed introduction to 
the measurement instruments, and special training in the grading of a pressure 
ulcer in infants and children (Schlüer et al., 2012a). For each hospital unit, an 
 internal and an external rater worked together. The internal rater was from the unit 
itself, while the external rater was from another unit or department. If the pair 
disagreed on their assessment, they were asked to find consensus. If no 
consensus could be reached, the external rater was given the right to decide. No 
statement about disagreement within the rater pairs can be made, as this was not 
an objective of the study.  
6.2.5 Data analysis 
Predictive Analytics Software (PASW) (version 18) was used to analyse the data. 
Frequencies and cross tables were calculated. Group differences were due to the 
type of data tested, with nonparametric tests for categorical data (Chi-Square). 
The relationship between pressure ulcers and possible influencing and conflicting 
factors was studied by logistic regression. To find the most suitable model for the 
logistic regression, the following variables were applied to the model: age, lower 
gestation age, department, medical devices overall, certain types of medical 
devices (categorized into ventilation support devices, feeding devices such as a 
nasogastric tubes, IV catheterization devices and monitoring sensors), gender, 
whether the child had undergo an operation in the two weeks prior to the study 
assessment and length of stay. The data were entered into the model followed by 
a forward stepwise selection of the important variables according to the use of 
likelihood quotients. The entry and removal probabilities were 0.05 and 0.10. A p-
value of 0.05 and lower was considered to be statistically significant. 
  
 6.3 Results 
The overall sample size of potential study participants who met the inclusion 
criteria was 270 (100%). In the 14 hospitals, the participation rate ranged from 65-
100%. The total number of participants was 194 (72%). Of the76 (28%) dropouts, 
parents/legal representatives refused participation in 26 cases (34%). Fourteen 
were excluded due to unexpected discharge or because an examination or 
operation lasted longer than the survey did (18%). In eight cases the parents were 
not available for informed consent (11%) or could not be asked for other reasons 
(n=9, 12%). Three (4%) children were not assessed due to an unexpected change 
in their condition to a critical level. Three patients dropped out due to language 
problems of the parents/legal representative. 
The demographic characteristics of the study sample are shown in table 2. The 
mean age of the study population was 5.7 weeks, with a median age of 3 weeks. 
Among patients, 107were neonates (55%) of which 75 (70%) had a gestational 
age of 24 to 32 weeks (very pre-term neonate) and 41 (30 %) a gestational age of 
32 to 37 weeks (pre-term neonate). Sixty percent of all patients were under the 
age of 28 days. The average length of stay of a patient was 15 days with a median 
of 12 days. Most of the patients had been in hospital for less than 30 days (83%) 
before the study assessment was conducted. 
Table 2: Demographics of total study sample 
Total study sample N (%) 
 194 (100) 
      
Gender Male    105 (54.1) 
  Female    88 (45.4) 
  Unknown    1 (0.5) 
     
Department Surgery   13 (6.7) 
  Rehabilitation   2 (1) 
  Pediatric medical   46 (23.7) 
  PICU   26 (13.4) 
  NICU/neonatal unit   107 (55.2) 
      
 Age categories 1-≤7 days    46 (23.7) 
  8 -≤ 30 days    74 (38.1) 
  31 -≤ 90 days    52 (36.8) 
  91 days -≤6months   14 (7.2) 
  >7 months    8 (4.1) 
    
Gestational age in 
neonates 
24-≤31 weeks gestation age  75 (70) 
  32-≤36 weeks gestation age  41 (30) 
      
Length of stay ≤ 14 days    115 (59.3) 
  15-≤30 days    48 (24.7) 
  31 -≤60days    24 (12.4) 
  >61 days    7 (3.6) 
     
Patient with external devices    176 (91) 
   
Patients with operation within 2 weeks before study assessment  28 (14.5) 
      
Age distribution over all in 
days 
mean Median sd Range  
43.6 23 63.56 1-300  
      
Length of stay in days 15.2 12 33.07 1-134  
6.3.1 PU prevalence rates and localization of PUs 
The overall PU prevalence rate in the total study sample was 45.4% (n= 88). The 
PU prevalence rate for more severe PUs (category 2 to 4) was 0.5% (n=1). PU 
prevalence rates for different characteristics and patient groups were calculated 
and are presented in table 3; they vary between 28.6% (infants of 91 days up to 
and including 6 months of age) and 62.5% (infants older than 7 month of age) 
(table 3). 
  
 Table 3: PU prevalence rates in different settings and number of PU per patient 
Total study sample  χ
2
/ p n (%) 
Overall PU prevalence rate 88(45.5) 
PU prevalence rate only category 2 to 4   1 (0.5) 
Department Surgery  χ
2
= 2.867 
p = 0.58 
5 (38.5) 
  Rehabilitation  0 
  Pediatric medical  24 (52) 
  PICU  12(46.2) 
  NICU/neonatal unit  47 (44) 
      
Age categories 1-≤7 days   χ
2
= 4.476 
p= 0.345 
20(43.5) 
  8 -≤ 30 days   31(41.9) 
  31 -≤ 90 days   28(53.8) 
  91 days -≤6months  4 (28.6) 
  >7 months   5 (62.5) 
      
Length of stay ≤ 14 days   χ
2
= 1.499 
p = 0.683 
49(42.6) 
  15-≤30 days   22(45.8) 
  31 -≤60days   11(54.2) 
  >61 days   4 (57.1) 
    
Gestational age in neonates 24-≤31 weeks gestation age χ
2
= 3.976 
p=0.137 
40(53.3) 
  32-≤36 weeks gestation age 16 (39) 
     
Patient with external devices   χ
2
= 2.475 
p=0.116 
83(47.2) 
   
Patients with operation within 2 weeks before study assessment χ
2
= 2.84 
p=0.37 
14 (50) 
Number of total PUs  173 (100) 
Patients with more than one PU 1 PU 44 (50) 
  2 PUs 23 (26) 
  3 PUs 12 (14) 
  4 PUs 4 (5) 
  5 PUs 1 (1) 
  6 PUs 2 (2) 
  9 PUs 1 (1) 
  10 PUs 1 (1) 
 
 Except for one case, all PUs were category 1 ulcers (99%). Fifty percent of all 
patients had one PU, whereas one patient had nine and another ten PUs (table 3). 
The most affected areas for PU occurrence were on a patient’s feet (n = 36), 
followed by the nose (n = 28) and the bottom (n = 16) (table 4). Most of these PUs 
(n = 165, 95%) occurred in the setting where the patient was hospitalized and 
lasted for at least 2 weeks prior to the inquiry (n = 166, p = 96%) (table 4).  
Table 4 Localization, point of time and point of occurrence of PUs 
 Total n (%) 
173 (100) 
Setting in which PU occurred n (%) 
 On the ward where the child is hospitalized 165 (95) 
 External ward 7 (4) 
 External hospital/ or transport 1 (1) 
Point of time  
 < 2 weeks 166 (96) 
 2weeks to 3 months 7 (4) 
    
Localization differentiation n % 
Lower extremity.    5 2.9 
  Knees 2 1.2 
  Ankles 5 2.9 
 Feet  36 20.8 
  Heels  9 5.2 
  Toe  2 1.2 
Upper extremity   6 3.5 
  Forearm 8 4.6 
  Elbow 1 0.6 
 Hand  9 5.2 
Sacrum, bottom     
  Bottom  16 9.3 
  Sacrum 3 1.7 
Back  Spinal 8 4.6 
  Clavicula 3 1.7 
Head   1 0.6 
  Ears 2 1.2 
  Forehead frontal 2 1.2 
  Nose 28 16.2 
  Cheek 11 6.4 
  Occiput 4 2.3 
Thorax/ abdomen   11 6.4 
Others   1 0.6 
Total   173   
 6.3.2 Risk factors and preventive measures 
All potential risk factors measured, namely age, gender, lower gestation age, 
department, medical devices overall, certain types of medical devices (categorized 
into ventilation support devices, feeding devices such as a nasogastric tubes and 
IV catheterization devices), whether the child had had an operation in the two 
weeks prior to the study assessment and length of stay where calculated 
separately with the chi square test. All risk factors mentioned were put into a 
logistic regression model. Only ventilation support of the patient (p = 0.015) was 
statistically significant related to the existence of a PU (table 5). The odds ratios 
and associated confidence intervals of the variables in the final model are 
presented in table 5. The Hosmer– Lemeshow-test for the goodness of fit for this 
model was p =0.025; Nagelkerke R2 = 0.054. 
Table 5: Odds ratios for PU occurrence with 95% confidence interval 
 Odds ratio 95% Confidence interval Sig 
  Lower level Upper level  
Ventilation support device 2.598 1.201 5.623 0.015 
Monitoring devices 0.877 0.329 2.340 0.793 
Feeding tubes 1.196 0.577 2.481 0.630 
Peripheral or central venous catheter 0.937 0.486 1.806 0.846 
Table 6 shows the preventive measures collected in the total study sample. Most 
of these measures were conducted at least once during the 24 hours before the 
assessment and included total skin assessment (66.5%), repositioning (68.1%) 
and skin care (50%). Next to these interventions, repositioning of monitoring 
devices was performed in 71.3% of cases; details are shown in table 5.  
  
 Table 6: Preventive measures conducted in the total study sample 
Preventive measures  Total 
188 (100) 
Intervention within last 24 hours  188 (100) 
Regular repositioning  128 (68.1) 
 Every 3 hours 15 (8) 
 Every 4 hours 52 (27.7) 
 Every 6 hours 56 (29.8) 
Rehydration  40 (21.3) 
Instruction of parents for PU 
prevention 
 15 (8) 
Skin care  95 (50.0) 
Daily skin inspection  125 (66.5) 
Use of skin barrier cream  32 (17.0) 
Padding of tubes/CPAP, ventilation 
devices 
 44 (23.4) 
Padding of splints and iv cannulas  30 (16.1) 
Reposition of monitoring cables, 
sensors 
 134 (71.3) 
 Never 53 (28.3) 
 Every 2 hours 2(1.1) 
 Every 3 hours 14 (7.5) 
 Every 4 hours 62 (33.2) 
 Every 6 hours 55 (29.4) 
 Every 8 hours 1 (0.5) 
 Every 24 hours 1 (0.5) 
Relieving of exposed body site  0 
Cloth diaper for positioning  113 (60.1) 
Gel ring for head  9 (4.8) 
Pressure relieving surfaces (foam)  73 (38.8) 
Incubator  36 (19.1) 
Artificial skin  28 (14.9) 
Repositioning not possible due to 
unstable life condition 
 5 (2.7) 
 
  
 6.4 Discussion 
In this study the PU prevalence rate (categories 1-4) in neonates and infants was 
high, with an overall prevalence of 45.5%; yet the PU prevalence rate for more 
severe PUs (categories 2-4) was low at 0.5%. Ventilation support devices such as 
CPAP or mechanical ventilation increased the risk of pressure ulcers more than 
twofold. Total skin assessment (66.5%), repositioning (68.1%) and skin care (50%) 
were conducted most frequently as preventive measures. For the first time PU 
prevalence rates for this patient group are presented and classified with regard to 
different departments and age categories as well as risk factors like patients with 
external devices.  
The overall PU prevalence rate is in line with previously published PU prevalence 
rates in hospitalized neonates and infants (table 1). Because of the high 
prevalence rate of category 1 PUs the question as to whether the measurement of 
PU category 1 was performed correctly arises. However all rater pairs were 
previous trained, and all raters had at least two years of experience working with 
neonates and infants. The training of the raters included specific training in the 
assessment and diagnosis of PUs, especially category 1 PUs, with special 
attention to their diagnosis in preterm neonates and infants. The raters were 
supervized by the first author and if they were unsure about the diagnosis of a PU 
they could obtain advice from the first author.  
In the literature (Baharestani et al, 2009) it is suggested that a category 1 PU can 
serve as an indication of being at risk for a category 2 to 4 PU. When a category 1 
PU occurs, preventive measurements are necessary. In our study only one infant 
developed a higher category PU than category 1, which makes it questionable 
whether a category 1 PU is a good indication of additional risk in this population. It 
is remarkable insofar as in clinical practice category 2 to 4 PUs are seen regularly 
in hospitalized neonates and infants, especially due to CPAP or other mechanical 
ventilation support devices (Schlüer et al., 2012b; Hoegeling et al.2011; Boesch et 
al, 2012; Curley et al., 2003; Neidig-Escher, 1989; McCord et al., 2004). To what 
extent the nonresponse patients were affected by a severe PU is unknown, but it 
is important to note that 4% of the dropouts were infants or neonates who were not 
assessed because their condition had changed to a critical level. We can assume 
 that these patients underwent intense treatment to stabilize their condition. With 
respect to the knowledge that a PICU stay (McCord et al., 2004; Escher-Neidig et 
al., 1989) as well as mechanical ventilation (Curley et al., 2003; Schindler et al., 
2007) (which are both intense treatments) increase the risk of severe PUs, we can 
assume that neonates and infants in critical condition are at high risk for severe 
PUs. Besides this methodological deficit it is of interest that in this study ventilation 
support devices were the only factors associated with the occurrence of PUs. 
According to the localization of the PUs, the feet and nose were the most 
commonly affected areas in this study sample. Feet, especially ankles or heels 
and toes, were also frequently affected areas in the study of Curley and 
colleagues (2003) as well as the occiput and ear. A possible explanation for this is 
that in neonates and infants monitoring devices like oxygenation sensors and IV 
catheters are fixed to the feet of the child, and therefore this localization can also 
be affected by medical device related PUs (Schlüer et al., 2012b). PUs in the area 
of the nose are often caused by a nasogastric feeding tube, ventilation tube or by 
a CPAP mask with Prongs. It is therefore of great importance to pay special 
attention to the careful application of ventilation support devices, and to the careful 
fixation and regular repositioning of any devices in neonates and infants in order to 
decrease the PU risk. 
Very pre-term neonates and infants with a longer stay in hospital are known to be 
patients at risk for PU development (Schindler et al., 2007; Cignacco, 2009; Curley 
et al., 2003). Due to their immaturity, hospitalized neonates are commonly 
provided with several monitoring and medical devices such as IV catheterization, 
ventilation support devices and nasogastric tubes. In this study population nearly 
95% of all children had devices like these. Since these are major PU risk factors 
for this patient group, the high prevalence rate in this study population seems 
feasible. Why infants of 31 to 90 days as well as 7 to 12 months of age are 
affected most in this study population remains unclear. One factor that might have 
led to this finding is the heterogeneity of the relatively small subgroup in these 
different age categories.  
Repositioning and turning of the patient was found to be frequent, although timely 
intervals varied between 3 and 6 hours and were most frequently conducted at 4- 
and 6-hour intervals. The current recommendation calls for a 1- to 3- hour time 
 interval in turning patients but cautions carers to weigh the benefit against the 
stress for the patients, especially for very low-term neonates (AWHONN/NANN, 
2001; Scott et al., 2011). Despite these recommendations, no guidelines with 
special attention to this population and its unique risk factors in terms of PU 
occurrence are available so far. 
There are also some limitations of this study that need to be mentioned. One is the 
fact that a cross-sectional design was used, which does not allow making causal 
interpretations. Further, the participation rate of 72% is sufficient, although the 
parental refusal rate involving 34% of non-participants is rather high, and needs 
further investigation of how to better inform parents about the need for such 
studies. One possible explanation is that many studies of these patients are 
conducted and parents may not have wanted to stress their child with another 
study.  
Further studies drawing attention to the increased risk of PU development are 
needed in this group to guide a trajectory towards an adapted and truly patient-
oriented prevention. To what extent ventilation support devices lead to more 
severe PUs and which patients are therefore at highest risk needs to be studied 
further in clinical trials with incidence measurements.  
6.5 Conclusion 
This study shows that the overall PU prevalence rate of hospitalized neonates and 
infants is 45.5% with even higher rates in certain patient groups. Patients with a 
longer of stay in hospital, very pre term neonates (24 to 32 weeks of gestation 
age) and infants between 31 and 90 days of age as well as infants between 7 and 
12 months of age show the highest PU prevalence rates.  
The prevention of PUs in this patient group must start early to avoid any further 
harm to their highly vulnerable skin. Therefore these children need evidence 
based and appropriate preventive measures to decrease their PU risk. At least 
daily head-to-toe-skin assessment of neonates and infants at risk of PUs should 
be performed. Monitoring and regular repositioning of any monitoring sensors and 
 cables should be conducted as well. Under-padding, careful fixation and 
positioning of medical devices, especially ventilation support devices, in these 
highly vulnerable patients are mandatory to decrease the risk of pressure ulcers.  
6.5.1 Impact 
What is known about the topic: Neonates and infants are at high risk of pressure 
ulcer development. Appropriate and evidence based preventive measures need to 
be implemented for these vulnerable patients.  
What this paper adds: Category 1 pressure ulcers are a major nursing care issue 
in neonates and infants and require appropriate preventive measures to avoid any 
further harm to the vulnerable skin of these patients. Ventilation support devices 
increase the risk of PUs in neonates and infants most. Effective PU prevention 
with device related under-padding and careful positioning and fixation of such 
devices is mandatory. Special attention should be paid to the fact that 
repositioning the patient must be weighed against the stress that such an 
intervention can cause, especially in low- and very low-term neonates and critically 
ill infants. So far the ideal time interval for turning and repositioning patients in this 
age group is unknown.  
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 Abstract  
Objective: To assess pressure ulcer treatment in Swiss hospitalized pediatric 
patients and to determine whether there are differences in pressure ulcer 
treatment according to demographic characteristics of the patients.  
Design: A descriptive multicenter point prevalence study was conducted in June 
2009 in all German-speaking pediatric hospitals in Switzerland.  
Setting: All hospitalized patients from birth up to ≤17 years of age in fourteen 
Swiss pediatric hospitals, including all pediatric departments were assessed.  
Patients: A total of 412 patients participated in this study.  
Main Outcome Measures: The instrument and method of the Dutch National 
Prevalence Measurement of Care Problems was used.  
Main results: Thirty five percent of the patients had a pressure ulcer. Almost all of 
these PU’s (94.1%) were of category 1. The most severe pressure ulcers occurred 
in patients older than eight years of age. Age of the patient and department where 
the only characteristics, which significantly influenced the occurrence of pressure 
ulcers category 2 to 4. Pressure ulcers category 2 to 4 were mostly covered with 
hydrocolloid or polyurethane foam dressings. No pediatric specific guideline 
according pressure ulcer treatment is used in the involved hospitals.   
Conclusion: Most of all patients had pressure ulcers of category 1, so appropriate 
prevention to decrease any further trauma in these patients is necessary. Severe 
pressure ulcers (category 2-4) are mostly limited to older pediatric (over the age of 
eight years) patients with chronic condition or after surgery intervention. A 
pressure ulcer treatment guideline adapted for pediatric needs is recommended.  
  
 7.1 Introduction 
A pressure ulcer (PU) is a localized injury to the skin and/or underlying tissue as a 
result of pressure, or pressure in combination with shear forces (National Pressure 
Ulcer Advisory Panel (NPUAP)/ European Pressure Ulcer Advisory Panel 
(EPUAP), 2009). Although PUs have gained a great deal of attention in adults, far 
less is known about PUs in children and neonates (Baharestani and Ratliff, 2007). 
Recent investigations indicate that PUs are also common in hospitalized infants 
and children: reported PU prevalence rates in children including all PU categories 
range from approximately 3% to 35% in hospitals (Kottner, Wilborn, Dassen, 2010, 
Schlüer, Halfens, Schols, 2012). In some departments and pediatric care settings, 
such as neonate departments and Pediatric Intensive Care Units (PICU), the PU 
prevalence rate may rise to even 50% (Schlüer et al., 2012). While it is well known 
that the costs for PU treatment in adult patients are extensive (Xakelis and Frantz, 
1996, Anthony, Reynolds, Russell, 2004, Bennet, Dealy, Posnett, 2004, Allmann, 
Goode, Burst, Bartolucci, Thomas, 1999), only vague suggestions have mentioned 
that the costs for the pediatric population are comparable to those for adult 
patients (Pickersgill, 1997, Singh, Bartlett, Low, Kirschner, 2002, Butler, 2007, 
Gabriel et al., 2009).  
There are several guidelines for wound treatment in adult patients regarding both 
the treatment of PUs as well as wounds in general (Fan, Tang, Escandon, Kirsner, 
2011, Adams, Sabesan, Easley, 2012, Henzel, Bohie, Guihan, Ho, 2011, Warriner 
III and Carter, 2010, McGinnis and Stubbs, 2011, McInnes, Jammali-Blasi, Bell-
Syer, Dumville, Cullum, 2012). To our best knowledge no specific guideline for 
wound treatment in pediatric pressure ulcer wounds is available today.  
Epidemiological studies and empirical evidence state that the most common 
wound types in pediatric patients include epidermal stripping, extravasation 
injuries, surgical wounds, incontinence associated dermatitis, chemical and 
thermal injuries, wounds secondary to congenital abnormalities and pressure 
ulcers (Baharestani and Ratliff, 2007, Baharestani, 2007a). Wound care in 
pediatric patients needs to take account of several relevant differences between 
child and adult patients (Baharestani and Ratliff, 2007, Singh et al., 2002, Gabriel 
et al., 2009, Baharestani et al., 2009b, Stone McCord and Levy, 2006) which 
 render the management of acute and chronic wounds of various etiologies in the 
pediatric population a challenge (Baharestani et al., 2009b). Due to their small 
body sites, especially in newborns, neonates and infants, pediatric patients 
present difficulties for finding an appropriate wound treatment (Baharestani and 
Ratliff, 2007). The skin of infants, newborns and children is morphologically and 
functionally different from that of adults (Nikolovskis, Stamatas, Kollias, Wiegand, 
2008, Stamatas, Nikolovski, Luedtke, Kollias, Wiegand, 2010). Appropriate pain 
management, age-appropriate communications strategies according to wound 
treatment and early mobility and activity especially in infants and toddlers all add a 
greater aspect of complexity in wound care (Gabriel et al., 2009, Baharestani et 
al., 2009a). Small sized dressings that are easy to apply even to the small fingers 
and toes of very low term neonates with adequate adhesion, but which do not stick 
to the skin are for instance necessary to meet specific pediatric needs 
(Baharestani et al., 2009b). 
Only a few research publications about the treatment of pediatric PUs could be 
found. In the study of Cisler-Cahill (2006) a total of 48 wounds of all types were 
treated with amorphous hydrogel and healed without surgical intervention. PU 
related wounds were included, but no information on the number, severity or 
localization of the PUs, or on the explicit treatment and duration of a wound was 
given. In three case reports on forehead pressure necrosis wounds in neonates 
following continuous positive airway pressure (CPAP), these PUs were treated 
with hydrocolloids for an unknown time period. The PUs were not categorized but 
described as pressure necrosis. In all three cases a slight but visible scarring 
remained after an 18-month follow up period (Hoegeling, Fardin, Frieden, Wargon, 
2011). In a study of Stasikelis et al. (1999), out of 79 children with cerebral palsy 
undergoing osteotomies, 5 developed a PU (not categorized) after cast removal. 
The wound treatment was conducted with undefined local wound treatment 
without interfering with the planned rehabilitation program. All 5 PUs healed within 
2-8 weeks (Stasikelis et al., 1999).  
In a study on the surgical treatment of PUs, the successful technique of specific 
muscle flap operations in pediatric patients with ischial pressure ulcer category 
three and four is described (Ahluwalia, Martin, Mahoney, 2010). In another study 
the long-term outcome of surgical reconstruction of pediatric PUs is described 
 (Singh et al., 2002). In this study a total of 19 paraplegic patients between 9 and 
16 years of age with 20 PUs localized as sacral (n=7), ischial (n=9), trochanteric 
(n=3) and iliac crest (n=1) were treated surgically with myocutaneous flaps. The 
overall PU recurrence rate after treatment was 1 out of 20 (5%). The long-term 
follow up over a five year time period showed that the treatment was successful 
and provided long-term skin integrity (Singh et al., 2002).  
In three studies the use of negative pressure wound therapy (NPWT) for PU 
related pediatric wounds were studied (Gabriel et al., 2009, Baharestani et al., 
2009b, Baharestani 2007b). In the study of Bahasterani (2007b) three PUs were 
treated with NPWT, with a total closure of the wound in two and an 80% closing of 
the wound in one case. In the study of Gabriel et al. (2009) five patients all showed 
category 3 and 4 PUs (child 3 to 12 years of age n=2, adolescent 13 to 21 years of 
age n=3). After a 15 day NPWT treatment in these patients, two PUs were closed 
completely (40%) and three wounds needed further treatment. No further 
references to age or treatment are made (Gabriel et al., 2009). In the clinical 
review of Bahasterani et al. (2009a) the recommendation was made that NPWT 
should be used in PUs category 3 and 4.However, category 3 and 4 PUs were not 
further described in this study (Baharestani 2007a).  
Up to now, there has been a lack of knowledge and research to guide clinical 
practice in the field of PU treatment in pediatric patients (Baharestani et al., 2009a, 
Stone McCord and Levy, 2006, Butler, 2007, Cisler-Cahill, 2006).  
7.1.1 Study purpose 
Because of this lack of knowledge the following research questions were 
formulated for this study: 
(1) Which pediatric patients show severe PUs of category 2, 3 and 4 compared 
with patients at risk (patients with category 1 PU)? 
(2) What is the current PU treatment in Swiss pediatric hospitals? 
(3) Are there any differences in the treatment of severe PUs (category 2 to4) 
according to demographic characteristics of patients? 
 7.2 Methods 
In 2009 a multicenter, cross-sectional, point prevalence study was conducted in all 
14 pediatric hospitals in the German-speaking part of Switzerland on one day in 
June (Schlüer et al., 2012). These 14 hospitals had a total of 70 wards. All 
pediatric departments at the participating sites were included.  
7.2.1 Patients 
Children in all departments, including PICUs, neonatal intensive care units 
(NICUs), all surgical units, all pediatric medical units as well as the departments 
for pediatric rehabilitation care, were invited to participate if they met the inclusion 
criteria. Inclusion criteria were an age of 24 hours up to and including 17 years, 
and being hospitalized for at least one day in the respective institutions. Exclusion 
criteria were a) hospitalization in psychiatric units, b) children whose legal 
representatives did not allow participation, and c) children who refused to 
participate; this included no informed consent form from children 10 years and 
older as well as younger children who verbally refused to participation (Schlüer et 
al., 2012).  
7.2.2 Ethical approval  
The ethics board of each hospital and all cantonal ethics committees approved the 
study. All patients and their families were verbally informed about the study and 
also received the same information in written form. The information letter, as well 
as the informed consent form, was available in eight different languages. Children 
10 years of age and older were asked to give their own written consent; in other 
cases the parents or legal representatives were asked to do this (Schlüer et al., 
2012).  
  
 7.2.3 Measurements 
The instrument and method of data collection of the Dutch National Prevalence 
Measurement of Care Problems (LPZ) (Halfens et al., 2010) was used to assess 
the treatment of pressure ulcers. This instrument is widely used in Europe and 
elsewhere, and has been shown to be reliable and valid (Halfens et al., 2010). It 
collects among other things the following categories of data on patient level: (1) 
patient characteristics (demographic and clinical data), (2) assessment of the 
severity of pressure ulcers, as well as (3) prevention and treatment interventions. 
Furthermore a few questions were asked about the policy of the hospital and ward 
about PU, as if they have a guideline for PU.  
To differentiate risk factors for the development of more severe PUs (category 2 to 
4) patients with a PU category 1 were defined as patients at risk. This is in line 
with Bahasterani et al. (2009b) and with recommendations from pediatric specific 
PU research findings (Curley, Razmus, Roberts, Wypij, 2003) whereas PUs 
category one seem to be the most important risk factor for pediatric patients to 
develop severe PUs. 
The method of data collection related to PUs involved a direct and systematic 
inspection and judgment of the skin of the patient. The EPUAP (2009) pressure 
ulcer category system consisting of four categories was used (NPUAP/ EPUAP, 
2009). Demographic and clinical data, such as date of birth, weight and size, body 
mass index and diagnosis, were collected from the patient charts. The wound 
treatment applied was assessed by direct inspection as well as by analyzing the 
patients’ charts and wound documentation.  
7.2.4 Procedure 
Previously trained rater pairs gathered data from each patient. Each rater pair 
consisted of a health care worker who worked on the ward surveyed, and a health 
care worker who did not work on that ward. A total of 35 rater pairs were involved 
in the study. In all participating hospitals, nurses who worked either as wound 
consultants in their units or as clinical nurse specialists acted as raters. 
Preparatory training included methodological aspects, detailed information about 
 data collection, the role and responsibilities of the raters, a detailed introduction to 
the measurement instruments, and special training in the grading of a pressure 
ulcer.  
7.2.5 Data analysis 
Predictive Analytics Software (PASW) (version 18, formerly SPSS) was used to 
analyze the study data with descriptive methods. Distributions and frequencies 
were calculated and tested with the Chi square test (categorical data) and one 
Way-ANOVA.  
7.3 Results 
The overall sample size of potential study participants who met the inclusion 
criteria was 560. The total number of participants was 412 (74%) because 148 
(26%) dropped out before the assessment. In 67 cases (12%), either the parents 
or the child refused to participate. Sixty patients were excluded due to unexpected 
discharge or because examination or operations lasted longer than the survey 
(11%). Four patients were not assessed due to an unexpected change in their 
condition to a critical level. Five patients dropped out due to language problems of 
the parents, for 12 patients the reasons were unknown. 
7.3.1 Demographic characteristics 
As presented elsewhere (Schlüer et al., 2012), the participation rate in the 14 
clinics ranged from 6-97 patients (43-100%). The length of stay showed an 
average of 25 days and a median of 7 days. Of the 412 assessed patients, 67% 
(n= 275) had been hospitalized for less than 14 days. Patients with an oncology 
diagnosis, acute gastroenteritis, pneumonia or cardiology diagnosis represented 
the largest group with 33% (n=135) and were classified as pediatric medical 
department patients, followed by neonates (n=109, 27%), and patients in the 
surgery departments (including, plastic and burn surgery, visceral surgery, 
 neurosurgery and orthopedic and trauma patients) (n=99, 24%). The patient 
population in the PICU consisted of 36 children (9%). Furthermore, 33 patients 
(8%) were hospitalized for rehabilitation care (table 1). 
Eleven of the 14 hospitals (78%) had a guideline for PU treatment, but none 
specific for pediatrics, and19 wards of the 61 (31%) wards didn’t work according to 
a PU treatment guideline. Eight of the 14 hospitals (57%) organized in the last two 
years an extra training on prevention and treatment of PU but only based on the 
prevention and treatment of PUs of adult patients.  
Table 1: Demographic characteristics of the study sample 
  Mean Median SD n (%) 
Sex Female    181 (44) 
 Male    231 (56) 
Age (years)  4 1 5.4  
Age (months)  52 14 66.7  
Age group < 1 
year of age 
(weeks)  
 6 3 9 203 (49) 
Age category < 1 year    203 (49.3) 
 1-4    61 (14.8) 
 4-8    44 (10.7) 
 8-12    43 (10.4) 
 >12    61 (14.8) 
Duration of stay (days) related to divisions 
 Surgery 9.13 4 16.6 99 (24) 
 Pediatric medical 17 4.5 44.8 135 (33) 
 Rehabilitation 110.4 64 137.9 33 (8) 
 Neonatology 19.9 14 20.9 109 (27) 
 PICU 14.8 7 16.2 36 (9) 
7.3.2 Prevalence of PU 
Of the 412 patients taking part in this study, a total of 142 showed one or more 
pressure ulcers on the day of inquiry, which involved a PU prevalence rate of 35 
%. Of these 142 patients, 77 (54%) showed one, 35 (25%) two, 17 (12%) three, 6 
four (4%), 2 five (2%), 3 six (1%), 1 nine and one patient showed 10 pressure 
 ulcers. This resulted in a total number of 269 PUs. Almost all of these PU’s 
(94.1%)were of category 1, which we defined as at risk of PU (table 2).  
Table 2: Wound dressings used in the 142 patients with a total of 269 PUs categories 1 to 4 
Wound dressing Cat. 1 Cat. 2 Cat. 3 Cat. 4 n (%) 
No dressing 205 7   212 (78.8) 
Ointment 20    20 (7.3) 
Hydrocolloid 6 2   8 (3) 
Paraffin gauze dressing 3   1 4 (1.5) 
Polyurethane foam dressings 1 2 1  4 (1.5) 
Drying out /air dry 3    3 (1.2) 
Alginate 1  1  2 (0.7) 
Oil 1    1 (0.4) 
Dressing containing silver 1    1 (0.4) 
Film dressing 1    1 (0.4) 
Others 11  1 1* 13 (4.8) 
Totaln(%) 253(94) 11(4) 3(1) 2(1) 269(100) 
*Negative pressure wound therapy (NPWT) 
Age of the patient and the department where the patient was hospitalized were the 
only factors, which significantly influenced the occurrence of category 2 to 4 PUs 
in comparison to patients with category 1 PUs, whereas gender, body mass index, 
whether the hospital had a guideline according to PU prevention and/or treatment, 
or had an extra training, or worked according an PU guideline at the ward were not 
statistically significant. Patients in a pediatric medical department or a surgery 
department (χ2 = 12.005, P = 0.017), or who are older (over the age of eight 
years) showed more severe PUs (p = 0.000, F = 12.269).  
7.3.3 Treatment 
Tables 2 and 3 list the wound treatments/wound dressings applied in PUs 
according to category. In nearly 80% of all pressure ulcers belonging to category 1 
no dressings at all were used (n= 205). The use of ointment with a high level of 
lipid was common in 7% of category 1 PUs. Hydrocolloid dressings were used in 6 
patients (2.3%) as well as paraffin gauze dressings in 3 patients (1.2%). In more 
than half of all the pressure ulcer cases of category 2, no dressing was used (n=7, 
64%) (table 2). Category 3 and 4 PUs were treated with different dressings and 
 treatments, including the use of NPWT in one case (table 2). Of all possible wound 
dressings known, at the 14 clinics involved in the study, only ointment (7%) and 
hydrocolloid (3%) were used more frequently (table 2).  
‘Other dressings’ (5%) included all the different dressings that were used for 
pressure ulcer treatment. In category 1 PUs these included the use of a special 
biosynthetic skin substitute, the use of an antifungal solution and the use of 
creams brought by the family of the patient. The one category 3 PU (treatments 
score ‘other’) was disinfected and not covered, and the pressure ulcer rated as 
category 4 was treated with an NPWT (table 2). 
 
 
 Table 3: Differentiation of patients with category 2 to 4 PUs according to treatment and patient characteristics 
 Localization Length of time 
since PU 
occurrence 
Wound 
treatment 
Age of 
patient 
Division/ subdivision/ 
medical 
treatment/medical 
diagnosis 
Suspected cause 
for the PU 
development 
Duration of 
patient 
stay  
Further 
comments 
Category 2 
1 
+
 heel 2-4 weeks hydrocolloid 11 years Surgery/ Orthopedic, 
spinal cord, 
cast 99 days First description 
of PU after cast 
removal 
2 
+
 heel 2-4 weeks hydrocolloid 11 years Surgery/ Orthopedic, 
spinal cord, 
cast 99 days First description 
of PU after cast 
removal 
3 
*
 hip 2-4 weeks no 8 years Surgery/ Neuroorthopedic 
Cerebral palsy 
Post operative 15 days  
4 
*
 hip 2-4 weeks no  8 years Surgery/ Neuroorthopedic 
Cerebral palsy 
Post operative 15 days  
5 ° heel 3-6 months no 11 years Pediatric medical juvenile 
arthritis 
shoes 10 days  
6 ° heel 3-6 months no 11 years Pediatric medical juvenile 
arthritis 
shoes 10 days First occurrence 
of the PU at home 
7 hand < 2 weeks no 8 years Pediatric medical/ diabetes 
type I 
Splint of peripheral 
iv 
5 days  
8 heel < 2 weeks no 15 years Surgery/ orthopedic 
Cerebral palsy 
Positioning 
postoperative 
6 days  
9 
a
 heel 3-6 months Polyurethane 
foam 
16 years Pediatric medical/ 
oncology 
sarcoma 
positioning 1 day Decreased 
sensitivity, after 
tumor excision 
10 
a
 heel 3-6 months Polyurethane 
foam 
16 years Pediatric medical/ 
oncology 
sarcoma 
positioning 1 day Decreased 
sensitivity, after 
tumor excision 
 11 ear < 2 weeks no 5 days Neonate, 28 weeks of 
gestation 
CPAP mask 
fixation 
 5 days  
Category 3 
1 heel 3-6 months Alginate 17 years Surgery/ Orthopedic 
Femur-osteotomy 
cast 127 days PU development 
in another 
hospital 
2  sacrum 2-4 weeks Polyurethane 
foam 
8 years Surgery/ orthopedic 
Hip reconstruction 
Cerebral palsy 
cast 27 days  
3 
b
 Femur >1 year Other, 
disinfection and 
no cover 
17 years Surgery 
Cerebral palsy 
Chronic PU 
 141 days PU occurrence in 
home for 
handicapped 
Category 4 
1 heel < 2 weeks Paraffin gauze 
dressing 
9 years Surgery/ plastic 
reconstructive 
polytrauma 
 1 week First 5 days 
treatment at ICU 
2 
b
 sacrum >1 year Other, NPWT 17 years Surgery  
Cerebral palsy 
Chronic PU 
 141 days PU occurrence in 
home for 
handicapped 
+/ */ °/ a/ b: marks PUs of the same patient 
 
 7.4 Discussion 
This study was set out to survey the treatment for PUs in pediatric wards in 
German-speaking Switzerland. The results revealed a range of different 
treatments primarily related to differences in severity and location. In discussing 
the results a distinction will be made between category 1 and category 2 to 4 PUs. 
It seems reasonable that most of the category 1 PUs are not treated with a wound 
dressing, since in category 1 PUs the skin is still intact (NPUAP/ EPUAP, 2009). 
The nonuse of any dressing in category 1 PUs makes it possible to recognize any 
changes in these ulcers quickly and easily. In addition, it is very important to carry 
out appropriate preventive interventions in pediatric patients with a category 1 PU 
to avoid any further trauma to the skin (Baharestani and Ratliff, 2007). Regular risk 
assessment, daily skin assessment, repositioning and pressure relief are all 
components of effective PU prevention (Parnham, 2012). 
These preventive interventions need to be adapted to pediatric patients with 
regard to the varying needs in different age groups, e.g., neonates and infants, as 
well as in settings like the PICU (Parnham, 2012). 
With regard to the use of hydrocolloid and polyurethane foam dressings in 3% of 
all category 1PUs, this might also mainly have been done for preventive reasons 
to protect an affected or vulnerable skin area from further trauma (Butler, 2007, 
Quigley and Curley, 1996). One should be aware that hydrocolloid dressings for 
the prevention of PUs as well as for the protection of further trauma of PU sites are 
more common in daily practice with pediatric patients if devices like splints or 
tubes are used. No literature according to that practice is found, but to the 
knowledge of the authors this is often conducted in daily practice.  
The use of ointment (7%) as well as oil (n=1) in category 1 PUs might also be 
judged as a preventive intervention. However, the use of ointment, oil or antifungal 
solutions or creams brought by the family for patients with a category 1 PU is not 
in line with recommendations in the literature (Butler, 2007, Stone McCord and 
Levy, 2006, Baharestani, 2007b, Quigley and Curley, 1996, Lund, 1999). Such use 
 may of course be related to normal skin care but it is not clear whether this was 
the case here. Nevertheless, this finding needs critical reflection, especially in 
neonates and children below 5 years of age. Routine use of any ointments, oil, etc. 
is not recommended for skin care in pediatric patients of these ages, especially in 
children below the age of five years (Butler, 2007, Lund, 1999, Blume-Peytavi, 
Hauser, Stamatas, Pathirana, Garcia Bartels, 2012, Malloy and Perez-Woods, 
1991, Irving, 2001, Pasek et al., 2008). Therefore, this is an area for further 
research.  
The use of paraffin gauze, alginate and silver dressings for the treatment of 
category 1 PUs also calls for critical reflection. One may assume that there is no 
primary treatment indication for these dressings in category 1 PUs (which still 
imply intact skin) and what is more, that all these dressings need a second 
covering layer or dressing, thus making the PU invisible. This means that a 
category 1 PU cannot be assessed easily without changing or removing the 
dressings, and thus rendering children more sensitive. Finally, due to cost related 
factors, this strategy should not be advised either (Hollinworth, 2005, Meulemeire, 
2009). 
The use of any dressing in pediatric patients must rely on a clear goal for the 
intended treatment, with consideration of potential critical aspects like further harm 
or trauma. In addition, any dressing use in pediatric patients must protect the skin 
from further harm, like epidermal stripping (Butler, 2007, Baharestani 2007b, 
Meulemeire, 2009). 
Regarding the treatment of category 2 to 4 PUs, the use and type of dressings 
found in this study seem reasonable. The use of polyurethane foam dressings as 
well as of hydrocolloid dressings is in line with recommendations for the pediatric 
population (Butler, 2007, Baharestani 2007b, Meulemeire, 2009). Why 7 (64%) 
category 2 PUs, which were not covered with any dressing, we can only surmise. 
If these category 2 PUs involved blisters with still intact skin, then this strategy can 
be understood. Any change in the category 2 PU can be assessed easily then and 
unnecessary wound dressing changes can be avoided. Of course, appropriate 
preventive interventions to avoid further trauma of blisters is of great importance 
and yet, if the blister breaks, an appropriate dressing subsequently needs to be 
chosen (Meulemeire, 2009). 
 The use of alginate in a category 3 PU seems reasonable as well. Pediatric 
wounds classified for the use of an alginate dressing mostly show partial and full 
thickness skin loss (Stone McCord and Levy, 2006). The control of bleeding from a 
wound, using alginate has been studied in adult patients but not in children 
(Baharestani 2007a). In fact, the use of calcium alginate in neonates is not 
recommended due to the unknown absorption of calcium in these patients 
(Baharestani, 2007a). However, in this study the patient with alginate treatment of 
his category 3 PU was 17 years of age.  
NPWT for PU treatment is highly recommended in some studies in pediatric 
patients with, for example, PU wounds as well as acute and chronic wounds with 
partial and full thickness skin loss and considerable exudation (Baharestani, 
2007a, Gabriel et al., 2009, Baharestani et al., 2009a). The advantages of the use 
of NPWT in pediatric patients are well described in those studies. In the present 
study, NPWT was used in only one case of a category 4PU.  
As described in the literature (Singh et al., 2002, Gabriel et al., 2009, Baharestani, 
2007a, Stasikelis et al., 1999, El-Sabbagh, 2011), a comparatively high proportion 
of surgical patients, especially patients after orthopedic treatment or patients with 
cerebral palsy and spinal cord lesions showed category 3 and 4 PUs and were 
older than 8 years of age in this study. This leads to the assumption that especially 
older pediatric patients with chronic conditions may be affected by more severe 
PUs.  
On hospital as well as on ward level, in more than half of all institutions surveyed, 
a PU treatment guideline was available but none of these was adapted to the 
needs of pediatric patients.  
7.5 Limitations of this study and implications for further research 
Prevalence studies are always subject to daily variations when small samples are 
used. The results presented here include all pediatric hospitals, and therefore the 
overall prevalence rate as the treatment of the patients will give a good indication 
of the situation in Switzerland.  
 Data are gathered by nurses of the hospital itself, which could have given a bias. 
However for participants it was clear that this study was not used to evaluate their 
work, or their institution, so there were no positive or negative incentives to make 
the results positive or negative.  
This study shows that severe PUs occur especially in older pediatric patients (over 
the age of eight years) with chronicle condition and/or after surgical interventions. 
It is of great importance to assess these patients carefully for their risk of PU 
development and that health care professionals are aware of these high-risk 
patients. 
For pediatric patients no research based wound care guidelines are available and 
wound dressings are often not tested in different pediatric populations, such as 
neonates, infants and children. Only several earlier studies about NPWT use and 
surgical techniques in pediatric patients provide some research-based information 
about PU treatment in pediatric patients. As already noted, specific wound care 
guidance with regard to different age groups in pediatric patients is of great 
importance. Further research in this area is therefore crucial, as well as research 
to obtain more evidence for the different types of wound dressings in children with 
PUs. 
7.5.1 Conclusions and implications for clinical practice 
To our best knowledge for the first time data on the treatment of PUs in pediatric 
patients are presented. Most of the PUs in these hospitalized pediatric patients are 
category 1. Therefore appropriate preventive interventions to avoid any further 
trauma or worsening of these patients’ PUs are mandatory. Severe PUs of 
category 2, 3 and 4 are mostly limited to older pediatric (over the age of eight 
years) patients especially with chronic conditions or after surgical, especially 
orthopedic interventions.  
In addition, there is an explicit need for an evidence-based pediatric specific 
guideline about the treatment of PUs.  
It is a clinical challenge to use dressings, which are both appropriate to the goal 
that has to be achieved in wound healing as well as to specific pediatric needs. In 
 addition, the choice of a dressing in children with PUs should be balanced and well 
documented as well as regularly evaluated. Pediatric patients are not small adults, 
and this is also true for wound care.   
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 8 General discussion 
  
 8.1 General discussion and future directions 
The aims of this thesis were to obtain more information about the prevalence, risk 
factors and characteristics of pediatric patients with a pressure ulcer (PU), as well 
as information on risk assessment scales for the pediatric population. In addition, 
another aim was to address the prevention and treatment of pressure ulcers (PUs) 
in different pediatric patient populations.  
8.1.1 Main results 
This dissertation shows that the prevalence of PUs in pediatric patients is high. 
However pediatric patients are mainly affected by category 1 PUs. Severe PUs of 
category 2, 3 and 4 are limited to a few groups of pediatric patients, such as older 
children (over the age of 8 years) with chronic diseases and after orthopedic 
interventions.  
There is an overall PU prevalence rate of 35% for the total population in Swiss 
pediatric hospitals. Neonates and infants, especially those in critical life conditions 
who are hospitalized in a PICU or NICU setting are highly affected by category 1 
PUs, with a prevalence rate of 44% (NICU) and 46% (PICU), respectively. 
Hospitalized pediatric patients older than one year of age showed a PU 
prevalence rate of 26.5%.  
With regard to patient characteristics, children with a longer stay in hospital, very 
pre term neonates (24 to 32 weeks of gestation age) and infants between 31 and 
90 days of age as well as infants between 7 and 12 months of age show the 
highest PU prevalence rates. 
With regard to the localization of PUs in pediatric patients, the feet are the most 
common site, with 34% in children older than 1 year and 21% in neonates and 
infants. The nose is also a frequent localization in neonates and infants (16.2%), 
whereas the area around any medical devices (like, tubes, iv boards/splints) in 
pediatric patients older than 1 year (38.5%) is most frequent.  
 Ventilation support devices more than double the risk of PUs in neonates and 
infants treated in a PICU, whereas limited mobility and activity and external 
devices are relevant risk factors in children older than 1 year. 
Prevention of PUs starts with a risk assessment. Several PU risk assessment 
tools, mostly adapted from adult PU risk assessment are available for the pediatric 
setting. However, a systematic literature review revealed that no pediatric specific 
risk assessment tool can be recommended today. It is of great importance that risk 
assessment tools for the pediatric population should focus on specific pediatric risk 
factors like external devices, younger age (under the age of 5 years) and limited 
mobility.  
Effective PU preventive measures in pediatric patients need to focus on the 
specific risk factors as well as on the localizations of PUs, which differ from those 
seen in adult patients. The preventive measures include regular head to toe skin 
assessment, including extra attention to the specific localizations of PUs in 
pediatric patients, regular repositioning of the patients, application of specific 
preventive measures like under-padding of devices and the regular as well as 
careful check whether a younger child (< 5 years) is not lying on a device or other 
object which may cause pressure on the skin.  
With regard to category 1-4 PUs, a variety of wound care treatments are used in 
pediatric patients, with hydrocolloid dressings and ointments being used most 
frequently. No evidence based wound treatment guideline, meeting the unique 
needs of pediatric patients is available so far.  
8.1.2 Discussion of the main results with reliance to the literature 
8.1.3 Prevalence of PUs 
The rather high prevalence of PUs in children makes it a relevant care problem for 
this target population. The overall prevalence figure of 35% is higher than figures 
already reported in the literature, which varied from 3% (Dixon and Ratliff, 2005, 
McLane et al., 2004) to 28% (Kottner et al., 2010).  
 Pediatric patients hospitalized in the PICU setting were most often affected by a 
PU (44%). This is in line with a prior study of Escher-Neidig et al. (1989), which 
assessed a PU prevalence of 40% in PICU patients after heart surgery. The 
prevalence rate in neonates and infants was 45.5%. Prevalence rates for neonates 
and infants appear to vary between 26% (McLane et al., 2004) and 61.5% 
(Groeneveld et al., 2004).  
Most pediatric patients are affected by a category 1 PU and severe PUs are 
limited to older pediatric patients. Most category 1 PUs are reversible (Kottner 
2011). Several authors have therefore recommended defining pressure ulcer 
prevalence by starting the category system at category 2 (Halfens et al., 2001, 
Defloor 1999), and to consider a category 1 PU as the most important risk factor 
for developing a higher category of PUs (Defloor 1999, Noonan et al. 2011, 
Coleman et al., 2013). Following this line of reasoning would implicate that many 
pediatric patients are in fact at high risk.  
Yet, the overall prevalence rate of category 2 and higher was only 3%. This is 
lower than the prevalence of severe pressure ulcers in the study of Suddaby et al. 
2003 and Groeneveld et al. 2004 (both 5.1%) and also lower than the PU 
prevalence in the pilot study of Schlüer et al. (2009) (4.5%) (Chapter 2). This 
means that the progression to a higher category PU in fact seems to occur rather 
infrequently.  
Nevertheless the diagnosis of a category 1 PU requires appropriate preventive 
intervention. 
8.1.4 Risk factors, localizations of PU, characteristics of patients showing a PU 
and risk assessment tools for the pediatric population 
The studies in this thesis have shown that the risk factors and the anatomical 
localizations of PUs, as well as the risk of PUs due to external devices, differ from 
those in an adult population.  
Medical devices on the skin are the predominant risk factor for PU occurrence in 
pediatric patients. This finding is in line with prior studies (Willock et al., 2005, 
Escher-Neidig et a., 1989, Waterlow, 1997, Curley et al., 2003), where external 
 devices were also the major risk factor in pediatric patients. With regard to 
neonates and infants, in whom mechanical ventilation support devices have shown 
to be the major risk factor, this was also reported in the studies of Schindler et al. 
(2007), Curley et al. (2003) and Boesch et al. (2012).  
Younger age can also be considered as major PU risk factor in pediatric patients. 
In our studies neonates born at 24 to 31 weeks of gestation age, as well as 
neonates 1 to 7 days old and infants older than 7 months were mostly affected by 
PUs (Chapter 6). Pediatric patients of under the age of 2 years are also described 
as a risk group in the studies of Curley et al., (2003), Schindler et al., (2007); 
McCord et al., (2004), and Escher-Neidig et al., (1989). Due to their developmental 
status, young pediatric patients (under the age of five years) are, unable to 
differentiate pressure from other sensory perceptions of such devices properly and 
therefore are most vulnerable. 
In pediatric patients older than 1 year PU risk assessment was carried out using 
the Braden scale (Schlüer et al., 2012, Schlüer et al., 2013b). Nutrition and activity 
were the subcategories, which were limited most in patients showing a PU. This 
had not been established in previous studies. With regard to activity, it seems 
logical that pediatric patients, who cannot actively change their position, are at risk 
for PU development. Nutrition is also known as a relevant factor with regard to skin 
integrity (Rodriguez-Key, 2007) in pediatric patients. No clinical trials investigating 
the influence of malnutrition in pediatric patients with regard to PU occurrence 
could be found. With regard to the fact that there is not a single risk factor, which 
can explain a PU risk in adult patients (Coleman et al., 2013), this seems also true 
for pediatric patients.  
Regarding the localization of PUs, the feet and nose were the most commonly 
affected areas in pediatric patients. The feet, especially ankles or heels and toes, 
were also frequently affected areas in the study of Curley and colleagues (2003), 
as were the occiput and ear. A possible explanation for this is that in neonates and 
infants monitoring devices like oxygenation sensors and IV catheters are fixed to 
the feet of the child (Schlüer et al., 2009; Schlüer et al., 2012). PUs in the area of 
the nose are often caused by a nasogastric feeding tube, ventilation tube or by a 
CPAP mask with prongs (Schlüer et al., 2013c).  
 Based on our systematic review we conclude that there is little evidence about the 
performance of PU risk assessment scales in pediatric practice (Kottner et al., 
2013). On the basis of these sparse results and according to the findings of 
Anthony et al. (2010). Whether the application of PU risk scales makes any 
difference to PU occurrence in pediatric patients is unknown as well.  
With regard to the risk factors established in this thesis, medical devices, 
especially mechanical ventilation support devices, a PICU stay, younger age and 
limited nutrition and activity were the major risk factors. In the development of risk 
assessment tools for the pediatric population, the risk factor “devices on the skin” 
has only become part of such scales since 1998 (Kottner et al, 2013). PICU stay 
and younger age as risk factors are not part of a pediatric risk assessment scale. 
We can conclude that the use of risk assessment scales in pediatric health care 
should focus specifically on external medical devices and on limited mobility and 
activity. Risk assessment scales for adults are not precise enough to cover all 
relevant pediatric risk factors. According to our findings, and in line with clinical 
expertise in the field of PU development in children, it is more reliable to focus on 
different pediatric risk populations, and also to assess device related factors 
contributing to the development of PUs.  
8.1.5 Prevention 
Preventive measures targeting medical devices are most frequently performed in 
pediatric patients to decrease the risk of PU occurrence (Schlüer et al., 2013c). 
This is in line with the fact that these devices are THE major risk factor for PU 
occurrence in pediatric patients and that pediatric patients treated in PICUs are a 
high-risk group. 
To the best of our knowledge no study assessing preventive measures to 
decrease PU risk and prevalence in the pediatric population is available today.  
Total skin assessment, repositioning and skin care were conducted frequently as 
preventive measures in our studies (Schlüer et al., 2013c). With regard to different 
skin condition in different age groups, like the immature skin of neonates 
(especially preterm neonates), regular head to toe skin assessment and 
 appropriate skin care seem important as preventive measures to decrease PU risk 
in pediatric patients.  
The use of pressure related surfaces is not very common in pediatric patients.  
Devices especially adapted to pediatric needs, like small sizes for lower weight, 
are not widely available (Parnham, 2012, Law, 2002).  
Finally, no guidelines for effective PU preventive measures with special attention 
to the pediatric population and their unique risk factors in terms of PU occurrence 
are available so far. 
8.1.6 Treatment 
Data on the treatment of PUs in pediatric patients are presented in chapter seven. 
Severe PUs of category 2, 3 and 4 were mostly limited to older (over the age of 
eight years) pediatric patients, especially those with chronic conditions or after 
surgical interventions, especially orthopedic surgery.  
Only a few research publications on the treatment of pediatric PUs could be found 
(Cisler-Cahill, 2006; Hoegeling et al, 2011). The use of any dressing in pediatric 
patients must rely on a clear goal for the intended treatment, with consideration of 
potential critical aspects like further harm or trauma. It remains a clinical challenge 
to use dressings which are both appropriate to the goal that has to be achieved in 
wound healing as well as to the specific pediatric needs, such as the different skin 
condition in different age categories, small body sites and active patients 
(Baharestani and Ratliff, 2007).  
8.2 Methodological aspects 
The methodological aspects of each study are discussed in the respective 
chapters. In general, the cross sectional design must be regarded as a limitation. 
Consequently, no causal relationships can be established related to PU 
 development. This is important insofar as most of the PUs were assumed to 
develop due to external devices.  
Yet, besides this overall limitation, the strengths of this thesis are connected with 
the careful planning of how the studies were conducted in all hospitals, the training 
of the raters by the principal investigator at all study sites and the careful and 
intense recruitment of the pediatric patients and their parents. The participation 
rate varied from sufficient (43%) to excellent (100%) and thus may be considered 
to reflect the population of pediatric patients in the German speaking part of 
Switzerland. The results are transferable to pediatric patients treated in hospitals 
with comparable standards of care and they establish the importance of PU 
prevention in daily pediatric care. 
8.2.1 The study sample 
The study sample involved all hospitalized children meeting the inclusion criteria 
on the day of the respective study measurements. All pediatric departments at the 
participating sites were included, involving children from departments like PICU, 
NICU, all surgical disciplines, all pediatric medical disciplines as well as the 
departments for pediatric rehabilitation care.  
About 70% of all participating patients were under the age of five years and 50% 
were younger than one year. This is representative for the population of pediatric 
patients in Switzerland (Kind & Spital, 2011).  
The recruitment of the study participants was mostly performed on the day prior to 
when the study was carried out by trained nurses, who also acted as raters. Study 
participation varied between 43% and 100% in the hospitals. Most drop-outs were 
due to parents/legal guardian and/or or children themselves refusing to participate 
(12%). The participation rate in the PICU and NICU setting as well as in the 
neonatology departments was over 80%. It can therefore be assumed that the 
information procedure by the nurses was adequate enough for the parents to 
decide on the participation of their child in the study. The information letter as well 
as the informed consent form for parents was available in eight different languages 
 (German, French, Italian, English, Portuguese, Albanian, Serbian, Turkish). The 
drop-out rate due to language problems was only 0.5%.  
8.2.2 Clinical research with children as participants 
Clinical research with children as participants involves several challenges and 
needs to protect the right of children of all ages as well as their right to 
independent decision-making (Knox and Burkhart, 2007, American Academy of 
Paediatrics (AAP), 1995). Informed consent must be obtained from the parent or 
guardian and also from the child who is able to read and understand an adapted 
version of the study information provided. In Switzerland this is defined as children 
older than 10 years of age (Schubiger et al., 2009). The recruitment of preterm 
neonates is even more challenging, due to the unexpected birth of a preterm 
neonate and due to the possibility that the baby needs special medical attention, 
because of a critical life condition after birth, and that the mother is not available 
for an information and informed consent (Pickler and Martin, 2010). To what extent 
this was a limitation in the study presented in chapter six remains unclear.   
8.2.3 Measurements tool 
To assess the prevalence, severity, as well as predisposing factors of pressure 
ulcers and to explore the prevention and treatment of PUs, the instrument and 
methodology of data collection of the Dutch National Prevalence Measurement 
Care Problems (LPZ) (Halfens et al., 2010) were used in this study. This 
instrument is widely used in Europe and has been shown to be reliable and valid. 
In addition to the original instrument, we also assessed all installations on the 
patient’s body at the time of the assessment (e.g. tubes, IV catheterizations, 
continuous positive airways pressure (CPAP), splints). This was done, based on 
the findings of our earlier pilot study (Chapter 2) (Schlüer et al., 2009).  
 8.3 Implications for future research  
When researching PU related factors in the pediatric population our studies have 
revealed that (Schlüer et al., 2009, chapter 2, Schlüer et al., 2012, chapter 3) it is 
of great importance to use an adapted overall measurement tool (risk factors, 
preventive measures, prevalence and treatment) addressing the specific 
characteristics and needs of the pediatric population (Baharestani and Ratliff, 
2007, Baharestani, 2007).  
Therefore, based on the results and experiences of our studies, an adapted 
pediatric version of the LPZ PU measurement tool has been developed that will be 
tested for the first time in Switzerland in November 2013, when a nationwide 
pressure ulcer prevalence measurement will be conducted in all pediatric hospitals 
(Nationaler Verein zur Qualitätssicherung in Spitälern und Kliniken (ANQ) and 
Berner Fachhochschule (BFH), 2013).  
Furthermore there is a need for more longitudinal research in this population to 
determine when, why and within which settings pediatric patients most often 
develop PUs. Future studies are also necessary to guide a trajectory towards an 
adapted and truly pediatric patient-oriented PU prevention and treatment. This will 
require adequately randomized controlled trials on the effect and process of 
tailored preventive interventions, including the use of appropriate risk assessment 
scales, and also on relevant PU treatment modalities, among which studies on the 
effect of different types of wound dressings. 
8.4 Implications for clinical practice 
Pediatric patients are vulnerable to PU development. It is vital that pediatric nurses 
are trained to recognize the early stages of pressure ulcers. Category 1 PUs are a 
major nursing care issue in neonates and infants, and require appropriate 
preventive measures to avoid any further harm to the vulnerable skin. Ventilation 
support devices greatly increase the risk of PUs in neonates and infants. Effective 
PU prevention includes device related under-padding and careful positioning and 
 fixation of such devices. At least daily head-to-toe-skin assessment of neonates 
and infants at risk of PUs should be performed. Monitoring and regular 
repositioning of any monitoring sensors and cables should be conducted as well. 
Special attention should be paid to the fact that repositioning of the pediatric 
patient must be weighed against the stress that such an intervention can cause, 
especially in low- and very low-term neonates and critically ill infants.  
This thesis shows that the risk factors, the anatomical localities of PUs as well as 
the risk of PUs due to external devices differ from those in an adult population. 
Therefore, specialized preventive interventions based on the specific needs of the 
pediatric population are mandatory, including a careful assessment of younger 
patients (under the age of five years) with regard to their inability to distinguish and 
sense pressure on the skin adequately.  
Based on the systematic review of pediatric pressure ulcer risk assessment tools, 
no instrument can be regarded yet as superior to others. According to our findings, 
it is important to focus on different risk populations, such as children hospitalized 
in a PICU and very low term neonates.  
Regarding the treatment of already present PUs, it remains a clinical challenge to 
use dressings which are both appropriate to the goal to be achieved in wound 
healing as well as to specific pediatric needs (e.g. being easy to apply and fitting 
small body sites like fingers and toes even in low term neonates). In addition, the 
choice of a dressing in children with PUs should be balanced and well 
documented as well as regularly evaluated. 
Finally, there is an explicit need for evidence based pediatric specific guidelines on 
the prevention and treatment of PUs.  
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 9 Summary 
Pressure ulcers are a common and highly relevant nursing care problem in 
hospitals. They are associated with psychological and physical suffering, 
increased morbidity and mortality rates and higher costs for health care worldwide. 
Pressure ulcer development can be attributed to multiple factors that are fairly 
well-studied in adults and elderly people. While the problem of pressure ulcers in 
adults has received a great deal of attention, far less is known about pressure 
ulcers in children and neonates. With regard to pediatric care settings, some 
challenges remain. The overall health status of hospitalized children is generally 
better and multi-morbidity is limited to a small percentage of patients, such as very 
low term neonates (born before 32 weeks of gestation age), newborns with 
congenital abnormalities and children with chronic conditions. Survival rates of 
both critically and chronically ill neonates, infants and children have improved 
dramatically in recent years. This fact introduces new challenges for medical and 
nursing care for these patients.  
Children’s skin undergoes several changes throughout the first 18 years of life. 
Within the first days of life neonates undergo various adaptation processes 
needed to accommodate to the transition from the wet intrauterine environment to 
the dry outside environment. During the first months and years the skin continues 
to develop and evolve its structure and functions. It is known that any skin 
breakdown, especially in critically ill neonates and infants, increases the risk of 
septicemia as well as related severe complications and higher mortality. Pressure 
ulcers also cause an increase in pain, infection and calorie expenditure in pediatric 
patients, and therefore it is of great importance to avoid any damage to the fragile 
skin of pediatric patients.  
With regard to pressure ulcer risk factors in pediatric patients, immobility and 
decreased skin sensitivity are known. Sick children in general and - due to their 
limited communication skills - neonates, infants and toddlers, disabled and 
neurologically impaired children in particular, seem to be at high risk of developing 
pressure ulcers. Despite the known risk factors, a reliable and valid pressure ulcer 
risk assessment tool with validated cut-off points, applicable to a wide range of the 
juvenile population from neonates to adolescents, is not available.  
 Pressure ulcer prevention is multifaceted and requires skills, knowledge and 
consistency in nursing practice. Risk assessment, skin assessment, repositioning 
and pressure relief are integral components of effective prevention of pressure 
ulcers in children. The preventive measures taken for children are often those 
recommended for adult patients. However, several authors have highlighted the 
importance of specific age-related preventive strategies. Preventive measures 
should meet the individual needs of each child, and special attention must be paid 
to neonates and infants. The same is true when it comes to pressure ulcer 
treatment. No specific guideline for wound treatment of pediatric pressure ulcer 
wounds is available today.  
There is a considerable lack of knowledge with regard to the problem of pressure 
ulcers in pediatric patients. This thesis, entitled “Pressure ulcers in pediatric 
patients: a challenge!” presents different aspects of the problem of pressure ulcers 
in pediatric patients.  
The introduction in Chapter one presents the scope of the topic. It first provides 
insight into the topic of pressure ulcers and highlights the unique needs of 
pediatric patients of all ages with regard to this issue.  
Chapter two presents the results of the first pilot study on pressure ulcer 
prevalence in four Swiss pediatric hospitals. This study reveals a high prevalence 
rate of 27.7%. The prevalence of pressure ulcers category 2 and higher accounts 
for only 4.5%. Although not all pressure ulcers are preventable, the high 
prevalence rates indicate a need to improve preventive actions as well as risk 
assessment and to start raising staff’s awareness of the pressure ulcer issue in the 
pediatric health care setting. This study marks an important first step in 
recognizing the relevance of the pressure ulcer issue in the pediatric health care 
setting.  
In Chapter three the results of a multicenter point prevalence pressure ulcer study 
conducted in all pediatric hospitals of the German speaking part of Switzerland are 
described. The study reveals a very high pressure ulcer prevalence rate of 35% in 
the 14 Swiss pediatric hospitals. However the prevalence rate of category 2 and 
higher is only 3%. Especially the age of the patients, the Braden risk score for 
pressure ulcer development as well as the institution in which the patients were 
 hospitalized appear to be related to the development of pressure ulcers. The most 
frequently affected patient group in this study involved very young patients in the 
Pediatric Intensive Care Unit setting showing mostly category 1 pressure ulcers. 
The pressure ulcer prevalence of nearly 45% in this patient group and the figure of 
60% being at risk is disconcerting and needs special attention. Patients in the 
Neonatal Intensive Care Unit setting also show an overall prevalence of nearly 
45%. Children treated in a Neonatal Intensive Care Unit or/and Pediatric Intensive 
Care Unit care setting are mostly vulnerable due to several factors like the 
immaturity of the skin in very young neonates and newborns and also because of 
anatomical, physiological and immunological differences. In general these children 
are in a critical clinical condition and often undergo lifesaving treatments. If one 
takes into consideration that in these patients often many external medical devices 
are applied which might affect the skin, the high vulnerability to getting a pressure 
ulcer seems feasible. In view of this and the findings presented in this study, the 
question arises whether in the pediatric population a prevalence rate for children 
with and without external medical devices like tubes and fixation devices might be 
an important marker. Further, it highlights the importance of evidence based 
pressure ulcer prevention in these patients.  
Chapter four presents a systematic review in which the validation and clinical 
impact of pressure ulcer risk assessment tools used in pediatric care settings is 
explored. Over the last five decades more than 30 standardized pressure ulcer risk 
scales for adults have been developed, tested and modified. A total of 12 pediatric 
specific risk assessment tools were identified. Many of them are modifications of 
pressure ulcer risk scales for adults and contain variables deemed especially 
important for pressure ulcer development in the adult population, e.g. continence, 
moisture, nutrition. “Mobility” was part of every scale. Assessing the degree of 
mobility to determine pressure ulcer risk in children seems reasonable, because 
the relation between mobility and pressure ulcer development is well established. 
On the other hand, it should be noted that there are only a few studies 
investigating specific factors for pressure ulcer development in the pediatric 
population. Although long known to be a problem in infants and children, the risk 
factor “devices on the skin” has only been considered in the newer scales since 
1998. The degree of validation of these risk assessment tools is poor. Five studies 
provided evidence about interrater reliability and the agreement of four 
 instruments. Besides the discussed validity and reliability aspects, the question 
arises if it is feasible to develop a pressure ulcer risk scale covering all the 
necessary aspects of the whole pediatric population. Considering the immaturity 
as well as the anatomical, physiological and immunological differences and 
vulnerability of this population’s skin and tissues, especially during the neonatal 
period, it is clear that pressure ulcer risk profiles vary across the different age 
groups.  
Chapter five focuses on certain risk factors and prevalence among hospitalized 
pediatric patients over one year of age. In this study hospitalized pediatric patients 
older than one year showed a pressure ulcer prevalence rate of 26.5%. These 
patients present with several factors that may lead to the development of a 
pressure ulcer. First of all the presence of medical devices seems to be a 
particular risk factor in all age categories. Second, in these patients limited activity 
and mobility appeared to be particular risk factors as well. The most affected 
anatomical region for the development of a pressure ulcer was the lower extremity 
especially the foot. Older patients over the age of 12 years showed slightly more 
frequent pressure ulcers (32%) than children under the age of eight years. 
Patients hospitalized in the Pediatric Intensive Care Unit setting were most often 
affected by a pressure ulcer (40%). 
Most of the pressure ulcers assessed in this study developed due to external 
devices (38.5%). Young pediatric patients (under the age of five years) are, due to 
their developmental status, unable to differentiate pressure from other sensory 
perceptions of such devices properly and are therefore mostly vulnerable. 
Equipment-related risk factors, e.g. those connected with traction, tubes and IV 
catheterization, are therefore additional potential pressure ulcer risk factors in the 
pediatric health care setting. This is also in line with the fact that the most frequent 
localization of a pressure ulcer was the lower extremities, especially the feet 
(40%). The reason for this might be the fact that the majority of pressure ulcers 
were developed because of splints/iv boards or cables and sensors, as well as IV 
catheterization used at this anatomic site.  
In Chapter six the prevalence, risk factors and preventive measures in 
hospitalized neonates and infants in all 14 hospitals of the German speaking part 
of Switzerland are presented. In this study the pressure ulcer prevalence rate 
 (categories 1-4) in neonates and infants was high, with an overall prevalence of 
45.5%; yet the pressure ulcer prevalence rate for more severe pressure ulcers 
(categories 2-4) was low, at 0.5%. Ventilation support devices such as Continuous 
Positive Airways Pressure or mechanical ventilation increased the risk of pressure 
ulcers more than twofold. Total skin assessment (66.5%), repositioning (68.1%) 
and skin care (50%) were conducted most frequently as preventive measures. In 
the literature it is suggested that a category 1 pressure ulcer can serve as an 
indication of being at risk for a category 2 to 4 pressure ulcers. When a category 1 
pressure ulcer occurs, preventive measures are necessary. In our study only one 
infant developed a pressure ulcer higher than category 1, which makes it 
questionable whether a category 1 pressure ulcer is a good indication of additional 
risk in this population. According to the localization of the pressure ulcers, the feet 
and nose were the most commonly affected areas in this study sample. Regarding 
the feet, especially the ankles, heels and toes, were frequently affected areas and 
regarding the head, next to the nose also the occiput and ear. A possible 
explanation for this is that in neonates and infants monitoring devices like 
oxygenation sensors and IV catheters are fixed to the feet of the child, and 
therefore this localization can also be affected by medical device related pressure 
ulcers. Pressure ulcers in the area of the nose are often caused by a nasogastric 
feeding tube, ventilation tube or by a Continuous Positive Airways Pressure mask 
with Prongs. It is therefore of great importance to pay special attention to the 
careful application of ventilation support devices, and to the careful fixation and 
regular repositioning of any devices in neonates and infants in order to decrease 
the pressure ulcer risk.  
In Chapter seven pediatric specific topics with regard to pressure ulcer wound 
treatment are highlighted. The results revealed a range of different treatments 
primarily related to differences in severity and location. Most of the category 1 
pressure ulcers are not treated with a wound dressing, since in category 1 
pressure ulcers the skin is still intact. The nonuse of any dressing in category 1 
pressure ulcers makes it possible to recognize any changes in these ulcers quickly 
and easily. In addition, it is very important to carry out appropriate preventive 
interventions in pediatric patients with a category 1 pressure ulcer to avoid any 
further trauma to the skin. The use of any dressing in pediatric patients with higher 
categories of pressure ulcers must rely on a clear goal for the intended treatment. 
 In addition, any dressing use in pediatric patients must protect the skin from further 
harm, like epidermal stripping.  
In Chapter eight the main findings of all studies conducted are presented. The 
core of this chapter encompasses the general discussion of the study results as 
well as their consequences for clinical practice and further research in this field. 
Furthermore it highlights methodological aspects, including the ethical topic of 
clinical research in which children are participants.  
Pediatric patients of all ages are beyond doubt at risk of developing a pressure 
ulcer. Evidence based guidelines for effective pressure ulcer prevention and 
treatment in pediatric patients are mandatory, taking into account their unique 
needs. Health care staff has to be aware of pediatric specific risk factors for 
pressure ulcer development, like the application of external devices. In addition, 
adequate preventive and treatment measures have to be taken and monitored 
regularly.  
 Samenvatting  
Decubitus is een algemeen voorkomend en uiterst relevant verpleegkundig 
probleem in ziekenhuizen. Het wordt geassocieerd met psychisch en fysiek lijden, 
een grotere morbiditeit, hogere mortaliteitscijfers en wereldwijd hogere uitgaven 
voor gezondheidszorg. Het ontstaan van decubitus kan worden toegeschreven 
aan meerdere factoren die zowel bij volwassenen als ouderen redelijk goed zijn 
onderzocht. Echter, terwijl het probleem van decubitus bij volwassenen veel 
aandacht heeft gekregen, is beduidend minder bekend over decubitus bij kinderen 
en pasgeborenen. Wat betreft de pediatrische zorg resten er derhalve nog wel 
enige uitdagingen. De algehele gezondheid van gehospitaliseerde kinderen is in 
het algemeen goed, maar de multi-morbiditeit is beperkt tot een klein percentage 
van de patiënten, zoals zeer vroeg geborenen (vroeger dan 32 weken in de 
zwangerschapsperiode), pasgeborenen met congenitale afwijkingen en kinderen 
met chronische aandoeningen. De overlevingscijfers van zowel kritieke als 
chronisch zieke pasgeborenen, zuigelingen en kinderen zijn de laatste jaren sterk 
toegenomen. Dit brengt echter nieuwe uitdagingen met zich mee bij de medische 
en verpleegkundige zorg voor deze patiënten.  
De kinderhuid ondergaat meerdere veranderingen gedurende de eerste 18 
levensjaren. De eerste levensdagen maken pasgeborenen verschillende 
processen door om zich aan te passen aan de overgang van de vochtige intra-
uterine naar de droge omgeving daarbuiten. Gedurende de eerste maanden blijft 
de huid zich vervolgens qua structuur en functies ontwikkelen. Het is bekend dat 
elk huidprobleem, vooral bij pasgeborenen en zuigelingen in kritieke toestand, het 
risico op sepsis, bijkomende ernstige complicaties en een hogere mortaliteit kan 
vergroten. Ook decubitus veroorzaakt pijn, infecties en hoger calorieverbruik bij 
pediatrische patiënten en derhalve is het van groot belang om enigerlei 
beschadiging van de fragiele huid bij deze patiënten te voorkomen.  
Wat betreft de risicofactoren van decubitus bij pediatrische patiënten zijn 
immobiliteit en verminderde sensitiviteit van de huid goed bekend. Zieke kinderen 
in het algemeen en pasgeborenen, zuigelingen, peuters alsmede (neurologisch) 
gehandicapten in het bijzonder, lijken door hun beperkte 
 communicatievaardigheden een grote kans op het ontwikkelen van decubitus te 
hebben.  
Echter, ondanks de bekende risicofactoren is een betrouwbaar en geldig 
decubitus-risico assessment instrument met vastgestelde grenswaarden, dat 
toepasbaar is bij jongeren, variërend van pasgeborenen tot adolescenten, niet 
beschikbaar.  
Decubituspreventie heeft vele facetten en vereist vaardigheid en kennis bij de 
verpleging. Een goede risicoanalyse, regelmatige inspectie van de huid, 
wisselligging en verminderen van druk zijn ook onderdelen van decubituspreventie 
bij kinderen. Deze preventieve maatregelen die bij kinderen worden genomen, zijn 
vaak dezelfde als die welke worden aanbevolen bij volwassen patiënten. 
Verschillende auteurs hebben ook het belang van specifieke, leeftijdsgerelateerde 
preventiestrategieën belicht. Preventieve maatregelen dienen daarbij tegemoet te 
komen aan de individuele behoeften van elk kind en bijzondere aandacht moet 
uitgaan naar pasgeborenen en zuigelingen. Hetzelfde geldt voor de behandeling 
van decubitus. Er is momenteel nog geen specifieke richtlijn voor de 
decubitusbehandeling bij kinderen.  
Er bestaat ook nog een groot gebrek aan kennis over decubitus bij pediatrische 
patiënten. Dit proefschrift, getiteld “Decubitus bij pediatrische patiënten: een 
uitdaging!” toont verschillende aspecten van het decubitusprobleem bij 
pediatrische patiënten.  
De inleiding in Hoofdstuk 1 beschrijft het onderzoeksterrein. Inzicht wordt 
geboden in het onderwerp decubitus en in de unieke behoeften van pediatrische 
patiënten van alle leeftijden met betrekking tot dit zorgprobleem.  
Hoofdstuk 2 presenteert de resultaten van het eerste vooronderzoek over de 
prevalentie van decubitus in vier Zwitserse pediatrische ziekenhuizen. Deze studie 
laat een hoge prevalentiegraad van 27,7% zien. De prevalentie van 
decubituswonden categorie 2 en hoger is echter slechts 4,5%. Ofschoon niet alle 
decubitus valt te voorkomen, is het prevalentiecijfer van 27,5% toch een 
aanwijzing voor het feit dat de decubituspreventie beter kan. Deze begint met de 
bewustmaking bij het personeel in de pediatrische verpleging. Deze studie 
 markeert ook een eerste belangrijke stap in de erkenning van het belang van het 
onderwerp decubitus in de pediatrische verpleegkunde.  
In Hoofdstuk 3 worden de resultaten van een multicenter prevalentiestudie 
getoond, die in alle pediatrische ziekenhuizen van het Duitstalige deel van 
Zwitserland is uitgevoerd. De studie laat een zeer hoge decubitus-
prevalentiegraad van 35% in de veertien deelnemende Zwitserse pediatrische 
ziekenhuizen zien. De prevalentie van decubitus categorie 2 en hoger is opnieuw 
laag met 3%. De leeftijd van de pediatrische patiënten, de Braden risicoscorelijst 
voor het ontwikkelen van decubitus en de instelling waar de patiënten zijn 
opgenomen lijken met name gerelateerd te zijn aan het ontwikkelen van 
decubitus. De meest getroffen patiëntengroep in deze studie betrof de zeer jonge 
patiënten in pediatrische intensive care units, die overigens overwegend 
decubituswonden categorie 1 vertoonden. De prevalentie van decubitus van bijna 
45% in deze patiëntengroep alsmede het percentage van 60% dat een risico op 
decubitus heeft is verontrustend en vraagt om extra aandacht. Onder patiënten in 
neonatale intensive care units is de decubitusprevalentie ook bijna 45%. Kinderen 
die worden behandeld in neonatale en/of pediatrische intensive care units zijn 
inderdaad bijzonder kwetsbaar door verschillende factoren, zoals de immaturiteit 
van hun huid en andere anatomische, fysiologische en immunologische 
verschillen. Bovendien verkeren deze kinderen vaak in een kritieke klinische 
toestand en zijn niet zelden levensreddende behandelingen aangewezen. Als men 
dan in ogenschouw neemt dat bij deze patiënten vaak veel externe medische 
hulpmiddelen en apparatuur wordt toegepast, waarmee zij via draden, slangen 
etc. verbonden zijn, die vanwege hun directe fixatie aan de huid tot huidletsel 
kunnen leiden, is de grote kwetsbaarheid voor het krijgen van decubitus plausibel. 
Door dit aspect en de resultaten van deze studie rijst de vraag of we specifiek bij 
de pediatrische populatie moeten kijken naar de decubitusprevalentie bij kinderen 
met en zonder externe medische hulpmiddelen met gebruik van, draden, slangen 
en andere fixatiemiddelen. Verder benadrukt een en ander het belang van 
doelgerichte decubitus-preventie bij deze patiënten.  
Hoofdstuk 4 beschrijft een review over de validatie en klinische invloed van 
decubitusrisicoscorelijsten in de pediatrische zorg. Gedurende de laatste vijf 
decennia zijn meer dan 30 gestandaardiseerde risicoschalen voor decubitus bij 
 volwassenen ontwikkeld, getest en aangepast. In totaal zijn er 12 specifieke 
pediatrische risicoscorelijsten vastgesteld. Vele hiervan zijn modificaties van 
decubitusrisicoscorelijsten voor volwassenen en bevatten variabelen die vooral 
van belang zijn bij de ontwikkeling van decubitus bij volwassenen, bijvoorbeeld 
incontinentie, vochtigheid en voeding. Het item “mobiliteit” maakt deel uit van elke 
schaal. Het vaststellen van de mate van mobiliteit om de kans op decubitus bij 
kinderen te meten, lijkt overigens redelijk, omdat de relatie tussen mobiliteit en het 
ontwikkelen van decubitus algemeen aanvaard is.   Aan de andere kant moet 
worden opgemerkt dat er slechts enkele studies bestaan die de specifieke 
factoren voor het ontwikkelen van decubitus bij kinderen onderzoeken. Ofschoon 
het een bekend probleem bij zuigelingen en kinderen is, wordt de risicofactor 
“medisch materiaal dat contact maakt met de huid” slechts in de nieuwere schalen 
vanaf 1998 meegenomen. De mate van validatie van deze risicoscorelijsten is nog 
gering. Vijf studies toonden de inter-rater betrouwbaarheid en overeenstemming 
bij vier instrumenten aan. Naast de besproken validiteits- en 
betrouwbaarheidsaspecten doet zich ook de vraag voor of het haalbaar is om een 
decubitusrisicoschaal te ontwikkelen die alle daartoe benodigde aspecten van de 
gehele pediatrische populatie omvat. Gezien de immaturiteit, de anatomische, 
fysiologische en immunologische verschillen en ook de kwetsbaarheid van de huid 
en de weefsels bij deze populatie tijdens met name de neonatale periode, is het 
duidelijk dat decubitusrisicoprofielen voor de verschillende leeftijdsgroepen 
pediatrische patiënten uiteenlopen.   
Hoofdstuk 5 is gericht op de risicofactoren en de prevalentie van decubitus bij 
gehospitaliseerde pediatrische patiënten ouder dan één jaar. In deze studie 
vertoonden gehospitaliseerde pediatrische patiënten boven één jaar een 
decubitus-prevalentie van 26,5%. Bij deze patiënten zijn er verschillende factoren 
die tot de ontwikkeling van decubitus kunnen leiden. Allereerst lijkt de 
aanwezigheid van medische hulpmiddelen opnieuw een bijzondere risicofactor te 
zijn. Ten tweede blijken bij deze patiënten de beperkte activiteit en mobiliteit 
eveneens relevante risicofactoren te zijn. De meest aangedane anatomische zone 
waren de lagere extremiteiten, in het bijzonder de voet. Patiënten ouder dan 12 
jaar vertoonden iets vaker decubitus (32%) dan kinderen onder de acht jaar. 
Patiënten die gehospitaliseerd waren in pediatrische intensive care units hadden 
het meest te maken met decubitus (40%). 
 De vastgestelde decubitus had zich overwegend door externe invloeden 
ontwikkeld (38,5%). Jonge pediatrische patiënten (onder de vijf jaar) zijn door hun 
ontwikkelingsstatus niet goed in staat om druk van andere sensorische 
waarnemingen te onderscheiden en daardoor extra kwetsbaar. Hulpmiddel-
gerelateerde risicofactoren, waaronder tractie, gebruik van slangen en IV-
katheterisatie, zijn zodoende extra potentiële risicofactoren voor decubitus in de 
pediatrische zorg voor deze groep. Dit sluit ook aan bij het feit dat de meest 
voorkomende locatie van decubitus de lagere extremiteiten zijn, in het bijzonder 
de voeten (40%). De meerderheid van de decubitus-gevallen deed zich voor door 
splints/IV-boards of snoeren en sensoren, evenals IV-katheterisatie die op deze 
anatomische plaats worden toegepast.   
In Hoofdstuk 6 worden de prevalentie van decubitus en de gerelateerde 
risicofactoren en preventieve maatregelen bij gehospitaliseerde pasgeborenen en 
zuigelingen gepresenteerd van alle 14 ziekenhuizen van het Duitssprekende deel 
van Zwitserland. In deze studie was de decubitusprevalentie (categorie 1-4) bij 
pasgeborenen en zuigelingen hoog, met een gemiddelde prevalentie van 45,5%. 
Niettemin was de prevalentie van de ernstigere vormen van decubitus (categorie 
2-4) laag met 0,5%. Beademingsapparatuur zoals Continuous Positive Airways 
Pressure (CPAP) apparatuur of mechanische beademing verdubbelden het risico 
op decubitus ruim. Regelmatige huidinspectie (66,5%), wisselligging (68,1%) en 
huidverzorging (50%) werden het vaakst uitgevoerd als preventieve maatregelen. 
In de literatuur wordt gesuggereerd dat categorie 1 decubitus een indicator kan 
zijn voor het risico op een categorie 2 tot 4 decubitus. Als zich een categorie 1 
decubitus voordoet, zijn preventieve maatregelen derhalve noodzakelijk. In onze 
studie ontwikkelde echter slechts één zuigeling een decubitus hoger dan categorie 
1, hetgeen het twijfelachtig maakt of een categorie 1 decubitus een goede 
indicator is van een extra risico bij deze populatie. Ten aanzien van de lokalisatie 
van decubitus bleken de voeten en neus de meest aangedane lichaamsdelen. Wat 
de voeten betreft waren vooral enkels of hielen en tenen vaak aangedaan; wat 
betreft het hoofd vooral, naast de neus vooral ook het achterhoofd en oor. Een 
mogelijke verklaring is dat bij pasgeborenen en zuigelingen allerlei 
bewakingsapparatuur zoals oxygenatie-sensoren en IV-catheters aan de voeten 
worden bevestigd. Het is dus  van groot belang om bijzondere aandacht te 
besteden aan de zorgvuldige toepassing van beademing ondersteunende 
 apparaten alsmede te zorgen voor een voorzichtige fixatie en het regelmatig 
repositioneren van hulpmiddelen bij pasgeborenen en zuigelingen teneinde de 
kans op decubitus te verkleinen.  
In Hoofdstuk 7 worden specifieke pediatrische aspecten belicht inzake de 
behandeling van decubituswonden. De resultaten laten een reeks verschillende 
behandelingen zien, vooral gerelateerd aan de ernst of de locatie van de 
decubitus. Categorie 1 decubitus wordt meestal niet behandeld met een 
wondverband, omdat in categorie 1 decubitus de huid nog intact is. Het 
achterwege laten van een verband bij een categorie 1 decubitus maakt het goed 
mogelijk om verdere veranderingen in de huid snel en makkelijk te herkennen. 
Daarnaast is het uiterst belangrijk om bij deze wonden passende preventieve 
maatregelen te nemen om verder trauma van de huid te vermijden. Het gebruik 
van wondverbanden bij pediatrische patiënten met hogere decubitus-categorieën 
hangt af van het gespecificeerde doel bij de voorgenomen behandeling. Tevens 
moet het gebruik van een wondverband bij pediatrische patiënten de huid 
beschermen tegen verdere verwonding.  
In Hoofdstuk 8 worden de voornaamste resultaten van alle uitgevoerde studies 
gepresenteerd. De kern van dit hoofdstuk omvat de algemene bespreking van de 
studieresultaten evenals hun consequenties voor klinische toepassing en verder 
(veld) onderzoek. Tevens belicht het hoofdstuk de methodologische aspecten 
inclusief het ethische vraagstuk van klinisch onderzoek waarin kinderen 
participeren.  
Duidelijk is geworden dat pediatrische patiënten van alle leeftijden een risico lopen 
om decubitus te ontwikkelen. Goede richtlijnen voor effectieve decubituspreventie 
en behandeling bij pediatrische patiënten zijn nodig, gezien hun unieke behoeften. 
Verpleegkundig personeel dient zich bewust te zijn van de pediatrisch-specifieke  
risicofactoren voor de ontwikkeling van decubitus, waaronder met name het 
gebruik van externe hulpmiddelen. Daarnaast moeten uiteraard relevante en 
kindvriendelijke preventieve en curatieve maatregelen genomen worden met 
secundaire monitoring van hun effect.  
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